WO2011140316A1 - Consumer products with protease variants - Google Patents
Consumer products with protease variants Download PDFInfo
- Publication number
- WO2011140316A1 WO2011140316A1 PCT/US2011/035319 US2011035319W WO2011140316A1 WO 2011140316 A1 WO2011140316 A1 WO 2011140316A1 US 2011035319 W US2011035319 W US 2011035319W WO 2011140316 A1 WO2011140316 A1 WO 2011140316A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- mutations
- composition
- amino acid
- protease
- protease variant
- Prior art date
Links
- 108091005804 Peptidases Proteins 0.000 title claims abstract description 282
- 239000004365 Protease Substances 0.000 title claims abstract description 280
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 title 1
- 102000035195 Peptidases Human genes 0.000 claims abstract description 281
- 102000004190 Enzymes Human genes 0.000 claims abstract description 100
- 108090000790 Enzymes Proteins 0.000 claims abstract description 100
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 84
- 229910001868 water Inorganic materials 0.000 claims abstract description 83
- 238000004140 cleaning Methods 0.000 claims abstract description 68
- 238000000034 method Methods 0.000 claims abstract description 57
- 241000193422 Bacillus lentus Species 0.000 claims abstract description 29
- 238000006467 substitution reaction Methods 0.000 claims abstract description 26
- 239000000203 mixture Substances 0.000 claims description 277
- 102220473477 E3 ubiquitin-protein ligase RAG1_H249R_mutation Human genes 0.000 claims description 218
- 125000003275 alpha amino acid group Chemical group 0.000 claims description 155
- 230000035772 mutation Effects 0.000 claims description 143
- 239000003599 detergent Substances 0.000 claims description 132
- 102220225954 rs1064795276 Human genes 0.000 claims description 115
- 229940088598 enzyme Drugs 0.000 claims description 97
- -1 alkali metal salts Chemical class 0.000 claims description 63
- 239000000463 material Substances 0.000 claims description 60
- 108090000787 Subtilisin Proteins 0.000 claims description 56
- 239000004744 fabric Substances 0.000 claims description 56
- 238000010998 test method Methods 0.000 claims description 49
- 239000004094 surface-active agent Substances 0.000 claims description 48
- 239000003795 chemical substances by application Substances 0.000 claims description 47
- 239000000975 dye Substances 0.000 claims description 47
- 239000007844 bleaching agent Substances 0.000 claims description 45
- 229920000642 polymer Polymers 0.000 claims description 32
- 102220465972 Cilium assembly protein DZIP1_S24R_mutation Human genes 0.000 claims description 29
- 239000010457 zeolite Substances 0.000 claims description 29
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 claims description 28
- 102200135148 rs1555306304 Human genes 0.000 claims description 28
- 239000003054 catalyst Substances 0.000 claims description 26
- 101000642797 Bacillus amyloliquefaciens Subtilisin BPN' Proteins 0.000 claims description 25
- 239000002304 perfume Substances 0.000 claims description 25
- 150000003839 salts Chemical class 0.000 claims description 24
- 102200025035 rs786203989 Human genes 0.000 claims description 23
- 102220642080 Lipoma-preferred partner_N43R_mutation Human genes 0.000 claims description 22
- 102220352322 c.232A>C Human genes 0.000 claims description 21
- 238000010936 aqueous wash Methods 0.000 claims description 19
- 102200104664 rs121908724 Human genes 0.000 claims description 19
- 108010084185 Cellulases Proteins 0.000 claims description 18
- 102000005575 Cellulases Human genes 0.000 claims description 18
- 229910019142 PO4 Inorganic materials 0.000 claims description 18
- 235000021317 phosphate Nutrition 0.000 claims description 18
- 102220286163 rs781670952 Human genes 0.000 claims description 18
- 108090001060 Lipase Proteins 0.000 claims description 17
- 102000004882 Lipase Human genes 0.000 claims description 17
- 239000002253 acid Substances 0.000 claims description 17
- 229910052720 vanadium Inorganic materials 0.000 claims description 17
- 239000004367 Lipase Substances 0.000 claims description 16
- 235000019421 lipase Nutrition 0.000 claims description 16
- 102200118206 rs33936967 Human genes 0.000 claims description 16
- 102200091604 rs863225072 Human genes 0.000 claims description 16
- 102220575769 4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase 9_N62Q_mutation Human genes 0.000 claims description 15
- JXLHNMVSKXFWAO-UHFFFAOYSA-N azane;7-fluoro-2,1,3-benzoxadiazole-4-sulfonic acid Chemical compound N.OS(=O)(=O)C1=CC=C(F)C2=NON=C12 JXLHNMVSKXFWAO-UHFFFAOYSA-N 0.000 claims description 15
- 102200152683 rs45479896 Human genes 0.000 claims description 15
- 239000002689 soil Substances 0.000 claims description 15
- 239000012190 activator Substances 0.000 claims description 14
- 230000001580 bacterial effect Effects 0.000 claims description 13
- 239000004115 Sodium Silicate Substances 0.000 claims description 12
- 102200082937 rs33945546 Human genes 0.000 claims description 12
- 150000004760 silicates Chemical class 0.000 claims description 12
- 229910052911 sodium silicate Inorganic materials 0.000 claims description 12
- 102220589215 DNA repair protein XRCC2_A16S_mutation Human genes 0.000 claims description 11
- 102220579616 SUN domain-containing protein 5_Q59A_mutation Human genes 0.000 claims description 11
- 150000001412 amines Chemical class 0.000 claims description 11
- 229920002678 cellulose Polymers 0.000 claims description 11
- 239000001913 cellulose Substances 0.000 claims description 11
- 102220083084 rs863224616 Human genes 0.000 claims description 11
- NTHWMYGWWRZVTN-UHFFFAOYSA-N sodium silicate Chemical compound [Na+].[Na+].[O-][Si]([O-])=O NTHWMYGWWRZVTN-UHFFFAOYSA-N 0.000 claims description 11
- 102220527632 Basigin_V26F_mutation Human genes 0.000 claims description 10
- 102220610345 Spectrin alpha chain, erythrocytic 1_R45T_mutation Human genes 0.000 claims description 10
- 102220419264 c.223C>T Human genes 0.000 claims description 10
- 102220348394 c.266A>G Human genes 0.000 claims description 10
- 102220330036 rs1555864368 Human genes 0.000 claims description 10
- 102200118280 rs33918343 Human genes 0.000 claims description 10
- 102200082933 rs33968721 Human genes 0.000 claims description 10
- 102200082939 rs33972975 Human genes 0.000 claims description 10
- 102220042823 rs35942089 Human genes 0.000 claims description 10
- 102220040531 rs587778361 Human genes 0.000 claims description 10
- 229910052723 transition metal Inorganic materials 0.000 claims description 10
- 102220504672 Activin receptor type-1B_L75A_mutation Human genes 0.000 claims description 9
- 102220491135 Putative postmeiotic segregation increased 2-like protein 1_N43A_mutation Human genes 0.000 claims description 9
- 230000002209 hydrophobic effect Effects 0.000 claims description 9
- 239000002736 nonionic surfactant Substances 0.000 claims description 9
- 102220202129 rs1057521108 Human genes 0.000 claims description 9
- 102220065718 rs747893076 Human genes 0.000 claims description 9
- 102200083228 rs964335184 Human genes 0.000 claims description 9
- 150000003624 transition metals Chemical class 0.000 claims description 9
- 102220485938 Probable ATP-dependent RNA helicase DHX34_K94R_mutation Human genes 0.000 claims description 8
- 102220315634 rs1196125127 Human genes 0.000 claims description 8
- DBVJJBKOTRCVKF-UHFFFAOYSA-N Etidronic acid Chemical compound OP(=O)(O)C(O)(C)P(O)(O)=O DBVJJBKOTRCVKF-UHFFFAOYSA-N 0.000 claims description 7
- QPCDCPDFJACHGM-UHFFFAOYSA-N N,N-bis{2-[bis(carboxymethyl)amino]ethyl}glycine Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(=O)O)CCN(CC(O)=O)CC(O)=O QPCDCPDFJACHGM-UHFFFAOYSA-N 0.000 claims description 7
- 108090000637 alpha-Amylases Proteins 0.000 claims description 7
- 229920001577 copolymer Polymers 0.000 claims description 7
- DUYCTCQXNHFCSJ-UHFFFAOYSA-N dtpmp Chemical compound OP(=O)(O)CN(CP(O)(O)=O)CCN(CP(O)(=O)O)CCN(CP(O)(O)=O)CP(O)(O)=O DUYCTCQXNHFCSJ-UHFFFAOYSA-N 0.000 claims description 7
- 229960003330 pentetic acid Drugs 0.000 claims description 7
- VKZRWSNIWNFCIQ-WDSKDSINSA-N (2s)-2-[2-[[(1s)-1,2-dicarboxyethyl]amino]ethylamino]butanedioic acid Chemical compound OC(=O)C[C@@H](C(O)=O)NCCN[C@H](C(O)=O)CC(O)=O VKZRWSNIWNFCIQ-WDSKDSINSA-N 0.000 claims description 6
- 125000000129 anionic group Chemical group 0.000 claims description 6
- 239000002775 capsule Substances 0.000 claims description 6
- 125000002091 cationic group Chemical group 0.000 claims description 6
- 150000001768 cations Chemical class 0.000 claims description 6
- 239000013522 chelant Substances 0.000 claims description 6
- 238000010521 absorption reaction Methods 0.000 claims description 5
- 102000004139 alpha-Amylases Human genes 0.000 claims description 5
- 150000007942 carboxylates Chemical class 0.000 claims description 5
- 229920001519 homopolymer Polymers 0.000 claims description 5
- 239000003446 ligand Substances 0.000 claims description 5
- 239000003094 microcapsule Substances 0.000 claims description 5
- 229920000058 polyacrylate Polymers 0.000 claims description 5
- 159000000000 sodium salts Chemical class 0.000 claims description 5
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 claims description 5
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 claims description 4
- 229910052783 alkali metal Inorganic materials 0.000 claims description 4
- 230000015572 biosynthetic process Effects 0.000 claims description 4
- 125000004122 cyclic group Chemical group 0.000 claims description 4
- 229920000831 ionic polymer Polymers 0.000 claims description 4
- 150000002576 ketones Chemical class 0.000 claims description 4
- MWNQXXOSWHCCOZ-UHFFFAOYSA-L sodium;oxido carbonate Chemical compound [Na+].[O-]OC([O-])=O MWNQXXOSWHCCOZ-UHFFFAOYSA-L 0.000 claims description 4
- LKHDXIBHVSGUHN-UHFFFAOYSA-N thiadiazole 1,1-dioxide Chemical class O=S1(=O)C=CN=N1 LKHDXIBHVSGUHN-UHFFFAOYSA-N 0.000 claims description 4
- GZFRVDZZXXKIGR-UHFFFAOYSA-N 2-decanoyloxybenzoic acid Chemical compound CCCCCCCCCC(=O)OC1=CC=CC=C1C(O)=O GZFRVDZZXXKIGR-UHFFFAOYSA-N 0.000 claims description 3
- 239000004111 Potassium silicate Substances 0.000 claims description 3
- 229920013820 alkyl cellulose Polymers 0.000 claims description 3
- 125000004181 carboxyalkyl group Chemical group 0.000 claims description 3
- 229960004585 etidronic acid Drugs 0.000 claims description 3
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 claims description 3
- 150000004682 monohydrates Chemical class 0.000 claims description 3
- 125000005342 perphosphate group Chemical group 0.000 claims description 3
- JRKICGRDRMAZLK-UHFFFAOYSA-L persulfate group Chemical group S(=O)(=O)([O-])OOS(=O)(=O)[O-] JRKICGRDRMAZLK-UHFFFAOYSA-L 0.000 claims description 3
- KROGEBGRISJYMV-UHFFFAOYSA-N phenyl 3,5,5-trimethylhexanoate Chemical compound CC(C)(C)CC(C)CC(=O)OC1=CC=CC=C1 KROGEBGRISJYMV-UHFFFAOYSA-N 0.000 claims description 3
- SIENSFABYFDZCL-UHFFFAOYSA-N phenyl decanoate Chemical compound CCCCCCCCCC(=O)OC1=CC=CC=C1 SIENSFABYFDZCL-UHFFFAOYSA-N 0.000 claims description 3
- ZPORCTAUIXXZAI-UHFFFAOYSA-N phenyl dodecanoate Chemical compound CCCCCCCCCCCC(=O)OC1=CC=CC=C1 ZPORCTAUIXXZAI-UHFFFAOYSA-N 0.000 claims description 3
- NNHHDJVEYQHLHG-UHFFFAOYSA-N potassium silicate Chemical compound [K+].[K+].[O-][Si]([O-])=O NNHHDJVEYQHLHG-UHFFFAOYSA-N 0.000 claims description 3
- 229910052913 potassium silicate Inorganic materials 0.000 claims description 3
- 235000019353 potassium silicate Nutrition 0.000 claims description 3
- 229920005604 random copolymer Polymers 0.000 claims description 3
- 150000004685 tetrahydrates Chemical class 0.000 claims description 3
- 102200023993 rs121908537 Human genes 0.000 claims 10
- FRPJTGXMTIIFIT-UHFFFAOYSA-N tetraacetylethylenediamine Chemical compound CC(=O)C(N)(C(C)=O)C(N)(C(C)=O)C(C)=O FRPJTGXMTIIFIT-UHFFFAOYSA-N 0.000 claims 2
- 238000001035 drying Methods 0.000 claims 1
- 125000002467 phosphate group Chemical class [H]OP(=O)(O[H])O[*] 0.000 claims 1
- 150000001413 amino acids Chemical class 0.000 abstract description 20
- 238000012217 deletion Methods 0.000 abstract description 11
- 230000037430 deletion Effects 0.000 abstract description 11
- 238000003780 insertion Methods 0.000 abstract description 9
- 230000037431 insertion Effects 0.000 abstract description 9
- 230000008569 process Effects 0.000 abstract description 9
- 239000000047 product Substances 0.000 description 108
- 235000001014 amino acid Nutrition 0.000 description 71
- 229910052717 sulfur Inorganic materials 0.000 description 42
- 238000003556 assay Methods 0.000 description 37
- 108090000623 proteins and genes Proteins 0.000 description 36
- 238000005406 washing Methods 0.000 description 35
- HNPSIPDUKPIQMN-UHFFFAOYSA-N dioxosilane;oxo(oxoalumanyloxy)alumane Chemical compound O=[Si]=O.O=[Al]O[Al]=O HNPSIPDUKPIQMN-UHFFFAOYSA-N 0.000 description 29
- 125000000217 alkyl group Chemical group 0.000 description 28
- 229910021536 Zeolite Inorganic materials 0.000 description 27
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 27
- 150000007523 nucleic acids Chemical class 0.000 description 26
- 230000002441 reversible effect Effects 0.000 description 26
- 239000000243 solution Substances 0.000 description 26
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 24
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 21
- 102000004169 proteins and genes Human genes 0.000 description 21
- 229910021653 sulphate ion Inorganic materials 0.000 description 21
- 108010056079 Subtilisins Proteins 0.000 description 20
- 102000005158 Subtilisins Human genes 0.000 description 20
- 230000000694 effects Effects 0.000 description 20
- 102000004157 Hydrolases Human genes 0.000 description 19
- 108090000604 Hydrolases Proteins 0.000 description 19
- 239000011575 calcium Substances 0.000 description 19
- 125000003147 glycosyl group Chemical group 0.000 description 19
- 239000013612 plasmid Substances 0.000 description 19
- 235000018102 proteins Nutrition 0.000 description 19
- 235000014469 Bacillus subtilis Nutrition 0.000 description 18
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 18
- 239000011734 sodium Substances 0.000 description 18
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 16
- 239000000872 buffer Substances 0.000 description 16
- 239000012634 fragment Substances 0.000 description 16
- 239000007788 liquid Substances 0.000 description 16
- 102000039446 nucleic acids Human genes 0.000 description 16
- 108020004707 nucleic acids Proteins 0.000 description 16
- 239000010452 phosphate Substances 0.000 description 16
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 16
- 108020004414 DNA Proteins 0.000 description 15
- 239000002609 medium Substances 0.000 description 15
- 238000002703 mutagenesis Methods 0.000 description 15
- 231100000350 mutagenesis Toxicity 0.000 description 15
- 150000004965 peroxy acids Chemical class 0.000 description 15
- 102220327453 rs1555509645 Human genes 0.000 description 15
- 229910052708 sodium Inorganic materials 0.000 description 15
- 241000193744 Bacillus amyloliquefaciens Species 0.000 description 14
- 239000007983 Tris buffer Substances 0.000 description 14
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 14
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 13
- 238000006243 chemical reaction Methods 0.000 description 13
- 241000193830 Bacillus <bacterium> Species 0.000 description 12
- 101000740449 Bacillus subtilis (strain 168) Biotin/lipoyl attachment protein Proteins 0.000 description 12
- 108010059892 Cellulase Proteins 0.000 description 12
- 108091028043 Nucleic acid sequence Proteins 0.000 description 12
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 12
- 238000004422 calculation algorithm Methods 0.000 description 12
- 238000010276 construction Methods 0.000 description 12
- 239000004615 ingredient Substances 0.000 description 12
- 108090000765 processed proteins & peptides Proteins 0.000 description 12
- 229910000029 sodium carbonate Inorganic materials 0.000 description 12
- 235000017550 sodium carbonate Nutrition 0.000 description 12
- 102000012479 Serine Proteases Human genes 0.000 description 11
- 108010022999 Serine Proteases Proteins 0.000 description 11
- 125000004432 carbon atom Chemical group C* 0.000 description 11
- 229940106157 cellulase Drugs 0.000 description 11
- 230000002797 proteolythic effect Effects 0.000 description 11
- 239000002904 solvent Substances 0.000 description 11
- 238000011282 treatment Methods 0.000 description 11
- YNJBWRMUSHSURL-UHFFFAOYSA-N trichloroacetic acid Chemical compound OC(=O)C(Cl)(Cl)Cl YNJBWRMUSHSURL-UHFFFAOYSA-N 0.000 description 11
- 239000002738 chelating agent Substances 0.000 description 10
- 238000004851 dishwashing Methods 0.000 description 10
- MHOFGBJTSNWTDT-UHFFFAOYSA-M 2-[n-ethyl-4-[(6-methoxy-3-methyl-1,3-benzothiazol-3-ium-2-yl)diazenyl]anilino]ethanol;methyl sulfate Chemical compound COS([O-])(=O)=O.C1=CC(N(CCO)CC)=CC=C1N=NC1=[N+](C)C2=CC=C(OC)C=C2S1 MHOFGBJTSNWTDT-UHFFFAOYSA-M 0.000 description 9
- 108010065511 Amylases Proteins 0.000 description 9
- 102000013142 Amylases Human genes 0.000 description 9
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 9
- 238000002835 absorbance Methods 0.000 description 9
- 125000000539 amino acid group Chemical group 0.000 description 9
- 235000019418 amylase Nutrition 0.000 description 9
- 229920002689 polyvinyl acetate Polymers 0.000 description 9
- 239000011118 polyvinyl acetate Substances 0.000 description 9
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 8
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 8
- 108010076504 Protein Sorting Signals Proteins 0.000 description 8
- 150000004996 alkyl benzenes Chemical class 0.000 description 8
- 150000005323 carbonate salts Chemical class 0.000 description 8
- 230000003197 catalytic effect Effects 0.000 description 8
- 239000004927 clay Substances 0.000 description 8
- VUJGKADZTYCLIL-YHPRVSEPSA-L disodium;5-[(4-anilino-6-morpholin-4-yl-1,3,5-triazin-2-yl)amino]-2-[(e)-2-[4-[(4-anilino-6-morpholin-4-yl-1,3,5-triazin-2-yl)amino]-2-sulfonatophenyl]ethenyl]benzenesulfonate Chemical compound [Na+].[Na+].C=1C=C(\C=C\C=2C(=CC(NC=3N=C(N=C(NC=4C=CC=CC=4)N=3)N3CCOCC3)=CC=2)S([O-])(=O)=O)C(S(=O)(=O)[O-])=CC=1NC(N=C(N=1)N2CCOCC2)=NC=1NC1=CC=CC=C1 VUJGKADZTYCLIL-YHPRVSEPSA-L 0.000 description 8
- 239000002270 dispersing agent Substances 0.000 description 8
- 239000013613 expression plasmid Substances 0.000 description 8
- 230000002401 inhibitory effect Effects 0.000 description 8
- DNIAPMSPPWPWGF-UHFFFAOYSA-N monopropylene glycol Natural products CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 8
- 231100000219 mutagenic Toxicity 0.000 description 8
- 230000003505 mutagenic effect Effects 0.000 description 8
- 125000003729 nucleotide group Chemical group 0.000 description 8
- 229920001184 polypeptide Chemical group 0.000 description 8
- 102000004196 processed proteins & peptides Human genes 0.000 description 8
- 238000012546 transfer Methods 0.000 description 8
- VRVDFJOCCWSFLI-UHFFFAOYSA-K trisodium 3-[[4-[(6-anilino-1-hydroxy-3-sulfonatonaphthalen-2-yl)diazenyl]-5-methoxy-2-methylphenyl]diazenyl]naphthalene-1,5-disulfonate Chemical compound [Na+].[Na+].[Na+].COc1cc(N=Nc2cc(c3cccc(c3c2)S([O-])(=O)=O)S([O-])(=O)=O)c(C)cc1N=Nc1c(O)c2ccc(Nc3ccccc3)cc2cc1S([O-])(=O)=O VRVDFJOCCWSFLI-UHFFFAOYSA-K 0.000 description 8
- BGRWYDHXPHLNKA-UHFFFAOYSA-N Tetraacetylethylenediamine Chemical compound CC(=O)N(C(C)=O)CCN(C(C)=O)C(C)=O BGRWYDHXPHLNKA-UHFFFAOYSA-N 0.000 description 7
- 230000008901 benefit Effects 0.000 description 7
- 239000001768 carboxy methyl cellulose Substances 0.000 description 7
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 7
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 7
- 229940105329 carboxymethylcellulose Drugs 0.000 description 7
- 239000011162 core material Substances 0.000 description 7
- 229920000578 graft copolymer Polymers 0.000 description 7
- 229910052751 metal Inorganic materials 0.000 description 7
- 239000002184 metal Substances 0.000 description 7
- 239000002773 nucleotide Substances 0.000 description 7
- UIIMBOGNXHQVGW-UHFFFAOYSA-M sodium bicarbonate Substances [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 7
- 235000019832 sodium triphosphate Nutrition 0.000 description 7
- 239000011550 stock solution Substances 0.000 description 7
- LKDMKWNDBAVNQZ-WJNSRDFLSA-N 4-[[(2s)-1-[[(2s)-1-[(2s)-2-[[(2s)-1-(4-nitroanilino)-1-oxo-3-phenylpropan-2-yl]carbamoyl]pyrrolidin-1-yl]-1-oxopropan-2-yl]amino]-1-oxopropan-2-yl]amino]-4-oxobutanoic acid Chemical compound OC(=O)CCC(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NC=1C=CC(=CC=1)[N+]([O-])=O)CC1=CC=CC=C1 LKDMKWNDBAVNQZ-WJNSRDFLSA-N 0.000 description 6
- 108020004705 Codon Proteins 0.000 description 6
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 6
- JLVVSXFLKOJNIY-UHFFFAOYSA-N Magnesium ion Chemical compound [Mg+2] JLVVSXFLKOJNIY-UHFFFAOYSA-N 0.000 description 6
- 102100031545 Microsomal triglyceride transfer protein large subunit Human genes 0.000 description 6
- 229930193140 Neomycin Natural products 0.000 description 6
- 229920002873 Polyethylenimine Polymers 0.000 description 6
- 238000004458 analytical method Methods 0.000 description 6
- 238000004061 bleaching Methods 0.000 description 6
- 229910001424 calcium ion Inorganic materials 0.000 description 6
- 150000001875 compounds Chemical class 0.000 description 6
- MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 description 6
- 238000011068 loading method Methods 0.000 description 6
- 229910001425 magnesium ion Inorganic materials 0.000 description 6
- 229960004927 neomycin Drugs 0.000 description 6
- 238000002741 site-directed mutagenesis Methods 0.000 description 6
- 241000894007 species Species 0.000 description 6
- 239000000126 substance Substances 0.000 description 6
- 108010082371 succinyl-alanyl-alanyl-prolyl-phenylalanine-4-nitroanilide Proteins 0.000 description 6
- 239000004382 Amylase Substances 0.000 description 5
- 102100032487 Beta-mannosidase Human genes 0.000 description 5
- 229920000877 Melamine resin Polymers 0.000 description 5
- 102000005741 Metalloproteases Human genes 0.000 description 5
- 108010006035 Metalloproteases Proteins 0.000 description 5
- 102220608441 Suppressor of cytokine signaling 2_L75E_mutation Human genes 0.000 description 5
- 150000007513 acids Chemical class 0.000 description 5
- 150000008051 alkyl sulfates Chemical class 0.000 description 5
- 108010055059 beta-Mannosidase Proteins 0.000 description 5
- 235000014113 dietary fatty acids Nutrition 0.000 description 5
- 238000010790 dilution Methods 0.000 description 5
- 239000012895 dilution Substances 0.000 description 5
- 238000007046 ethoxylation reaction Methods 0.000 description 5
- 239000000194 fatty acid Substances 0.000 description 5
- 229930195729 fatty acid Natural products 0.000 description 5
- 150000004665 fatty acids Chemical class 0.000 description 5
- 238000009472 formulation Methods 0.000 description 5
- 239000004519 grease Substances 0.000 description 5
- 230000005764 inhibitory process Effects 0.000 description 5
- 230000000670 limiting effect Effects 0.000 description 5
- 239000011777 magnesium Substances 0.000 description 5
- 239000011159 matrix material Substances 0.000 description 5
- SJGALSBBFTYSBA-UHFFFAOYSA-N oxaziridine Chemical group C1NO1 SJGALSBBFTYSBA-UHFFFAOYSA-N 0.000 description 5
- 239000000049 pigment Substances 0.000 description 5
- 108091008146 restriction endonucleases Proteins 0.000 description 5
- 102220032287 rs104895127 Human genes 0.000 description 5
- 102200058890 rs2227624 Human genes 0.000 description 5
- 239000007787 solid Substances 0.000 description 5
- 239000003381 stabilizer Substances 0.000 description 5
- 239000000758 substrate Substances 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- 239000013598 vector Substances 0.000 description 5
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 4
- 241001328119 Bacillus gibsonii Species 0.000 description 4
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 4
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 description 4
- RPNUMPOLZDHAAY-UHFFFAOYSA-N Diethylenetriamine Chemical compound NCCNCCN RPNUMPOLZDHAAY-UHFFFAOYSA-N 0.000 description 4
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 4
- 241000588724 Escherichia coli Species 0.000 description 4
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical group C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 4
- 102000004316 Oxidoreductases Human genes 0.000 description 4
- 108090000854 Oxidoreductases Proteins 0.000 description 4
- ABLZXFCXXLZCGV-UHFFFAOYSA-N Phosphorous acid Chemical compound OP(O)=O ABLZXFCXXLZCGV-UHFFFAOYSA-N 0.000 description 4
- 241000223258 Thermomyces lanuginosus Species 0.000 description 4
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 4
- 239000000654 additive Substances 0.000 description 4
- 230000003321 amplification Effects 0.000 description 4
- 229940025131 amylases Drugs 0.000 description 4
- 239000002585 base Substances 0.000 description 4
- 238000012742 biochemical analysis Methods 0.000 description 4
- 230000008859 change Effects 0.000 description 4
- VTIIJXUACCWYHX-UHFFFAOYSA-L disodium;carboxylatooxy carbonate Chemical compound [Na+].[Na+].[O-]C(=O)OOC([O-])=O VTIIJXUACCWYHX-UHFFFAOYSA-L 0.000 description 4
- 239000002979 fabric softener Substances 0.000 description 4
- 239000012530 fluid Substances 0.000 description 4
- 230000002538 fungal effect Effects 0.000 description 4
- 238000010348 incorporation Methods 0.000 description 4
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 4
- 230000000813 microbial effect Effects 0.000 description 4
- 108010020132 microbial serine proteinases Proteins 0.000 description 4
- 230000007935 neutral effect Effects 0.000 description 4
- 238000003199 nucleic acid amplification method Methods 0.000 description 4
- 239000002245 particle Substances 0.000 description 4
- 108010087558 pectate lyase Proteins 0.000 description 4
- 102000040430 polynucleotide Human genes 0.000 description 4
- 108091033319 polynucleotide Proteins 0.000 description 4
- 239000002157 polynucleotide Substances 0.000 description 4
- 229910052700 potassium Inorganic materials 0.000 description 4
- 229960004063 propylene glycol Drugs 0.000 description 4
- 235000013772 propylene glycol Nutrition 0.000 description 4
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 4
- 235000017557 sodium bicarbonate Nutrition 0.000 description 4
- 229940045872 sodium percarbonate Drugs 0.000 description 4
- 108010075550 termamyl Proteins 0.000 description 4
- HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 description 3
- YGUMVDWOQQJBGA-VAWYXSNFSA-N 5-[(4-anilino-6-morpholin-4-yl-1,3,5-triazin-2-yl)amino]-2-[(e)-2-[4-[(4-anilino-6-morpholin-4-yl-1,3,5-triazin-2-yl)amino]-2-sulfophenyl]ethenyl]benzenesulfonic acid Chemical compound C=1C=C(\C=C\C=2C(=CC(NC=3N=C(N=C(NC=4C=CC=CC=4)N=3)N3CCOCC3)=CC=2)S(O)(=O)=O)C(S(=O)(=O)O)=CC=1NC(N=C(N=1)N2CCOCC2)=NC=1NC1=CC=CC=C1 YGUMVDWOQQJBGA-VAWYXSNFSA-N 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical group CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 241000194108 Bacillus licheniformis Species 0.000 description 3
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 3
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 3
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 3
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 3
- BDAGIHXWWSANSR-UHFFFAOYSA-M Formate Chemical compound [O-]C=O BDAGIHXWWSANSR-UHFFFAOYSA-M 0.000 description 3
- 239000006137 Luria-Bertani broth Substances 0.000 description 3
- 239000006057 Non-nutritive feed additive Substances 0.000 description 3
- BPQQTUXANYXVAA-UHFFFAOYSA-N Orthosilicate Chemical compound [O-][Si]([O-])([O-])[O-] BPQQTUXANYXVAA-UHFFFAOYSA-N 0.000 description 3
- 241000179039 Paenibacillus Species 0.000 description 3
- 239000002202 Polyethylene glycol Substances 0.000 description 3
- 229940124158 Protease/peptidase inhibitor Drugs 0.000 description 3
- 102100021817 Splicing factor 3B subunit 6 Human genes 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- 125000001931 aliphatic group Chemical group 0.000 description 3
- 235000019270 ammonium chloride Nutrition 0.000 description 3
- 238000000149 argon plasma sintering Methods 0.000 description 3
- 229910021538 borax Inorganic materials 0.000 description 3
- 239000001110 calcium chloride Substances 0.000 description 3
- 229910001628 calcium chloride Inorganic materials 0.000 description 3
- 235000013877 carbamide Nutrition 0.000 description 3
- 125000002057 carboxymethyl group Chemical group [H]OC(=O)C([H])([H])[*] 0.000 description 3
- 239000000969 carrier Substances 0.000 description 3
- 239000003086 colorant Substances 0.000 description 3
- 230000003750 conditioning effect Effects 0.000 description 3
- 239000012228 culture supernatant Substances 0.000 description 3
- 230000001186 cumulative effect Effects 0.000 description 3
- 239000008367 deionised water Substances 0.000 description 3
- PMPJQLCPEQFEJW-HPKCLRQXSA-L disodium;2-[(e)-2-[4-[4-[(e)-2-(2-sulfonatophenyl)ethenyl]phenyl]phenyl]ethenyl]benzenesulfonate Chemical compound [Na+].[Na+].[O-]S(=O)(=O)C1=CC=CC=C1\C=C\C1=CC=C(C=2C=CC(\C=C\C=3C(=CC=CC=3)S([O-])(=O)=O)=CC=2)C=C1 PMPJQLCPEQFEJW-HPKCLRQXSA-L 0.000 description 3
- 229940071087 ethylenediamine disuccinate Drugs 0.000 description 3
- 229940044170 formate Drugs 0.000 description 3
- 239000000499 gel Substances 0.000 description 3
- 229930195733 hydrocarbon Natural products 0.000 description 3
- 150000002430 hydrocarbons Chemical class 0.000 description 3
- 229910052739 hydrogen Inorganic materials 0.000 description 3
- 239000003752 hydrotrope Substances 0.000 description 3
- 229910052742 iron Inorganic materials 0.000 description 3
- 229910052749 magnesium Inorganic materials 0.000 description 3
- 239000000137 peptide hydrolase inhibitor Substances 0.000 description 3
- 229920000728 polyester Polymers 0.000 description 3
- 229920001223 polyethylene glycol Polymers 0.000 description 3
- 229920001296 polysiloxane Polymers 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 238000000746 purification Methods 0.000 description 3
- 239000002002 slurry Substances 0.000 description 3
- 150000003384 small molecules Chemical class 0.000 description 3
- 239000001509 sodium citrate Substances 0.000 description 3
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 3
- 235000018341 sodium sesquicarbonate Nutrition 0.000 description 3
- 235000010339 sodium tetraborate Nutrition 0.000 description 3
- 238000010561 standard procedure Methods 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- 150000003577 thiophenes Chemical class 0.000 description 3
- 230000009466 transformation Effects 0.000 description 3
- 235000015112 vegetable and seed oil Nutrition 0.000 description 3
- 239000008158 vegetable oil Substances 0.000 description 3
- 229910052725 zinc Inorganic materials 0.000 description 3
- 239000011701 zinc Substances 0.000 description 3
- DNIAPMSPPWPWGF-GSVOUGTGSA-N (R)-(-)-Propylene glycol Chemical compound C[C@@H](O)CO DNIAPMSPPWPWGF-GSVOUGTGSA-N 0.000 description 2
- OVSKIKFHRZPJSS-UHFFFAOYSA-N 2,4-D Chemical compound OC(=O)COC1=CC=C(Cl)C=C1Cl OVSKIKFHRZPJSS-UHFFFAOYSA-N 0.000 description 2
- URDCARMUOSMFFI-UHFFFAOYSA-N 2-[2-[bis(carboxymethyl)amino]ethyl-(2-hydroxyethyl)amino]acetic acid Chemical compound OCCN(CC(O)=O)CCN(CC(O)=O)CC(O)=O URDCARMUOSMFFI-UHFFFAOYSA-N 0.000 description 2
- KWYJDIUEHHCHCZ-UHFFFAOYSA-N 3-[2-[bis(2-carboxyethyl)amino]ethyl-(2-carboxyethyl)amino]propanoic acid Chemical compound OC(=O)CCN(CCC(O)=O)CCN(CCC(O)=O)CCC(O)=O KWYJDIUEHHCHCZ-UHFFFAOYSA-N 0.000 description 2
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 description 2
- UHPMCKVQTMMPCG-UHFFFAOYSA-N 5,8-dihydroxy-2-methoxy-6-methyl-7-(2-oxopropyl)naphthalene-1,4-dione Chemical compound CC1=C(CC(C)=O)C(O)=C2C(=O)C(OC)=CC(=O)C2=C1O UHPMCKVQTMMPCG-UHFFFAOYSA-N 0.000 description 2
- CNGYZEMWVAWWOB-VAWYXSNFSA-N 5-[[4-anilino-6-[bis(2-hydroxyethyl)amino]-1,3,5-triazin-2-yl]amino]-2-[(e)-2-[4-[[4-anilino-6-[bis(2-hydroxyethyl)amino]-1,3,5-triazin-2-yl]amino]-2-sulfophenyl]ethenyl]benzenesulfonic acid Chemical compound N=1C(NC=2C=C(C(\C=C\C=3C(=CC(NC=4N=C(N=C(NC=5C=CC=CC=5)N=4)N(CCO)CCO)=CC=3)S(O)(=O)=O)=CC=2)S(O)(=O)=O)=NC(N(CCO)CCO)=NC=1NC1=CC=CC=C1 CNGYZEMWVAWWOB-VAWYXSNFSA-N 0.000 description 2
- 241000194103 Bacillus pumilus Species 0.000 description 2
- 241000194110 Bacillus sp. (in: Bacteria) Species 0.000 description 2
- 108010023736 Chondroitinases and Chondroitin Lyases Proteins 0.000 description 2
- 108090000317 Chymotrypsin Proteins 0.000 description 2
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- 101710121765 Endo-1,4-beta-xylanase Proteins 0.000 description 2
- 108090000371 Esterases Proteins 0.000 description 2
- 241000223218 Fusarium Species 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical class OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- 108010003272 Hyaluronate lyase Proteins 0.000 description 2
- 102000001974 Hyaluronidases Human genes 0.000 description 2
- 108010029541 Laccase Proteins 0.000 description 2
- 102000003820 Lipoxygenases Human genes 0.000 description 2
- 108090000128 Lipoxygenases Proteins 0.000 description 2
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 2
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 2
- FSVCELGFZIQNCK-UHFFFAOYSA-N N,N-bis(2-hydroxyethyl)glycine Chemical compound OCCN(CCO)CC(O)=O FSVCELGFZIQNCK-UHFFFAOYSA-N 0.000 description 2
- JYXGIOKAKDAARW-UHFFFAOYSA-N N-(2-hydroxyethyl)iminodiacetic acid Chemical compound OCCN(CC(O)=O)CC(O)=O JYXGIOKAKDAARW-UHFFFAOYSA-N 0.000 description 2
- 102100031688 N-acetylgalactosamine-6-sulfatase Human genes 0.000 description 2
- 108091034117 Oligonucleotide Proteins 0.000 description 2
- 108700020962 Peroxidase Proteins 0.000 description 2
- 102000003992 Peroxidases Human genes 0.000 description 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Natural products OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
- 108010064785 Phospholipases Proteins 0.000 description 2
- 102000015439 Phospholipases Human genes 0.000 description 2
- 108010059820 Polygalacturonase Proteins 0.000 description 2
- 239000004793 Polystyrene Substances 0.000 description 2
- 229920002396 Polyurea Polymers 0.000 description 2
- 108091007187 Reductases Proteins 0.000 description 2
- 102220528606 Ribonuclease P/MRP protein subunit POP5_S99D_mutation Human genes 0.000 description 2
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 2
- 229920001800 Shellac Polymers 0.000 description 2
- 239000004280 Sodium formate Substances 0.000 description 2
- 108090000631 Trypsin Proteins 0.000 description 2
- 102000004142 Trypsin Human genes 0.000 description 2
- 102000003425 Tyrosinase Human genes 0.000 description 2
- 108060008724 Tyrosinase Proteins 0.000 description 2
- 206010052428 Wound Diseases 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 2
- MBHRHUJRKGNOKX-UHFFFAOYSA-N [(4,6-diamino-1,3,5-triazin-2-yl)amino]methanol Chemical compound NC1=NC(N)=NC(NCO)=N1 MBHRHUJRKGNOKX-UHFFFAOYSA-N 0.000 description 2
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 2
- 230000000996 additive effect Effects 0.000 description 2
- 238000013019 agitation Methods 0.000 description 2
- 239000002386 air freshener Substances 0.000 description 2
- 150000001298 alcohols Chemical class 0.000 description 2
- 150000001299 aldehydes Chemical class 0.000 description 2
- 229910052910 alkali metal silicate Inorganic materials 0.000 description 2
- 125000003342 alkenyl group Chemical group 0.000 description 2
- 108010084650 alpha-N-arabinofuranosidase Proteins 0.000 description 2
- 229920003180 amino resin Polymers 0.000 description 2
- 150000001450 anions Chemical group 0.000 description 2
- 238000013459 approach Methods 0.000 description 2
- 239000000981 basic dye Substances 0.000 description 2
- 239000000440 bentonite Substances 0.000 description 2
- 235000012216 bentonite Nutrition 0.000 description 2
- 229910000278 bentonite Inorganic materials 0.000 description 2
- 229940092782 bentonite Drugs 0.000 description 2
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 230000003139 buffering effect Effects 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- 238000004364 calculation method Methods 0.000 description 2
- 239000004202 carbamide Substances 0.000 description 2
- FPPNZSSZRUTDAP-UWFZAAFLSA-N carbenicillin Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)C(C(O)=O)C1=CC=CC=C1 FPPNZSSZRUTDAP-UWFZAAFLSA-N 0.000 description 2
- 229960003669 carbenicillin Drugs 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 239000004359 castor oil Substances 0.000 description 2
- 235000019438 castor oil Nutrition 0.000 description 2
- 150000001860 citric acid derivatives Chemical class 0.000 description 2
- 239000010941 cobalt Substances 0.000 description 2
- 229910017052 cobalt Inorganic materials 0.000 description 2
- GUTLYIVDDKVIGB-UHFFFAOYSA-N cobalt atom Chemical compound [Co] GUTLYIVDDKVIGB-UHFFFAOYSA-N 0.000 description 2
- 239000003240 coconut oil Substances 0.000 description 2
- 235000019864 coconut oil Nutrition 0.000 description 2
- 229910052802 copper Inorganic materials 0.000 description 2
- 239000010949 copper Substances 0.000 description 2
- 108010005400 cutinase Proteins 0.000 description 2
- DOIRQSBPFJWKBE-UHFFFAOYSA-N dibutyl phthalate Chemical compound CCCCOC(=O)C1=CC=CC=C1C(=O)OCCCC DOIRQSBPFJWKBE-UHFFFAOYSA-N 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- ZLRROLLKQDRDPI-UHFFFAOYSA-L disodium;4,5-dihydroxybenzene-1,3-disulfonate;hydrate Chemical compound O.[Na+].[Na+].OC1=CC(S([O-])(=O)=O)=CC(S([O-])(=O)=O)=C1O ZLRROLLKQDRDPI-UHFFFAOYSA-L 0.000 description 2
- 230000007613 environmental effect Effects 0.000 description 2
- 230000002255 enzymatic effect Effects 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 2
- 229940071106 ethylenediaminetetraacetate Drugs 0.000 description 2
- 230000001747 exhibiting effect Effects 0.000 description 2
- 108010093305 exopolygalacturonase Proteins 0.000 description 2
- 239000000706 filtrate Substances 0.000 description 2
- 238000005187 foaming Methods 0.000 description 2
- IVJISJACKSSFGE-UHFFFAOYSA-N formaldehyde;1,3,5-triazine-2,4,6-triamine Chemical compound O=C.NC1=NC(N)=NC(N)=N1 IVJISJACKSSFGE-UHFFFAOYSA-N 0.000 description 2
- 230000004927 fusion Effects 0.000 description 2
- 150000004676 glycans Chemical class 0.000 description 2
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 2
- 239000008187 granular material Substances 0.000 description 2
- 108010002430 hemicellulase Proteins 0.000 description 2
- 229960002773 hyaluronidase Drugs 0.000 description 2
- 229910000359 iron(II) sulfate Inorganic materials 0.000 description 2
- 108010059345 keratinase Proteins 0.000 description 2
- 238000004900 laundering Methods 0.000 description 2
- 108010062085 ligninase Proteins 0.000 description 2
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 2
- 229910052748 manganese Inorganic materials 0.000 description 2
- 239000011572 manganese Substances 0.000 description 2
- JDSHMPZPIAZGSV-UHFFFAOYSA-N melamine Chemical compound NC1=NC(N)=NC(N)=N1 JDSHMPZPIAZGSV-UHFFFAOYSA-N 0.000 description 2
- 229910021645 metal ion Inorganic materials 0.000 description 2
- 125000000325 methylidene group Chemical group [H]C([H])=* 0.000 description 2
- 239000011259 mixed solution Substances 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- ONLRKTIYOMZEJM-UHFFFAOYSA-N n-methylmethanamine oxide Chemical compound C[NH+](C)[O-] ONLRKTIYOMZEJM-UHFFFAOYSA-N 0.000 description 2
- MGFYIUFZLHCRTH-UHFFFAOYSA-N nitrilotriacetic acid Chemical compound OC(=O)CN(CC(O)=O)CC(O)=O MGFYIUFZLHCRTH-UHFFFAOYSA-N 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- 235000019198 oils Nutrition 0.000 description 2
- 239000011368 organic material Substances 0.000 description 2
- 125000004430 oxygen atom Chemical group O* 0.000 description 2
- QUBQYFYWUJJAAK-UHFFFAOYSA-N oxymethurea Chemical compound OCNC(=O)NCO QUBQYFYWUJJAAK-UHFFFAOYSA-N 0.000 description 2
- 230000008447 perception Effects 0.000 description 2
- 125000000843 phenylene group Chemical class C1(=C(C=CC=C1)*)* 0.000 description 2
- 229910052698 phosphorus Inorganic materials 0.000 description 2
- IEQIEDJGQAUEQZ-UHFFFAOYSA-N phthalocyanine Chemical compound N1C(N=C2C3=CC=CC=C3C(N=C3C4=CC=CC=C4C(=N4)N3)=N2)=C(C=CC=C2)C2=C1N=C1C2=CC=CC=C2C4=N1 IEQIEDJGQAUEQZ-UHFFFAOYSA-N 0.000 description 2
- 238000003752 polymerase chain reaction Methods 0.000 description 2
- 229920001282 polysaccharide Polymers 0.000 description 2
- 239000005017 polysaccharide Substances 0.000 description 2
- 229920000136 polysorbate Polymers 0.000 description 2
- 229920002223 polystyrene Polymers 0.000 description 2
- 239000002243 precursor Substances 0.000 description 2
- 230000000750 progressive effect Effects 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 239000011541 reaction mixture Substances 0.000 description 2
- 238000005096 rolling process Methods 0.000 description 2
- 102220272575 rs767681165 Human genes 0.000 description 2
- 229920006395 saturated elastomer Polymers 0.000 description 2
- 230000035945 sensitivity Effects 0.000 description 2
- 239000002453 shampoo Substances 0.000 description 2
- 239000004208 shellac Substances 0.000 description 2
- ZLGIYFNHBLSMPS-ATJNOEHPSA-N shellac Chemical compound OCCCCCC(O)C(O)CCCCCCCC(O)=O.C1C23[C@H](C(O)=O)CCC2[C@](C)(CO)[C@@H]1C(C(O)=O)=C[C@@H]3O ZLGIYFNHBLSMPS-ATJNOEHPSA-N 0.000 description 2
- 229940113147 shellac Drugs 0.000 description 2
- 235000013874 shellac Nutrition 0.000 description 2
- 229910021647 smectite Inorganic materials 0.000 description 2
- HLBBKKJFGFRGMU-UHFFFAOYSA-M sodium formate Chemical compound [Na+].[O-]C=O HLBBKKJFGFRGMU-UHFFFAOYSA-M 0.000 description 2
- 235000019254 sodium formate Nutrition 0.000 description 2
- 229910000031 sodium sesquicarbonate Inorganic materials 0.000 description 2
- 239000004328 sodium tetraborate Substances 0.000 description 2
- AXMCIYLNKNGNOT-UHFFFAOYSA-N sodium;3-[[4-[(4-dimethylazaniumylidenecyclohexa-2,5-dien-1-ylidene)-[4-[ethyl-[(3-sulfophenyl)methyl]amino]phenyl]methyl]-n-ethylanilino]methyl]benzenesulfonate Chemical compound [Na+].C=1C=C(C(=C2C=CC(C=C2)=[N+](C)C)C=2C=CC(=CC=2)N(CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C=CC=1N(CC)CC1=CC=CC(S(O)(=O)=O)=C1 AXMCIYLNKNGNOT-UHFFFAOYSA-N 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 108010038851 tannase Proteins 0.000 description 2
- HLZKNKRTKFSKGZ-UHFFFAOYSA-N tetradecan-1-ol Chemical compound CCCCCCCCCCCCCCO HLZKNKRTKFSKGZ-UHFFFAOYSA-N 0.000 description 2
- WCTAGTRAWPDFQO-UHFFFAOYSA-K trisodium;hydrogen carbonate;carbonate Chemical compound [Na+].[Na+].[Na+].OC([O-])=O.[O-]C([O-])=O WCTAGTRAWPDFQO-UHFFFAOYSA-K 0.000 description 2
- 238000011179 visual inspection Methods 0.000 description 2
- 239000001993 wax Substances 0.000 description 2
- 239000012224 working solution Substances 0.000 description 2
- SCMDRBZEIUMBBQ-UHFFFAOYSA-N (1e)-1-[(8-amino-3,7-dimethyl-10-phenylphenazin-10-ium-2-yl)hydrazinylidene]naphthalen-2-one;chloride Chemical compound [Cl-].C=12C=C(N)C(C)=CC2=NC2=CC(C)=C(N\N=C\3C4=CC=CC=C4C=CC/3=O)C=C2[N+]=1C1=CC=CC=C1 SCMDRBZEIUMBBQ-UHFFFAOYSA-N 0.000 description 1
- QTKIQLNGOKOPOE-UHFFFAOYSA-N 1,1'-biphenyl;propane Chemical group CCC.C1=CC=CC=C1C1=CC=CC=C1 QTKIQLNGOKOPOE-UHFFFAOYSA-N 0.000 description 1
- KXTWDIPAGFPHCA-UHFFFAOYSA-N 1,2-dipropylnaphthalene Chemical compound C1=CC=CC2=C(CCC)C(CCC)=CC=C21 KXTWDIPAGFPHCA-UHFFFAOYSA-N 0.000 description 1
- KZYAYVSWIPZDKL-UHFFFAOYSA-N 1,4-diamino-2,3-dichloroanthracene-9,10-dione Chemical compound O=C1C2=CC=CC=C2C(=O)C2=C1C(N)=C(Cl)C(Cl)=C2N KZYAYVSWIPZDKL-UHFFFAOYSA-N 0.000 description 1
- ZNQIAQXHADXXQI-UHFFFAOYSA-N 1-anilino-4-hydroxyanthracene-9,10-dione Chemical compound C1=2C(=O)C3=CC=CC=C3C(=O)C=2C(O)=CC=C1NC1=CC=CC=C1 ZNQIAQXHADXXQI-UHFFFAOYSA-N 0.000 description 1
- OSSNTDFYBPYIEC-UHFFFAOYSA-N 1-ethenylimidazole Chemical compound C=CN1C=CN=C1 OSSNTDFYBPYIEC-UHFFFAOYSA-N 0.000 description 1
- YEVQZPWSVWZAOB-UHFFFAOYSA-N 2-(bromomethyl)-1-iodo-4-(trifluoromethyl)benzene Chemical compound FC(F)(F)C1=CC=C(I)C(CBr)=C1 YEVQZPWSVWZAOB-UHFFFAOYSA-N 0.000 description 1
- CULIYQPRUGMRRT-UHFFFAOYSA-N 2-chloro-n-[2-[(2-cyano-4-nitrophenyl)diazenyl]-5-(diethylamino)phenyl]acetamide Chemical compound ClCC(=O)NC1=CC(N(CC)CC)=CC=C1N=NC1=CC=C([N+]([O-])=O)C=C1C#N CULIYQPRUGMRRT-UHFFFAOYSA-N 0.000 description 1
- UWOFGIXNNCPENM-UHFFFAOYSA-N 3,3-difluoropentan-2-one Chemical compound CCC(F)(F)C(C)=O UWOFGIXNNCPENM-UHFFFAOYSA-N 0.000 description 1
- POELEEGOWIJNBI-UHFFFAOYSA-N 3-[2-[[4-(diethylamino)phenyl]diazenyl]-6-ethoxy-1,3-benzothiazol-3-ium-3-yl]propanamide;chloride Chemical compound [Cl-].S1C2=CC(OCC)=CC=C2[N+](CCC(N)=O)=C1N=NC1=CC=C(N(CC)CC)C=C1 POELEEGOWIJNBI-UHFFFAOYSA-N 0.000 description 1
- VZOOHWGPNLPIHR-UHFFFAOYSA-N 3-[2-[[4-[bis(2-chloroethyl)amino]phenyl]diazenyl]-6-methoxy-1,3-benzothiazol-3-ium-3-yl]propanamide;chloride Chemical compound [Cl-].S1C2=CC(OC)=CC=C2[N+](CCC(N)=O)=C1N=NC1=CC=C(N(CCCl)CCCl)C=C1 VZOOHWGPNLPIHR-UHFFFAOYSA-N 0.000 description 1
- GQYGJYJXYHQAHX-UHFFFAOYSA-N 4,11-diethyl-1,4,8,11-tetrazabicyclo[6.6.2]hexadecane Chemical compound C1CN(CC)CCCN2CCN(CC)CCCN1CC2 GQYGJYJXYHQAHX-UHFFFAOYSA-N 0.000 description 1
- ZXVONLUNISGICL-UHFFFAOYSA-N 4,6-dinitro-o-cresol Chemical compound CC1=CC([N+]([O-])=O)=CC([N+]([O-])=O)=C1O ZXVONLUNISGICL-UHFFFAOYSA-N 0.000 description 1
- XSVSPKKXQGNHMD-UHFFFAOYSA-N 5-bromo-3-methyl-1,2-thiazole Chemical compound CC=1C=C(Br)SN=1 XSVSPKKXQGNHMD-UHFFFAOYSA-N 0.000 description 1
- SFHBJXIEBWOOFA-UHFFFAOYSA-N 5-methyl-3,6-dioxabicyclo[6.2.2]dodeca-1(10),8,11-triene-2,7-dione Chemical compound O=C1OC(C)COC(=O)C2=CC=C1C=C2 SFHBJXIEBWOOFA-UHFFFAOYSA-N 0.000 description 1
- JHRDMNILWGIFBI-UHFFFAOYSA-N 6-diazenyl-1,3,5-triazine-2,4-diamine Chemical compound NC1=NC(N)=NC(N=N)=N1 JHRDMNILWGIFBI-UHFFFAOYSA-N 0.000 description 1
- VRFMFQHSDWKYDM-UHFFFAOYSA-N 6-o-benzyl 1-o-butyl hexanedioate Chemical compound CCCCOC(=O)CCCCC(=O)OCC1=CC=CC=C1 VRFMFQHSDWKYDM-UHFFFAOYSA-N 0.000 description 1
- DECACTMEFWAFRE-UHFFFAOYSA-N 6-o-benzyl 1-o-octyl hexanedioate Chemical compound CCCCCCCCOC(=O)CCCCC(=O)OCC1=CC=CC=C1 DECACTMEFWAFRE-UHFFFAOYSA-N 0.000 description 1
- GZVHEAJQGPRDLQ-UHFFFAOYSA-N 6-phenyl-1,3,5-triazine-2,4-diamine Chemical compound NC1=NC(N)=NC(C=2C=CC=CC=2)=N1 GZVHEAJQGPRDLQ-UHFFFAOYSA-N 0.000 description 1
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 description 1
- 102220476899 ATPase family AAA domain-containing protein 3A_S101N_mutation Human genes 0.000 description 1
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 1
- 241001019659 Acremonium <Plectosphaerellaceae> Species 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- AOMZHDJXSYHPKS-DROYEMJCSA-L Amido Black 10B Chemical compound [Na+].[Na+].[O-]S(=O)(=O)C1=CC2=CC(S([O-])(=O)=O)=C(\N=N\C=3C=CC=CC=3)C(O)=C2C(N)=C1\N=N\C1=CC=C(N(=O)=O)C=C1 AOMZHDJXSYHPKS-DROYEMJCSA-L 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 1
- 101100519158 Arabidopsis thaliana PCR2 gene Proteins 0.000 description 1
- 241000193381 Bacillus sp. 707 Species 0.000 description 1
- 244000063299 Bacillus subtilis Species 0.000 description 1
- 108091005658 Basic proteases Proteins 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical compound OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 description 1
- LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 240000002791 Brassica napus Species 0.000 description 1
- 235000004977 Brassica sinapistrum Nutrition 0.000 description 1
- SGHZXLIDFTYFHQ-UHFFFAOYSA-L Brilliant Blue Chemical compound [Na+].[Na+].C=1C=C(C(=C2C=CC(C=C2)=[N+](CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C=2C(=CC=CC=2)S([O-])(=O)=O)C=CC=1N(CC)CC1=CC=CC(S([O-])(=O)=O)=C1 SGHZXLIDFTYFHQ-UHFFFAOYSA-L 0.000 description 1
- CBOCVOKPQGJKKJ-UHFFFAOYSA-L Calcium formate Chemical compound [Ca+2].[O-]C=O.[O-]C=O CBOCVOKPQGJKKJ-UHFFFAOYSA-L 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 102000014914 Carrier Proteins Human genes 0.000 description 1
- 229920001661 Chitosan Polymers 0.000 description 1
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 1
- 108090000227 Chymases Proteins 0.000 description 1
- 102000003858 Chymases Human genes 0.000 description 1
- 229910021580 Cobalt(II) chloride Inorganic materials 0.000 description 1
- 229910021592 Copper(II) chloride Inorganic materials 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- 102000012410 DNA Ligases Human genes 0.000 description 1
- 108010061982 DNA Ligases Proteins 0.000 description 1
- 102000016559 DNA Primase Human genes 0.000 description 1
- 108010092681 DNA Primase Proteins 0.000 description 1
- 238000007400 DNA extraction Methods 0.000 description 1
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 1
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 1
- 108010031746 Dam methyltransferase Proteins 0.000 description 1
- XTJFFFGAUHQWII-UHFFFAOYSA-N Dibutyl adipate Chemical compound CCCCOC(=O)CCCCC(=O)OCCCC XTJFFFGAUHQWII-UHFFFAOYSA-N 0.000 description 1
- RWSOTUBLDIXVET-UHFFFAOYSA-N Dihydrogen sulfide Chemical class S RWSOTUBLDIXVET-UHFFFAOYSA-N 0.000 description 1
- 108010083608 Durazym Proteins 0.000 description 1
- 101710111935 Endo-beta-1,4-glucanase Proteins 0.000 description 1
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 description 1
- 239000005977 Ethylene Substances 0.000 description 1
- PIICEJLVQHRZGT-UHFFFAOYSA-N Ethylenediamine Chemical compound NCCN PIICEJLVQHRZGT-UHFFFAOYSA-N 0.000 description 1
- 241000223221 Fusarium oxysporum Species 0.000 description 1
- 102100040004 Gamma-glutamylcyclotransferase Human genes 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 241000193385 Geobacillus stearothermophilus Species 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 241000237902 Hirudo medicinalis Species 0.000 description 1
- 101000886680 Homo sapiens Gamma-glutamylcyclotransferase Proteins 0.000 description 1
- 101001054807 Homo sapiens Importin subunit alpha-6 Proteins 0.000 description 1
- 241000223198 Humicola Species 0.000 description 1
- 241001480714 Humicola insolens Species 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- 229920001479 Hydroxyethyl methyl cellulose Polymers 0.000 description 1
- 102100027007 Importin subunit alpha-6 Human genes 0.000 description 1
- 241000157919 Jonesia Species 0.000 description 1
- 102100027612 Kallikrein-11 Human genes 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- 235000019501 Lemon oil Nutrition 0.000 description 1
- 102100038007 Low affinity immunoglobulin epsilon Fc receptor Human genes 0.000 description 1
- 241001625930 Luria Species 0.000 description 1
- 239000007993 MOPS buffer Substances 0.000 description 1
- 239000005913 Maltodextrin Substances 0.000 description 1
- 229920002774 Maltodextrin Polymers 0.000 description 1
- PWHULOQIROXLJO-UHFFFAOYSA-N Manganese Chemical compound [Mn] PWHULOQIROXLJO-UHFFFAOYSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 239000012901 Milli-Q water Substances 0.000 description 1
- ZOKXTWBITQBERF-UHFFFAOYSA-N Molybdenum Chemical compound [Mo] ZOKXTWBITQBERF-UHFFFAOYSA-N 0.000 description 1
- WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 description 1
- 229910000503 Na-aluminosilicate Inorganic materials 0.000 description 1
- 108091005507 Neutral proteases Proteins 0.000 description 1
- 238000012408 PCR amplification Methods 0.000 description 1
- 101150102573 PCR1 gene Proteins 0.000 description 1
- 235000019482 Palm oil Nutrition 0.000 description 1
- 235000019483 Peanut oil Nutrition 0.000 description 1
- 244000146510 Pereskia bleo Species 0.000 description 1
- 239000004952 Polyamide Substances 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 239000004614 Process Aid Substances 0.000 description 1
- 102220643724 Prolactin-inducible protein_A90Y_mutation Human genes 0.000 description 1
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 1
- GOOHAUXETOMSMM-UHFFFAOYSA-N Propylene oxide Chemical compound CC1CO1 GOOHAUXETOMSMM-UHFFFAOYSA-N 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 241000589516 Pseudomonas Species 0.000 description 1
- 241000220010 Rhode Species 0.000 description 1
- KJTLSVCANCCWHF-UHFFFAOYSA-N Ruthenium Chemical compound [Ru] KJTLSVCANCCWHF-UHFFFAOYSA-N 0.000 description 1
- 235000019485 Safflower oil Nutrition 0.000 description 1
- 241001292348 Salipaludibacillus agaradhaerens Species 0.000 description 1
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 description 1
- 239000004902 Softening Agent Substances 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- YSMRWXYRXBRSND-UHFFFAOYSA-N TOTP Chemical compound CC1=CC=CC=C1OP(=O)(OC=1C(=CC=CC=1)C)OC1=CC=CC=C1C YSMRWXYRXBRSND-UHFFFAOYSA-N 0.000 description 1
- 101000865057 Thermococcus litoralis DNA polymerase Proteins 0.000 description 1
- 241001313536 Thermothelomyces thermophila Species 0.000 description 1
- 241001494489 Thielavia Species 0.000 description 1
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 1
- 241000499912 Trichoderma reesei Species 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 1
- 101710152431 Trypsin-like protease Proteins 0.000 description 1
- XTXRWKRVRITETP-UHFFFAOYSA-N Vinyl acetate Chemical compound CC(=O)OC=C XTXRWKRVRITETP-UHFFFAOYSA-N 0.000 description 1
- 229920002000 Xyloglucan Polymers 0.000 description 1
- IURGIPVDZKDLIX-UHFFFAOYSA-M [7-(diethylamino)phenoxazin-3-ylidene]-diethylazanium;chloride Chemical compound [Cl-].C1=CC(=[N+](CC)CC)C=C2OC3=CC(N(CC)CC)=CC=C3N=C21 IURGIPVDZKDLIX-UHFFFAOYSA-M 0.000 description 1
- USNWAMPROKAEIT-UHFFFAOYSA-N [Na].C(C=C)(=O)O Chemical compound [Na].C(C=C)(=O)O USNWAMPROKAEIT-UHFFFAOYSA-N 0.000 description 1
- GTZCVFVGUGFEME-UHFFFAOYSA-N aconitic acid Chemical compound OC(=O)CC(C(O)=O)=CC(O)=O GTZCVFVGUGFEME-UHFFFAOYSA-N 0.000 description 1
- 239000008186 active pharmaceutical agent Substances 0.000 description 1
- 238000005273 aeration Methods 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 235000004279 alanine Nutrition 0.000 description 1
- 229940072056 alginate Drugs 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 229910000288 alkali metal carbonate Inorganic materials 0.000 description 1
- 150000001340 alkali metals Chemical class 0.000 description 1
- 125000003545 alkoxy group Chemical group 0.000 description 1
- 229940024171 alpha-amylase Drugs 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- 239000003945 anionic surfactant Substances 0.000 description 1
- 238000000137 annealing Methods 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 239000002518 antifoaming agent Substances 0.000 description 1
- 239000012736 aqueous medium Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 239000003849 aromatic solvent Substances 0.000 description 1
- 125000003710 aryl alkyl group Chemical group 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- SRSXLGNVWSONIS-UHFFFAOYSA-M benzenesulfonate Chemical compound [O-]S(=O)(=O)C1=CC=CC=C1 SRSXLGNVWSONIS-UHFFFAOYSA-M 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 108091008324 binding proteins Proteins 0.000 description 1
- 108010064866 biozym Proteins 0.000 description 1
- 235000010290 biphenyl Nutrition 0.000 description 1
- OYVAGSVQBOHSSS-UAPAGMARSA-O bleomycin A2 Chemical compound N([C@H](C(=O)N[C@H](C)[C@@H](O)[C@H](C)C(=O)N[C@@H]([C@H](O)C)C(=O)NCCC=1SC=C(N=1)C=1SC=C(N=1)C(=O)NCCC[S+](C)C)[C@@H](O[C@H]1[C@H]([C@@H](O)[C@H](O)[C@H](CO)O1)O[C@@H]1[C@H]([C@@H](OC(N)=O)[C@H](O)[C@@H](CO)O1)O)C=1N=CNC=1)C(=O)C1=NC([C@H](CC(N)=O)NC[C@H](N)C(N)=O)=NC(N)=C1C OYVAGSVQBOHSSS-UAPAGMARSA-O 0.000 description 1
- 108010083912 bleomycin N-acetyltransferase Proteins 0.000 description 1
- 239000001045 blue dye Substances 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- KGBXLFKZBHKPEV-UHFFFAOYSA-N boric acid Chemical compound OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 description 1
- 239000004327 boric acid Substances 0.000 description 1
- 150000001639 boron compounds Chemical class 0.000 description 1
- 150000001642 boronic acid derivatives Chemical class 0.000 description 1
- 235000012745 brilliant blue FCF Nutrition 0.000 description 1
- 239000004161 brilliant blue FCF Substances 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 239000004281 calcium formate Substances 0.000 description 1
- 235000019255 calcium formate Nutrition 0.000 description 1
- 229940044172 calcium formate Drugs 0.000 description 1
- 239000003093 cationic surfactant Substances 0.000 description 1
- 108010052085 cellobiose-quinone oxidoreductase Proteins 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 239000000919 ceramic Substances 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 229910052804 chromium Inorganic materials 0.000 description 1
- 239000011651 chromium Substances 0.000 description 1
- 239000012459 cleaning agent Substances 0.000 description 1
- 238000010367 cloning Methods 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 239000002299 complementary DNA Substances 0.000 description 1
- 239000013256 coordination polymer Substances 0.000 description 1
- ORTQZVOHEJQUHG-UHFFFAOYSA-L copper(II) chloride Chemical compound Cl[Cu]Cl ORTQZVOHEJQUHG-UHFFFAOYSA-L 0.000 description 1
- 239000002285 corn oil Substances 0.000 description 1
- 235000005687 corn oil Nutrition 0.000 description 1
- 235000012343 cottonseed oil Nutrition 0.000 description 1
- 239000002385 cottonseed oil Substances 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 230000001351 cycling effect Effects 0.000 description 1
- 125000000753 cycloalkyl group Chemical group 0.000 description 1
- 229910021641 deionized water Inorganic materials 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 239000000645 desinfectant Substances 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 229940100539 dibutyl adipate Drugs 0.000 description 1
- 239000013024 dilution buffer Substances 0.000 description 1
- 150000002009 diols Chemical class 0.000 description 1
- 229910000396 dipotassium phosphate Inorganic materials 0.000 description 1
- LHRXTFDXJQAGAV-UHFFFAOYSA-L disodium 3-hydroxy-4-(naphthalen-1-yldiazenyl)naphthalene-2,7-disulfonate Chemical compound [Na+].[Na+].Oc1c(cc2cc(ccc2c1N=Nc1cccc2ccccc12)S([O-])(=O)=O)S([O-])(=O)=O LHRXTFDXJQAGAV-UHFFFAOYSA-L 0.000 description 1
- QCWPZYSLMIXIHM-UHFFFAOYSA-L disodium 4-amino-5-hydroxy-3-[(3-nitrophenyl)diazenyl]-6-phenyldiazenylnaphthalene-2,7-disulfonate Chemical compound [Na+].[Na+].Nc1c(N=Nc2cccc(c2)[N+]([O-])=O)c(cc2cc(c(N=Nc3ccccc3)c(O)c12)S([O-])(=O)=O)S([O-])(=O)=O QCWPZYSLMIXIHM-UHFFFAOYSA-L 0.000 description 1
- VDRKHPFIMDTBNX-UHFFFAOYSA-L disodium 7-amino-8-[[4-[4-[(2-amino-8-oxido-6-sulfonaphthalen-1-yl)diazenyl]phenyl]phenyl]diazenyl]-3-sulfonaphthalen-1-olate Chemical compound C1=CC(=CC=C1C2=CC=C(C=C2)N=NC3=C(C=CC4=CC(=CC(=C43)[O-])S(=O)(=O)O)N)N=NC5=C(C=CC6=CC(=CC(=C65)[O-])S(=O)(=O)O)N.[Na+].[Na+] VDRKHPFIMDTBNX-UHFFFAOYSA-L 0.000 description 1
- NJPXFJXCALXJCX-UHFFFAOYSA-L disodium 7-anilino-3-[[4-[(2,4-dimethyl-6-sulfonatophenyl)diazenyl]-2,5-dimethylphenyl]diazenyl]-4-hydroxynaphthalene-2-sulfonate Chemical compound [Na+].[Na+].Cc1cc(C)c(N=Nc2cc(C)c(cc2C)N=Nc2c(O)c3ccc(Nc4ccccc4)cc3cc2S([O-])(=O)=O)c(c1)S([O-])(=O)=O NJPXFJXCALXJCX-UHFFFAOYSA-L 0.000 description 1
- LARMRMCFZNGNNX-UHFFFAOYSA-L disodium 7-anilino-3-[[4-[(2,4-dimethyl-6-sulfonatophenyl)diazenyl]-2-methoxy-5-methylphenyl]diazenyl]-4-hydroxynaphthalene-2-sulfonate Chemical compound [Na+].[Na+].COc1cc(N=Nc2c(C)cc(C)cc2S([O-])(=O)=O)c(C)cc1N=Nc1c(O)c2ccc(Nc3ccccc3)cc2cc1S([O-])(=O)=O LARMRMCFZNGNNX-UHFFFAOYSA-L 0.000 description 1
- 231100000673 dose–response relationship Toxicity 0.000 description 1
- 239000000428 dust Substances 0.000 description 1
- 231100000463 ecotoxicology Toxicity 0.000 description 1
- NFDRPXJGHKJRLJ-UHFFFAOYSA-N edtmp Chemical compound OP(O)(=O)CN(CP(O)(O)=O)CCN(CP(O)(O)=O)CP(O)(O)=O NFDRPXJGHKJRLJ-UHFFFAOYSA-N 0.000 description 1
- 108010031145 eglin proteinase inhibitors Proteins 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000006353 environmental stress Effects 0.000 description 1
- 239000003822 epoxy resin Substances 0.000 description 1
- TVQGDYNRXLTQAP-UHFFFAOYSA-N ethyl heptanoate Chemical compound CCCCCCC(=O)OCC TVQGDYNRXLTQAP-UHFFFAOYSA-N 0.000 description 1
- LYCAIKOWRPUZTN-UHFFFAOYSA-N ethylene glycol Natural products OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000013604 expression vector Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 239000011888 foil Substances 0.000 description 1
- 230000037433 frameshift Effects 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 238000010353 genetic engineering Methods 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- VPVSTMAPERLKKM-UHFFFAOYSA-N glycoluril Chemical compound N1C(=O)NC2NC(=O)NC21 VPVSTMAPERLKKM-UHFFFAOYSA-N 0.000 description 1
- 150000004820 halides Chemical class 0.000 description 1
- 125000005843 halogen group Chemical group 0.000 description 1
- LNEPOXFFQSENCJ-UHFFFAOYSA-N haloperidol Chemical compound C1CC(O)(C=2C=CC(Cl)=CC=2)CCN1CCCC(=O)C1=CC=C(F)C=C1 LNEPOXFFQSENCJ-UHFFFAOYSA-N 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 238000002744 homologous recombination Methods 0.000 description 1
- 230000006801 homologous recombination Effects 0.000 description 1
- 235000003642 hunger Nutrition 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 125000002768 hydroxyalkyl group Chemical group 0.000 description 1
- 125000004029 hydroxymethyl group Chemical group [H]OC([H])([H])* 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 239000000976 ink Substances 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 239000000077 insect repellent Substances 0.000 description 1
- 238000002743 insertional mutagenesis Methods 0.000 description 1
- 239000002563 ionic surfactant Substances 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- AWJUIBRHMBBTKR-UHFFFAOYSA-N isoquinoline Chemical group C1=NC=CC2=CC=CC=C21 AWJUIBRHMBBTKR-UHFFFAOYSA-N 0.000 description 1
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 1
- 229960000318 kanamycin Drugs 0.000 description 1
- 229930027917 kanamycin Natural products 0.000 description 1
- 229930182823 kanamycin A Natural products 0.000 description 1
- 239000003350 kerosene Substances 0.000 description 1
- 239000010501 lemon oil Substances 0.000 description 1
- 108010076363 licheninase Proteins 0.000 description 1
- 125000005647 linker group Chemical group 0.000 description 1
- 239000000944 linseed oil Substances 0.000 description 1
- 235000021388 linseed oil Nutrition 0.000 description 1
- 229910052744 lithium Inorganic materials 0.000 description 1
- 244000144972 livestock Species 0.000 description 1
- 108010026228 mRNA guanylyltransferase Proteins 0.000 description 1
- 229910001629 magnesium chloride Inorganic materials 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 239000011976 maleic acid Substances 0.000 description 1
- 229940035034 maltodextrin Drugs 0.000 description 1
- 150000002697 manganese compounds Chemical class 0.000 description 1
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 1
- 229910000357 manganese(II) sulfate Inorganic materials 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 150000007974 melamines Chemical class 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 108010003855 mesentericopeptidase Proteins 0.000 description 1
- MYWUZJCMWCOHBA-VIFPVBQESA-N methamphetamine Chemical compound CN[C@@H](C)CC1=CC=CC=C1 MYWUZJCMWCOHBA-VIFPVBQESA-N 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 235000010981 methylcellulose Nutrition 0.000 description 1
- 108010009355 microbial metalloproteinases Proteins 0.000 description 1
- 239000011785 micronutrient Substances 0.000 description 1
- 235000013369 micronutrients Nutrition 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 239000002480 mineral oil Substances 0.000 description 1
- 235000010446 mineral oil Nutrition 0.000 description 1
- 229910052750 molybdenum Inorganic materials 0.000 description 1
- 239000011733 molybdenum Substances 0.000 description 1
- 238000002887 multiple sequence alignment Methods 0.000 description 1
- DMMDCPMHDXAIRV-UHFFFAOYSA-N n-[5-[bis(2-methoxyethyl)amino]-2-[(2-cyano-4-nitrophenyl)diazenyl]phenyl]acetamide Chemical compound CC(=O)NC1=CC(N(CCOC)CCOC)=CC=C1N=NC1=CC=C([N+]([O-])=O)C=C1C#N DMMDCPMHDXAIRV-UHFFFAOYSA-N 0.000 description 1
- 150000002790 naphthalenes Chemical class 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 101150077915 oppA gene Proteins 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 239000007800 oxidant agent Substances 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 229950005308 oxymethurea Drugs 0.000 description 1
- 239000003346 palm kernel oil Substances 0.000 description 1
- 235000019865 palm kernel oil Nutrition 0.000 description 1
- 239000002540 palm oil Substances 0.000 description 1
- 239000006072 paste Substances 0.000 description 1
- 239000000312 peanut oil Substances 0.000 description 1
- HWGNBUXHKFFFIH-UHFFFAOYSA-I pentasodium;[oxido(phosphonatooxy)phosphoryl] phosphate Chemical compound [Na+].[Na+].[Na+].[Na+].[Na+].[O-]P([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O HWGNBUXHKFFFIH-UHFFFAOYSA-I 0.000 description 1
- 150000002978 peroxides Chemical class 0.000 description 1
- 150000004968 peroxymonosulfuric acids Chemical class 0.000 description 1
- 238000010419 pet care Methods 0.000 description 1
- 239000003208 petroleum Substances 0.000 description 1
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 1
- 125000005498 phthalate group Chemical class 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920001983 poloxamer Polymers 0.000 description 1
- 229920002006 poly(N-vinylimidazole) polymer Polymers 0.000 description 1
- 229920001495 poly(sodium acrylate) polymer Polymers 0.000 description 1
- 229920000162 poly(ureaurethane) Polymers 0.000 description 1
- 229920002647 polyamide Polymers 0.000 description 1
- 229920000768 polyamine Polymers 0.000 description 1
- 239000004417 polycarbonate Substances 0.000 description 1
- 229920000515 polycarbonate Polymers 0.000 description 1
- 229920000647 polyepoxide Polymers 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 229920001195 polyisoprene Polymers 0.000 description 1
- 229920000098 polyolefin Polymers 0.000 description 1
- 229920002635 polyurethane Polymers 0.000 description 1
- 239000004814 polyurethane Substances 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000002203 pretreatment Methods 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 239000011164 primary particle Substances 0.000 description 1
- 229940121649 protein inhibitor Drugs 0.000 description 1
- 239000012268 protein inhibitor Substances 0.000 description 1
- 230000006920 protein precipitation Effects 0.000 description 1
- ROSDSFDQCJNGOL-UHFFFAOYSA-N protonated dimethyl amine Natural products CNC ROSDSFDQCJNGOL-UHFFFAOYSA-N 0.000 description 1
- 150000003856 quaternary ammonium compounds Chemical class 0.000 description 1
- 238000002708 random mutagenesis Methods 0.000 description 1
- 238000010188 recombinant method Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- KUIXZSYWBHSYCN-UHFFFAOYSA-L remazol brilliant blue r Chemical compound [Na+].[Na+].C1=C(S([O-])(=O)=O)C(N)=C2C(=O)C3=CC=CC=C3C(=O)C2=C1NC1=CC=CC(S(=O)(=O)CCOS([O-])(=O)=O)=C1 KUIXZSYWBHSYCN-UHFFFAOYSA-L 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 239000013557 residual solvent Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229910052707 ruthenium Inorganic materials 0.000 description 1
- 108010038196 saccharide-binding proteins Proteins 0.000 description 1
- 235000005713 safflower oil Nutrition 0.000 description 1
- 239000003813 safflower oil Substances 0.000 description 1
- 231100000241 scar Toxicity 0.000 description 1
- 238000005201 scrubbing Methods 0.000 description 1
- 150000003333 secondary alcohols Chemical group 0.000 description 1
- 238000002864 sequence alignment Methods 0.000 description 1
- 229920002545 silicone oil Polymers 0.000 description 1
- RYMZZMVNJRMUDD-HGQWONQESA-N simvastatin Chemical compound C([C@H]1[C@@H](C)C=CC2=C[C@H](C)C[C@@H]([C@H]12)OC(=O)C(C)(C)CC)C[C@@H]1C[C@@H](O)CC(=O)O1 RYMZZMVNJRMUDD-HGQWONQESA-N 0.000 description 1
- 235000020183 skimmed milk Nutrition 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 239000000429 sodium aluminium silicate Substances 0.000 description 1
- 235000012217 sodium aluminium silicate Nutrition 0.000 description 1
- URGAHOPLAPQHLN-UHFFFAOYSA-N sodium aluminosilicate Chemical compound [Na+].[Al+3].[O-][Si]([O-])=O.[O-][Si]([O-])=O URGAHOPLAPQHLN-UHFFFAOYSA-N 0.000 description 1
- NNMHYFLPFNGQFZ-UHFFFAOYSA-M sodium polyacrylate Chemical compound [Na+].[O-]C(=O)C=C NNMHYFLPFNGQFZ-UHFFFAOYSA-M 0.000 description 1
- GIPRGFRQMWSHAK-UHFFFAOYSA-M sodium;2-propan-2-ylbenzenesulfonate Chemical compound [Na+].CC(C)C1=CC=CC=C1S([O-])(=O)=O GIPRGFRQMWSHAK-UHFFFAOYSA-M 0.000 description 1
- FJBHGWADYLMEJG-UHFFFAOYSA-M sodium;3-[[4-[[4-(diethylamino)phenyl]-[4-[ethyl-[(3-sulfonatophenyl)methyl]azaniumylidene]cyclohexa-2,5-dien-1-ylidene]methyl]-n-ethylanilino]methyl]benzenesulfonate Chemical compound [Na+].C1=CC(N(CC)CC)=CC=C1C(C=1C=CC(=CC=1)N(CC)CC=1C=C(C=CC=1)S([O-])(=O)=O)=C(C=C1)C=CC1=[N+](CC)CC1=CC=CC(S([O-])(=O)=O)=C1 FJBHGWADYLMEJG-UHFFFAOYSA-M 0.000 description 1
- LJFWQNJLLOFIJK-UHFFFAOYSA-N solvent violet 13 Chemical compound C1=CC(C)=CC=C1NC1=CC=C(O)C2=C1C(=O)C1=CC=CC=C1C2=O LJFWQNJLLOFIJK-UHFFFAOYSA-N 0.000 description 1
- 239000003549 soybean oil Substances 0.000 description 1
- 235000012424 soybean oil Nutrition 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 235000015096 spirit Nutrition 0.000 description 1
- 238000007619 statistical method Methods 0.000 description 1
- KKEYFWRCBNTPAC-UHFFFAOYSA-L terephthalate(2-) Chemical compound [O-]C(=O)C1=CC=C(C([O-])=O)C=C1 KKEYFWRCBNTPAC-UHFFFAOYSA-L 0.000 description 1
- 150000001911 terphenyls Chemical class 0.000 description 1
- 125000005207 tetraalkylammonium group Chemical group 0.000 description 1
- 239000004753 textile Substances 0.000 description 1
- 230000036964 tight binding Effects 0.000 description 1
- 229910052719 titanium Inorganic materials 0.000 description 1
- 239000010936 titanium Substances 0.000 description 1
- 238000004448 titration Methods 0.000 description 1
- 125000005208 trialkylammonium group Chemical group 0.000 description 1
- BSVBQGMMJUBVOD-UHFFFAOYSA-N trisodium borate Chemical compound [Na+].[Na+].[Na+].[O-]B([O-])[O-] BSVBQGMMJUBVOD-UHFFFAOYSA-N 0.000 description 1
- 239000012588 trypsin Substances 0.000 description 1
- 230000001810 trypsinlike Effects 0.000 description 1
- WFKWXMTUELFFGS-UHFFFAOYSA-N tungsten Chemical compound [W] WFKWXMTUELFFGS-UHFFFAOYSA-N 0.000 description 1
- 229910052721 tungsten Inorganic materials 0.000 description 1
- 239000010937 tungsten Substances 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- 238000000108 ultra-filtration Methods 0.000 description 1
- 150000003672 ureas Chemical class 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 239000001018 xanthene dye Substances 0.000 description 1
- 101150038987 xylR gene Proteins 0.000 description 1
- 108010083879 xyloglucan endo(1-4)-beta-D-glucanase Proteins 0.000 description 1
- 229910000368 zinc sulfate Inorganic materials 0.000 description 1
- 239000002888 zwitterionic surfactant Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/52—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from bacteria or Archaea
- C12N9/54—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from bacteria or Archaea bacteria being Bacillus
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D3/00—Other compounding ingredients of detergent compositions covered in group C11D1/00
- C11D3/16—Organic compounds
- C11D3/38—Products with no well-defined composition, e.g. natural products
- C11D3/386—Preparations containing enzymes, e.g. protease or amylase
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D3/00—Other compounding ingredients of detergent compositions covered in group C11D1/00
- C11D3/16—Organic compounds
- C11D3/38—Products with no well-defined composition, e.g. natural products
- C11D3/386—Preparations containing enzymes, e.g. protease or amylase
- C11D3/38681—Chemically modified or immobilised enzymes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
- C12Y304/21—Serine endopeptidases (3.4.21)
- C12Y304/21062—Subtilisin (3.4.21.62)
Definitions
- This invention relates to consumer products comprising proteases, as well as methods of making and using such consumer products.
- a laundry detergent composition that may, in one aspect, comprise a hueing agent, a cold-water soluble brightener, a bleach catalyst, a first wash lipase, a bacterial cleaning cellulase, a Guerbet nonionic surfactant and/or a perfume capsule, improves one or more of the cleaning, whiteness, whiteness perception, and/or freshness profile of such consumer product.
- This invention relates to consumer products comprising proteases, particularly cold water proteases and processes for making and using such products.
- proteases are derived from a parent enzyme, subtilisin derived from Bacillus lentus, by substitution, insertion and/or deletion of one or more of the parent enzymes' amino acids.
- FIG. 1 provides an alignment of the mature reference proteases including: Bacillus amyloliquefaciens subtilisin BPN' (SEQ ID NO:2) and B. lentus subtilisin GG36 protease (SEQ ID NO: l ).
- Each amino acid position of each protease variant described herein, including each cold water protease variant is numbered according to the numbering of the corresponding amino acid position in the amino acid sequence of Bacillus amyloliquefaciens subtilisin BPN' shown in Figure 1 as determined by alignment of the protease variant amino acid sequence with the Bacillus amyloliquefaciens subtilisin BPN' amino acid sequence.
- Figure 2 shows the pHPLT-GG36 Expression Plasmid.
- Figure 3 shows the pRA68 Expression Plasmid.
- Figure 4 shows the pRA96 Expression Plasmid. DETAILED DESCRIPTION OF THE INVENTION
- consumer product means fabric and home care product.
- fabric and home care product refers to fabric and home care products and/or generally intended to be used or consumed in the form in which they are sold and that are for treating fabrics, hard surfaces and any other surfaces, and cleaning systems all for the care and cleaning of inanimate surfaces, as well as fabric conditioner products and other products designed specifically for the care and maintenance of fabrics, and air care products, including: air care including air fresheners and scent delivery systems, car care, pet care, livestock care, personal care, jewelry care, dishwashing, fabric conditioning (including softening and/or freshening), laundry detergency, laundry and rinse additive and/or care, pre-treatment cleaning compositions, hard surface cleaning and/or treatment including floor and toilet bowl cleaners, glass cleaners and/or treatments, tile cleaners and /or treatments, ceramic cleaners and/or treatments, and other cleaning for consumer or institutional use.
- air care including air fresheners and scent delivery systems
- car care including air fresheners and scent delivery systems
- car care including air fresheners and scent delivery systems
- car care including air fresheners and scent delivery systems
- the fabric and home care products are suitable for use on wounds and/or skin.
- “Fabric and home care product” includes consumer and institutional products. This definition does not include products (a) intended to be used to clean contact lenses, or ultrafiltration membranes, or (b) in healing wounds or for the medical treatment of skin conditions. Such fabric and home care products are generally intended to be used or consumed in the form in which they are sold.
- cleaning and/or treatment composition is a subset of fabric and home care products.
- Such products include, but are not limited to, products for treating fabrics, hard surfaces and any other surfaces in the area of fabric and home care, including: air care including air fresheners and scent delivery systems, car care, dishwashing, fabric conditioning (including softening and/or freshening), laundry detergency, laundry and rinse additive and/or care, hard surface cleaning and/or treatment including floor and toilet bowl cleaners, granular or powder-form all-purpose or "heavy-duty” washing agents, especially cleaning detergents; liquid, gel or paste-form all-purpose washing agents, especially the so-called heavy-duty liquid types; liquid fine-fabric detergents; hand dishwashing agents or light duty dishwashing agents, especially those of the high-foaming type; machine dishwashing agents, including the various tablet, granular, liquid and rinse-aid types for household and institutional use: car or carpet shampoos, bathroom cleaners including toilet bowl cleaners; as well as cleaning auxiliaries such
- the term "fabric and/or hard surface cleaning and/or treatment composition” is a subset of cleaning and treatment compositions that includes, unless otherwise indicated, granular or powder-form all-purpose or "heavy-duty” washing agents, especially cleaning detergents; liquid, gel or paste-form all-purpose washing agents, especially the so-called heavy-duty liquid types; liquid fine-fabric detergents; hand dishwashing agents or light duty dishwashing agents, especially those of the high-foaming type; machine dishwashing agents, including the various tablet, granular, liquid and rinse-aid types for household and institutional use; liquid cleaning and disinfecting agents, car or carpet shampoos, bathroom cleaners including toilet bowl cleaners; fabric conditioning products including softening and/or freshening that may be in liquid, solid and/or dryer sheet form ; as well as cleaning auxiliaries such as bleach additives and "stain-stick" or pre-treat types, substrate-laden products such as dryer added sheets. All of such products which are applicable may be in standard, concentrated or even highly concentrated form even
- the term "cold water protease variant” means a variant of a parent protease, said parent protease' s sequence being at least 90%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, at least 99.5% or 100% identical to the amino acid sequence of SEQ ID NO: 1 , said variant having one or more of the following characteristics:
- a Test Method 6 performance index of at least 1.1 , at least 1.2, at least 1.3, at least 1.4, at least 1.5, at least 1.6, at least 1.7, at least 1.8, at least 1.9, at least 2; from 1.1 to about 10, from 1.1 to about 8 or even from 1.1 to about 5, wherein each amino acid position is numbered according to the numbering of the corresponding amino acid position in the amino acid sequence of Bacillus amyloliquefaciens subtilisin BPN' .
- Preferred cold water proteases suitable for use in the present invention have the characteristics according to Test Method 6 as defined in d) above.
- Test Method 2 Test Method 3
- Test Method 4 Test Method 6
- protease variant means a variant of a parent protease, said parent protease' s sequence being at least 90%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, at least 99.5% or 100% identical to the amino acid sequence of SEQ ID NO: 1.wherein each amino acid position is numbered according to the numbering of the corresponding amino acid position in the amino acid sequence of Bacillus amyloliquefaciens subtilisin BPN' .
- solid includes granular, powder, bar and tablet product forms.
- fluid includes liquid, gel, paste and gas product forms.
- situs includes fabrics, garments, and/or hard surfaces.
- component or composition levels are in reference to the active portion of that component or composition, and are exclusive of impurities, for example, residual solvents or by-products, which may be present in commercially available sources of such components or compositions.
- the consumer products comprising the variant proteases disclosed herein find particular use in the cleaning industry, for example, laundry and dish detergents. These applications place enzymes under various environmental stresses.
- the variant proteases employed in the present invention provide advantages over many currently used enzymes, due, at least in part to, their stability under various conditions.
- wash conditions including varying detergent formulations, wash water volumes, wash water temperatures, and lengths of wash time, to which proteases involved in washing are exposed.
- detergent formulations used in different geographical areas have different concentrations of their relevant components present in the wash water.
- European detergents typically have about 4500-5000 ppm of detergent components in the wash water
- Japanese detergents typically have approximately 667 ppm of detergent components in the wash water.
- detergents typically have about 975 ppm of detergent components present in the wash water.
- a low detergent concentration system includes detergents where less than about 800 ppm of the detergent components are present in the wash water.
- Japanese detergents are typically considered low detergent concentration system as they have approximately 667 ppm of detergent components present in the wash water.
- a medium detergent concentration includes detergents where between about 800 ppm and about 2000ppm of the detergent components are present in the wash water.
- North American detergents are generally considered to be medium detergent concentration systems as they have
- a high detergent concentration system includes detergents where greater than about 2000 ppm of the detergent components are present in the wash water.
- European detergents are generally considered to be high detergent concentration systems as they have approximately 4500-5000 ppm of detergent components in the wash water.
- Latin American detergents are generally high suds phosphate builder detergents and the range of detergents used in Latin America can fall in both the medium and high detergent concentrations as they range from 1500 ppm to 6000 ppm of detergent components in the wash water. As mentioned above, Brazil typically has approximately 1500 ppm of detergent components present in the wash water. However, other high suds phosphate builder detergent geographies, not limited to other Latin American countries, may have high detergent concentration systems up to about 6000 ppm of detergent components present in the wash water.
- concentrations of detergent compositions in typical wash solutions throughout the world varies from less than about 800 ppm of detergent composition ("low detergent concentration geographies"), for example about 667 ppm in Japan, to between about 800 ppm to about 2000 ppm ("medium detergent concentration geographies” ), for example about 975 ppm in U.S. and about 1500 ppm in Brazil, to greater than about 2000 ppm ("high detergent concentration geographies”), for example about 4500 ppm to about 5000 ppm in Europe and about 6000 ppm in high suds phosphate builder geographies.
- low detergent concentration geographies for example about 667 ppm in Japan
- intermediate detergent concentration geographies for example about 975 ppm in U.S. and about 1500 ppm in Brazil
- high detergent concentration geographies for example about 4500 ppm to about 5000 ppm in Europe and about 6000 ppm in high suds phosphate builder geographies.
- concentrations of the typical wash solutions are determined empirically. For example, in the U.S., a typical washing machine holds a volume of about 64.4 L of wash solution. Accordingly, in order to obtain a concentration of about 975 ppm of detergent within the wash solution about 62.79 g of detergent composition must be added to the 64.4 L of wash solution. This amount is the typical amount measured into the wash water by the consumer using the measuring cup provided with the detergent.
- different geographies use different wash temperatures.
- the temperature of the wash water in Japan is typically less than that used in Europe.
- the temperature of the wash water in North America and Japan is typically between about 10 and about 30°C (e.g., about 20°C), whereas the temperature of wash water in Europe is typically between about 30 and about 60°C (e.g., about 40°C).
- cold water is typically used for laundry, as well as dish washing applications.
- the "cold water washing" of the present invention utilizes washing at temperatures from about 10°C to about 40°C, or from about 20°C to about 30°C, or from about 15°C to about 25°C, as well as all other combinations within the range of about 15°C to about 35°C, and all ranges within 10°C to 40°C.
- Water hardness is usually described in terms of the grains per gallon mixed Ca 2+ Mg 2+ .
- Hardness is a measure of the amount of calcium (Ca 2+ ) and magnesium (Mg 2+ ) in the water. Most water in the United States is hard, but the degree of hardness varies.
- Moderately hard (60- 120 ppm) to hard ( 121 - 181 ppm) water has 60 to 181 parts per million (parts per million converted to grains per ⁇ U.S. gallon is ppm # divided by 17.1 equals grains per gallon) of hardness minerals.
- European water hardness is typically greater than about 10.5 (for example about 10.5 to about 20.0) grains per gallon mixed Ca 2 7Mg 2+ (e.g., about 15 grains per gallon mixed Ca 2+ /Mg 2+ ).
- North American water hardness is typically greater than Japanese water hardness, but less than European water hardness.
- North American water hardness can be between about 3 to about 10 grains, about 3 to about 8 grains or about 6 grains.
- Japanese water hardness is typically lower than North American water hardness, usually less than about 4, for example about 3 grains per gallon mixed Ca 2+ /Mg 2+ .
- the present invention provides consumer products that show surprising wash performance in at least one set of wash conditions (e.g., water temperature, water hardness, and/or detergent concentration).
- wash conditions e.g., water temperature, water hardness, and/or detergent concentration.
- the present invention comprises a method for washing
- the consumer products of the present invention are comparable in wash performance to other consumer products comprising other subtilisin proteases. In some embodiments, the consumer products of the present invention exhibit enhanced wash
- the consumer products comprising the variant proteases provided herein exhibit enhanced cleaning due, at least in part to, to enhanced oxidative stability, enhanced thermal stability, enhanced cleaning capabilities under various conditions, and/or enhanced chelator stability of the enzymes employed.
- compositions disclosed herein are consumer products.
- a composition comprising an adjunct material and a cold water protease variant, said composition being a consumer product, is disclosed.
- Test Method 2 Test Method 3
- Test Method 4 Test Method 6
- said protease variant comprises one or more, or even two or more or preferably three or more of the following mutations XIR, X2S, X2M, X2A, X2R, X2W, X3R, X4R, X4S, X4C, X8A, X9A, X9F, X9W, XI OS, XI OA, XI OH, X10M, X12F, X12R, X14K, X14F, X14Q, X15R, X15F, X16S, X17R, X17M, X17F, X18R, X18K, X20F, X20K, X20R, X22A, X22R, X22Y, X22V, X22Q, X22L, X22W, X23A, X23S, X23F,
- said protease variant comprises one or more, preferably two or preferably three or more of the following mutations X1 R, X2S, X4R, X4S, X9A, X I OS, X14K, X 16S, X17R, X18R, X20R, X22A, X22R, X24R, X24W, X25R, X25V, X26F, X42I, X43R, X43A, X46R, X52F, X52E, X52N, X57R, X59A, X62E, X62Q, X68A, X68C, X71G, X72C, X74C.
- said protease variant comprises one or more of the following of sets of mutations X022R-X024R, X009A-X271L, X018R-X241 R, X018R-X 1 15R, X043R-X249R, X020R-X249R, X004R-X249R, X020R-X024R, X018R-X249R, X009A- X020R, X020R-X241 R, X009A-X078R, X020R-X 1 15R, X018R-X024R, X024R-X242R, X022R-X1 15R, X018R-X043R, X020R-X043R, X018R-X242R, X242R-X269R, X018R- X2
- said protease variant comprises a total of three, four, five, six, seven, eight, nine, 10, 1 1 , 12, 13, 14, 15, 16, 17, 18, 19, 20, 21 , 22, 23, 24, or even 25 mutations, preferably three or four, most preferably three mutations, selected from: X 1 R, X2S, X2M, X2A, X2R, X2W, X3R, X4R, X4S, X4C, X8A, X9A, X9F, X9W, X I OS, X I OA, X I OH, X10M, X12F, X12R, X14K, X14F, X14Q, X15R, X15F, X16S, X17R, X17M, X17F, X18R, X18K, X20F, X20K, X20R, X22A, X22R
- said protease variant comprises a total of three, four, five, six, seven, eight, nine, 10, 1 1 , 12, 13, 14, 15, 16, 17, 18, 19, 20, 21 , 22, 23, 24, or even 25 mutations, preferably three or four, most preferably three mutations, selected from: X1R, X2S, V4R, V4S, X9A, XI OS, X 14K, X16S, H17R, X18R, X20R, X22A, X22R, X24R, X24W, X25R, X25V, X26F, X42I, X43R, X43A, G46R, X52F, X52E, X52N, T57R, Q59A, X62E, X62Q, X68A, X68C, X71G, X72C, X74C, X75A, X75F, X75R,
- said protease variant comprises:
- protease variants having the amino acid sequence of SEQ ID NO: 1.
- protease variants may be particularly preferred in an aqueous wash liquor with low ionic strength or low detergent concentrations.
- said protease variant comprises:
- said parent protease can be selected from the group consisting of the enzymes commercially available under the tradenames Savinase®, Polarzyme®, Kannase®, Liquanase®, Liquanase Ultra®, Savinase Ultra®, Ovozyme® by Novozymes A/S (Denmark), those sold under the tradename Maxacal®, Properase®, Purafect®, FN3®, FN4®, Excellase®, and Purafect OXP® by Genencor International and those available from Henkel/ Kemira, namely BLAP (sequence shown in Figure 29 of US 5,352,604 with the following mutations S99D + SI 01 R + S I 03 A + V I 041 + G159S, hereinafter referred to as BLAP) and BLAP X (BLAP with S3T + V4I + V205I).
- said composition comprises a protease variant (e.g., variant subtilisin) whose parent has proteolytic activity, said variant protease comprising an amino acid sequence which differs from the amino acid sequence shown in SEQ ID NO: 1 by no more than 50, no more than 40, no more than 35, no more than 30, no more than 25, no more than 20, no more than 19, no more than 18, no more than 17, no more than 16, no more than 15, no more than 14, no more than 13, no more than 12, no more than 1 1 , no more than 10, no more than 9, or no more than 8 amino acid residues, wherein amino acid positions are numbered according to the numbering of corresponding amino acid positions in the amino acid sequence of Bacillus amyloliquefaciens subtilisin BPN' shown in SEQ ID NO:2, as determined by alignment of the variant protease amino acid sequence with the Bacillus amyloliquefaciens subtilisin BPN' amino acid sequence, wherein the variant subtilisin includes one of the following sets of substitutions
- said adjunct material may comprise an ingredient selected from the group consisting of: an encapsulate comprising a perfume, a hueing agent, surfactants, builders, chelating agents, dye transfer inhibiting agents, dispersants, additional enzymes, enzyme stabilizers, catalytic materials, bleach activators, hydrogen peroxide, sources of hydrogen peroxide, preformed peracids, polymeric dispersing agents, clay soil removal/anti- redeposition agents, brighteners, suds suppressors, dyes, perfumes, structure elasticizing agents, fabric softeners, carriers, hydrotropes, processing aids, solvents, pigments and mixtures thereof.
- an encapsulate comprising a perfume, a hueing agent, surfactants, builders, chelating agents, dye transfer inhibiting agents, dispersants, additional enzymes, enzyme stabilizers, catalytic materials, bleach activators, hydrogen peroxide, sources of hydrogen peroxide, preformed peracids, polymeric dispersing agents, clay soil removal/anti- redeposition agents, brighteners,
- said composition may comprise an adjunct material selected from the group consisting of:
- a bleach catalyst that may comprise a metal catalyst such as a transition metal catalyst, or more preferably, a material selected from the group consisting of iminium cations, iminium polyions; iminium zwitterions; modified amines; modified amine oxides; N-sulphonyl imines; N-phosphonyl imines; N-acyl imines; thiadiazole dioxides; perfluoroimines; cyclic sugar ketones and mixtures thereof;
- a metal catalyst such as a transition metal catalyst, or more preferably, a material selected from the group consisting of iminium cations, iminium polyions; iminium zwitterions; modified amines; modified amine oxides; N-sulphonyl imines; N-phosphonyl imines; N-acyl imines; thiadiazole dioxides; perfluoroimines; cyclic sugar ketones and mixtures thereof;
- said protease variant comprises one or more, or even two or more of the following mutations A001R, Q002S, Q002M, Q002A, Q002R, Q002W, S003R, V004R, V004S, V004C, I008A, S009A, S009F, S009W, R010S, R010A, R010H, R010M, Q012F, Q012R, P014K, P014F, P014Q, A015R, A015F, A016S, H017R, H017M, H017F, N018R, N018K, GO20F, G020K, G020R, T022A, T022R, T022Y, T022V, T022Q, T022L, T022W, G023A, G023S, G023F, S024R, S024
- said protease variant comprises one or more, or even two or more of the following mutations AIR, Q2S, V4R, V4S, S9A, R10S, P14 , A16S, H17R, N18R, G20R, T22A, T22R, S24R, S24W, G25R, G25V, V26F, L42I, N43R, N43A, G46R, P52F, P52E, P52N, T57R, Q59A, N62E, N62Q, V68A, V68C, T71G, I72C, A74C.
- a composition comprising an adjunct material and a protease variant, wherein said protease variant comprises one or more of the following sets of mutations: G020R-N043R, N062E-A 158E, S 103G-A 158E, S 128N-A 158E, A016S-A158E, V104L-A158E, E089P-A158E, LI 11V-A158E, T022A-A158E, S101A-A158E, L148I-A158E, P129E-A158E, T022A-E089P, A016S-E089P, N062E-E089P, N062E-E271F, A 158E-E27 IF, Rl 86H-E271 F, P 129E-E271 F, L 111 V-E271 F, Y209E-E271 F, AO 16S-E27
- the composition comprises a protease variant as described above wherein in addition to one or more of the defined sets of mutations, the total net charge of the variant is adjusted to a total net charge of 0, +1 , +2, +3, +4, +5, -1 , -2, -3, -4, or -5 relative to the total net charge of the Bacillus lentus subtilisin GG36 protease (SEQ ID NO: 1 ) by one or more additional substitutions selected from N43D, R45T, N62E, N76D, S 101 D, P 129E, A 158E, G159D, G159E, S 166D, S 188D, A230E, N18R, G20K, G20R, T22R, S24R, N43R, Gl 18R, Q245R, H249R, N269R, E271F and E271 L.
- SEQ ID NO: 1 Bacillus lentus subtilisin GG36 protease
- negative charge is added by one or more substitutions selected from N043D, R045T, N076D and A230E.
- positive charge is added by one or more substitutions selected from G020K, S024R, G 1 18R, Q245R, H249R, E271 F and E271 L.
- the protease variant is selected from protease variants having one or more of the sets of mutations selected from the group consisting of: G020R-N043R, N062E-A 158E, S 103G-A 158E, S 128N-A158E, A016S-A158E, V104L-A158E, E089P-A158E, LI 1 1V-A 158E, T022A-A 158E, S 101 A-A 158E, L148I-A 158E, P129E-A 158E, T022A-E089P, AO 16S-E089P, N062E-E089P, N062E-E271 F, A 158E-E271 F, R 186H-E271 F, P 129E-E271 F, L 1 1 1 V-E271 F, Y209E-E271 F, AO 16S-E271 F, S 188
- preferred proteases comprise at least one, or even two or more charged mutations selected from the group consisting of N062E, S 101 D, P129E, A 158E, G159D/E, S 166D and/or S I 88D: Such proteases are particularly preferred for incorporation into detergent compositions suitable for addition to water to make a wash liquor preferably having low ionic strength or low detergent concentration.
- these proteases will form part of a detergent composition that is added to water, either for a handwashing or machine washing process, typically within a washing machine, to form a wash liquor, whose conductivity is from about 0.1 mS/cm to about 3 mS/cm, from about 0.3 mS/cm to about 2.5 mS/cm, or even from about 0.5 mS/cm to about 2 mS/cm.
- such proteases that comprise at least one, or even two or more charged mutations selected from the group consisting of N062E, S 101 D, P129E, A 158E, G 159D/E, S 166D, and/or S 188D have a charge of 0, - 1 , -2, -3, -4 or -5, preferably 0, - 1 , -2 or -3, most preferably - 1 or -2 relative to the enzyme of SEQ ID NO: 1.
- Preferred mutations to arrive at a desired net charge comprise one, two or more mutations selected from the group consisting of: G20K, S024R, G l 18R, Q245R, H249R and E271 F/L.
- proteases for use in the invention:
- (c) comprise one, two, three or more mutations to arrive at a desired net charge selected from the group comprising G20K, S024R, Gl 18R, Q245R, H249R and/or E271F L.
- mutantations to arrive at a desired net charge it is intended to mean that when the enzyme variant is compared to the Bacillus lentus subtilisin GG36 protease, the total net charge of the variant relative to Bacillus lentus subtilisin GG36 can be adjusted to be within the preferred range by selecting one or more further mutations preferably selected from the mutations identified, for example listed in (c) above.
- these preferred proteases form part of a detergent composition that is added to water, either in a hand or machine washing process, typically within a washing machine, to form a wash liquor, whose conductivity is from about 0.1 mS/cm to about 3 mS/cm, from about 0.3 mS/cm to about 2.5 mS/cm, or even from about 0.5 mS/cm to about 2 mS/cm.
- preferred proteases comprise at least one or two or more charged mutations selected from the group consisting of N018R, G020K/R,
- proteases are particularly preferred for incorporation into detergent compositions which will be added to water to make a wash liquor preferably having high ionic strength or high detergent concentration.
- these preferred proteases may form part of a detergent composition that is added to water, either for hand washing or machine washing, typically within a washing machine, to form a wash liquor, whose conductivity is from above about 3 mS/cm to about 30 mS/cm, from about 3.5 mS/cm to about 20 mS/cm, or even from about 4mS/cm to about 10 mS/cm.
- such proteases comprise at least one, or two or even more charged mutations selected from the group consisting of N018R, G020K/R, T022R, S024R, N043R, Q245R, H249R and/or N269R have a charge of 0, + 1 , +2, +3, 4 or +5, preferably + 1 , +2 or +3, most preferably +2 relative to the enzyme of SEQ ID NO: 1.
- Preferred mutations to arrive at a desired net charge comprise one, two or more mutations selected from the group consisting of: N043D, R045T, N076D and/or A230E.
- (a) comprise one or two or more charged mutations selected from the group consisting of N018R, G020K/R, T022R, S024R, N043R, Q245R, H249R and/or N269R; and/or
- (b) have a charge of 0, + 1 , +2, +3, +4 or +5, preferably +1 , +2 or +3, most preferably +2 relative to the enzyme of SEQ ID NO: 1 ;
- (c) comprise mutations to arrive at a desired net charge selected from the group consisting of N043D, R045T, N076D and/or A230E.
- these proteases form part of a detergent composition that is added to water either in a hand or machine washing process, typically within a washing machine, to form a wash liquor, whose conductivity is from above about 3 mS/cm to about 30 mS/cm, from about 3.5 mS/cm to about 20 mS/cm, or even from about 4mS/cm to about 10 mS/cm.
- said protease variant comprises one or more, preferably two or more, or three or more of the following sets of mutations T022R-S024R, S009A-E271 L, N018R-W241 R, N018R-G1 15R, N043R-H249R, G020R-H249R, V004R- H249R, G020R-S024R, N018R-H249R, S009A-G020R, G020R-W241 R, S009A-S078R,
- said protease variant comprises one or more of the following of sets of mutations: G020K-G023 A-N043 W-G 1 18R-S 128I-P 129E-G 159D-S 188D, G020K-G023A-N062E-N1 16L, G020K-G023A-N062E-N1 16L-S 188D, G020K-G023A- N062E-N 1 16L-S 188D-T213 A, G020K-G 100S-N 1 16L- A 158E-S 166D-N243F, G020K- N043W-N062E-N1 16L-S 188D, G020K-N062E, G020K-N062E- 1 16L, G020K-N062E- N 1 16L-S 188D, G020K-N062E- 1 16L, G020K-N062E
- T ese protease variants are highly preferred protease variants for use in methods of treating and/or cleaning surfaces in which (i) the surface is contacted with a composition comprising an adjunct material and a protease variant in an aqueous wash liquor; and (ii) the surface is then rinsed and/or dried in which the aqueous wash liquor preferably has low ionic strength and/or low detergent concentration.
- said protease variant comprises one or more of the following sets of mutations: A016S-N062E-A 158E-H249R-E271 F, A016S-N062E-S 128N- R 186H-E27 I F, AO 16S-N062E- V 104L-R 186H-S 188D-E271 F, AO 16S-S 101 A-S 128N-R 186H, AO 16S-S 128N-A 158E-R 186H, AO 16S- V 104L-A 158E-R 186H-E27 I F, AO 16S- V 104L-S 188D- H249R, A 158E-R 186H-H249R, A 158E-R 186H-S 188D-H249R-E271 F, G020K-G023A- N i l 6L-S 188D, G020K-G023A
- protease variants are preferred variants for use in methods of treating and/or cleaning surfaces in which (i) the surface is contacted with a composition comprising an adjunct material and a protease variant in an aqueous wash liquor; and (ii) the surface is then rinsed and/or dried in which the aqueous wash liquor preferably has low ionic strength and/or low detergent concentration.
- said protease variant comprises one or more of the following of sets of mutations: A016S-S 128N-R186H-E271 F, N076D-S 101 G-S 103 A-V 1041- A 158E-S 188D-M222S- A232V-Q245R-N248D-H249R, S024R-S 101 G-S 103A-V 104I-S 128L- P 129Q-A 158E-N 183D-S 188D-A232V-Q245R-N248D-H249R, S024R-S 101 G-S 103A-V 1041- S 128L-P 129Q-A 158E-S 188D- A232 V-Q245R-N248D-H249R-E271 G, S024R-S 101 G-S 103 A- V 104I-S 128L-P 129Q-S 130A-A-A-A-A
- protease variants are useful especially in methods of treating and/or cleaning surfaces in which (i) the surface is contacted with a composition comprising an adjunct material and a protease variant in an aqueous wash liquor; and (ii) the surface is then rinsed and/or dried in which the aqueous wash liquor preferably has low ionic strength and/or low detergent concentration.
- said protease variant comprises one or more of the following of sets of mutations: G l 18R-Y209A, Gl 18R-Y209A-N243F, L021 M-S024R-T033S, P005S-S078R-G1 18R-W241 R, P086W-G1 18R-A 133V, P086W-G1 18R-N243F, P086W- G1 18R-Y209A, P086W-Y209A-N243F, S024R-A174T, S024R-G1 18R, S024R-G1 18R- Y209A, S024R-G1 18R-Y209A-K235F, S024R-G 1 18R- Y209A-N243F, S024R-K235F, S024R-P086R, S024R-P086S-S 141G, S024R-P086R
- G020R-N076D-S 101 G-S 103A-V 104I-A232V-Q245R-N269R, G020R-N 1 16A-N269R, G020R- P052N-N062Q- Y091 F- Y 192W, G020R-Q059A-S 144R-Y 192W-T224A, G020R-S024R- 27E- N043R-N076D-A230E, G020R-S024R-N043D-H249R, G020R-S024R-N043D-N076D- S078R-S 101 G-S 103 A-V 104I-A232V-Q245R, G020R-S024R-N043D-S242R, G020R-S024R- N043R-R045T, G020R-S024R-N043R-
- protease variants are highly preferred protease variants for use in methods of treating and/or cleaning surfaces in which (i) the surface is contacted with a composition comprising an adjunct material and a protease variant in an aqueous wash liquor; and (ii) the surface is then rinsed and/or dried in which the aqueous wash liquor preferably has high ionic strength and/or high detergent concentration.
- said protease variant comprises one or more of the following of sets of mutations: S 101 G-S 103A-V 104I-A232V-Q236H-Q245R-N252K, S 101G- S 103 A-V 104I-A232 V-Q245R-N248R, S 101 G-S 103A- V 104I-G 159R- A232V-Q245R-N248D, A232V-Q245R, E089I-N 1 17F-N 185I-A215F-L233C, G020R-E089I-L217E, G020R-G023A- V 104L-Y 192W-L233C, G020R-N043D-R045T-N076D-S242R-H249R, G020R-N043D-
- protease variants are preferred protease variants for use in methods of treating and/or cleaning surfaces in which (i) the surface is contacted with a composition comprising an adjunct material and a protease variant in an aqueous wash liquor; and (ii) the surface is then rinsed and/or dried in which the aqueous wash liquor preferably has high ionic strength and/or high detergent concentration.
- said protease variant comprises one or more of the following of sets of mutations: A015T-T033S, A016T-N043R-R045T-N076D-S 101G-S 103A- V104I-A232V-Q245R-N269R, A230E-H249R, A232V-H249R, E089I-S 105T-N1 16A-A215F- S216F, E089I- Y091 F-N 185I-G21 1 Q-A270C, G020R-A090S-S 101 G-S 103 A-V 104I- 1 16A- N 183D-T213 A- A215F- A232V-Q245R, G020R-N043D-S078R-S 101 G-S 103 A-V 1041- A232V- Q245R-H249R, G020R-N043R-N
- protease variants are useful protease variants for use in methods of treating and/or cleaning surfaces in which (i) the surface is contacted with a composition comprising an adjunct material and a protease variant in an aqueous wash liquor; and (ii) the surface is then rinsed and/or dried in which the aqueous wash liquor preferably has high ionic strength and/or high detergent concentration.
- said protease variant comprises three, four, five, six, seven, eight, nine, 10, 1 1 , 12, 13, 14, 15, 16, 17, 18, 19, 20, 21 , 22, 23, 24 or even 25 mutations within the group of positions comprising positions 1 , 2, 3, 4, 8, 9, 10, 12, 14, 15, 16, 17, 18, 20, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31 , 33, 34, 35, 36, 38, 40, 42, 43, 45, 46, 48, 50, 51 , 52, 55, 57, 59, 60, 62, 63, 64, 68, 69, 71 , 72, 74, 75, 76, 78, 79, 81 , 82, 85, 86, 89, 91 , 92, 94, 99, 100, 101 , 102, 103, 104, 105, 106, 107, 108, 109, 1 1 1, 1 12, 1 14, 1 15, 1 16, 1 17, 1 18, 1 19, 120, 121 , 123, 124, 128, 129, 132,
- said protease variant comprises three, four, five, six, seven, eight, nine, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20,21,22, 23, 24 or even 25 mutations within the group of positions comprising positions 1, 2, 4, 9, 10, 14, 16, 17, 18, 20, 22, 24, 25, 26, 42, 43, 46, 52, 57, 59, 62, 68, 71, 72, 74, 75, 76, 78, 82, 86, 89, 91, 94, 100, 101, 103, 104, 106, 108, 111, 112, 115, 117, 118, 121, 128, 129, 144, 148, 158, 159, 160, 166, 185, 186, 188, 197, 203, 209, 210, 212, 214, 215, 217, 224, 230, 231, 236, 238, 239, 241, 242, 243, 244, 248, 249, 250, 252, 253, 262, 263, 265, 267,
- said protease variant comprises a total of three, four, five, six, seven, eight, nine, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20,21,22, 23, 24, or even 25 mutations selected from: A001R, Q002S, Q002M, Q002A, Q002R, Q002W, S003R, V004R, V004S, V004C, I008A, S009A, S009F, S009W, R010S, R010A, R010H, R010M, Q012F, Q012R, P014 , P014F, P014Q, A015R, A015F, A016S, H017R, H017M, H017F, N018R, N018K, G020F, G020 , G020R, T022A, T022R, T022Y, T022V, T022Q, T022L
- said protease variant comprises a total of three, four, five, six, seven, eight, nine, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, or even 25 mutations selected from: AIR, Q2S, V4R, V4S, S9A, R10S, P14K, A16S, H17R, N18R, G20R, T22A, T22R, S24R, S24W, G25R, G25V, V26F, L42I, N43R, N43A, G46R, P52F, P52E, P52N, T57R, Q59A, N62E, N62Q, V68A, V68C, T71G, I72C, A74C, L75A, L75F, L75R, N76D, S78R, L82R, P86W, E89P, E89T, E89G, E89H, E89I, E89V, E89W, Y91N, K94N
- said protease variant comprises:
- protease variant having a total net charge of 0, +1 , +2, +3, +4 or +5, preferably having a total net positive charge, most preferably + 1 , +2 or +3, relative to B. lentus subtilisin GG36 protease having the amino acid sequence of SEQ ID NO: 1.
- said composition comprises a protease variant, wherein said protease variant is a mature form having proteolytic activity and which comprises amino acid sequences comprising a combination of amino acid substitutions selected from: X 1 R, X230E, X271 L, X I 15R, X20R, X249R, X235F, X27V F/L, X75E, X82R, X 18R, X269R, X43D, X43R, X76D, X45T, X212F, X242R, X24R, X78R, X9A, X22R, X 121 E, X244R, X28E, X30E, X4R, and X241R, wherein the amino acid positions of the subtilisin variant are numbered by correspondence with the amino acid sequence of B. amyloliquefaciens subtilisin BPN' set forth as SEQ ID
- said composition comprises a protease variant, that comprises an amino acid sequence which differs from the amino acid sequence of SEQ ID NO: l in no more than two, three, four, five, six, seven, eight, nine, 10, 1 1 , 12, 13, 14, 15, 16, 17, 18, 19, 20, 21 , 22, 23, 24, or 25 mutations selected from the group of A I R, A230E, E271 L, Gl 15R, G20R, H249R, K235F, K27V F/L, L75E, L82R, N18R, N269R, N43D, N43R, N76D, R45T, S212F, S242R, S24R, S78R, S9A, T22R, V 121 E, V244R, V28E, V30E, V4R, and W241 R, wherein amino acid positions of the protease variant are numbered according to the numbering of corresponding amino acid positions in the amino acid sequence of Bacillus amyloliquef
- said composition comprises a protease variant that comprises an amino acid sequence which differs from the amino acid sequence of SEQ ID NO: 1 in no more than two, three, four, five, six, seven, eight, nine, 10, 1 1 , 12, 13, 14, 15, 16, 17, 18, 19, 20, 21 , 22, 23, 24, or 25 mutations selected from the group of A I R, A230E, E271 L, Gl 15R, G20R, H249R, K235F, K27V/F/L, L75E, L82R, N18R, N269R, N43D, N43R, N76D, R45T, S212F, S242R, S24R, S78R, S9A, T22R, V 121E, V244R, V28E, V30E, V4R, and W241 R, and optionally comprises at least one mutation selected from the group of SI 03 A, G159D, Q236H, Q245R, N248D and N252K, where
- amyloliquefaciens subtilisin BPN' shown in SEQ ID NO:2 as determined by alignment of the protease variant amino acid sequence with the Bacillus amyloliquefaciens subtilisin BPN' amino acid sequence.
- said composition comprises a protease variant, wherein said protease variant is a mature form having proteolytic activity and which comprises amino acid sequences comprising a combination of amino acid substitutions selected from: X16S, X18R, X20R, X22A, X24R, X43R/D, X45T, X76D, X101A, X103G, X104L, XI 1 IV, X128N, XI 481, X230E, X242R, and X249R, wherein the amino acid positions of the subtilisin variant are numbered by correspondence with the amino acid sequence of B. amyloliquefaciens subtilisin BPN' set forth as SEQ ID NO:2.
- said composition comprises a protease variant, wherein said protease variant is a mature form having proteolytic activity and which comprises amino acid sequences comprising a combination of amino acid substitutions selected from: A16S, N18R, G20R, T22A, S24R , N43R, N43D, R45T, N76D, S101A, S 103G, V104L, LI 1 IV, S 128N, L148I, A230E, S242R, and H249R, wherein the amino acid positions of the subtilisin variant are numbered by correspondence with the amino acid sequence of B. amyloliquefaciens subtilisin BPN' set forth as SEQ ID NO:2.
- said composition comprises a protease variant, wherein said protease variant is a mature form having proteolytic activity and which comprises amino acid sequences comprising a combination of amino acid substitutions selected from: X20R-X43R-X249R, X20R-X22R-X43R, X20R-X43R-X242R, X20R- X43R-X271 L, X20R-X43R-X244R, X20R-X24R-X43R-X242R, X9A-X22R-X78R- X212F-X241R, X9A-X20R-X43R-X212F, X9A-X43R-X212F, X20R-X43R-X212F, .
- said composition comprises a protease variant, wherein said protease variant is a mature form having proteolytic activity and which comprises amino acid sequences comprising a combination of amino acid substitutions selected from: AI R, A230E, E271L, Gl 15R, G20R, H249R, K235F, K27V F/L, L75E, L82R, N18R, N269R, N43D, N43R, N76D, R45T, S212F, S242R, S24R, S78R, S9A, T22R, V121E, V244R, V28E, V30E, V4R, W241R, G20R-N43R-H249R, G20R-T22R- N43R, G20R-N43R-S242R, G20R-N43R-E271L, G20R-N43R-V244R, G20R-S24R- N43R-S
- amyloliquefaciens subtilisin BPN' set forth as SEQ ID NO:2.
- said composition comprises a protease variant, wherein said protease variant is a mature form having proteolytic activity and which comprises amino acid sequences comprising a combination of amino acid substitutions selected from: X101 G-X103A-X104I-X232V-X245R-X248D, X 101 G-X 103A-X 1041- X 159D-X232V-X245R, X 101 G-X 103 A-X 104I-X 159R-X232V-X245R-X248D, X 101 G- X 103 A-X 104I-X 159D-X232V-X245R-X248R, X 101 G-X 103 A-X 104I-X232V-X245R, X 101 G-X 103 A-X 104I-X232V-X245R, X 101 G-X 103 A-X 104I-X232V-X245R, X 101 G-X 103
- said composition comprises a protease variant, wherein said protease variant is a mature form having proteolytic activity and which comprises amino acid sequences comprising a combination of amino acid substitutions selected from: S101G-S 103A-V104I-A232V-Q245R-N248D, S 101 G-S 103 A- VI 041- G 159D-A232V-Q245R, S 101 G-S 103 A-V 104I-G 159R-A232V-Q245R-N248D, S 101 G- S 103 A-V 104I-G 159D- A232V-Q245R-N248R, S 101 G-S 103 A-V 104I-A232V-Q245R, S 101 G-S 103 A-V 1041- A232V-Q245R-N248R, S 101 G-S 103 A-V 104I-G 159R-A232V- Q245R-
- said composition comprises a protease variant, wherein said protease variant is a mature form having proteolytic activity and comprises amino acid sequences comprising a combination of amino acid substitutions selected from: X16S, X22A, X24R, X62E, X76D, X89P, X101A/G, X103G/A, X 104L/I, XI 1 I V, X128N, X129E, X232V, XI 481, X158E, X159D/E, X166D, X186H, X188D, X209E, X236H, X238R, X245R, X248D/R, X249R, X252 R, X253R, and X271 F, wherein the amino acid positions of the subtilisin variant are numbered by correspondence with the amino acid sequence of B. amyloliquefaciens subtilis subtilis subtilis subtilis
- said composition comprises a protease variant, wherein said protease variant is a mature form having proteolytic activity and comprises amino acid sequences comprising a combination of amino acid substitutions selected from: A16S, T22A, S24R, N62E, N76D, E89P, S 101A/G, S 103G/A, V104L/I, LI 1 I V, S 128N, P129E, A232V, LI 481, A 158E, G159D E, R186H, S 188D, Y209E, Q236H, Q245R, N248D/R, H249R, N252K R, T253R and E27 I F wherein amino acid positions of the subtilisin variant are numbered by correspondence with the amino acid sequence of B. amyloliquefaciens subtilisin BPN' set forth as SEQ ID NO:2.
- said composition comprises a protease variant that comprises an amino acid sequence which differs from the amino acid sequence of SEQ ID NO: l in no more than two, three, four, five, six, seven, eight, nine, 10, 1 1 , 12, 13, 14, 15, 16, 17, 18, 19, 20, 21 , 22, 23, 24, or 25 mutations selected from the group of A 16S, T22A, S24R, N62E, N76D, E89P, S 101A/G, S 103G/A, V 104L I, L1 1 1V, S128N, P129E, A232V, L148I, A158E, G159D/E, R186H, S188D, Y209E, Q236H, Q245R, N248D/R, H249R, N252K R, T253R, and E271F, wherein amino acid positions of the protease variant are numbered according to the numbering of corresponding amino acid positions in the amino acid sequence of Bacillus amy
- said composition comprises a protease variant that comprises an amino acid sequence which differs from the amino acid sequence of SEQ ID NO: 1 and wherein the total net charge of the protease variant is 0, +1, +2, +3, +4, +5, - 1 , -2, -3, -4, or -5 relative to the total net charge of the Bacillus lentus subtilisin GG36 protease, and wherein amino acid positions of the protease variant are numbered according to the numbering of corresponding amino acid positions in the amino acid sequence of Bacillus amyloliquefaciens subtilisin BPN' shown in SEQ ID NO:2 as determined by alignment of the protease variant amino acid sequence with the Bacillus amyloliquefaciens subtilisin BPN' amino acid sequence.
- said composition comprises a protease variant that comprises an amino acid sequence which differs from the amino acid sequence of SEQ ID NO: 1 in no more than two, three, four, five, six, seven, eight, nine, 10, 1 1, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21 , 22, 23, 24, or 25 mutations selected from the group of A IR, Q2S, V4R, V4S, S9A, R10S, P14 , A16S, H17R, N18R, G20R, T22A, T22R, S24R, S24W, G25R, G25V, V26F, L42I, N43R, N43A, G46R, P52F, P52E, P52N, T57R, Q59A, N62E, N62Q, V68A, V68C, T71 G, I72C, A74C.
- amyloliquefaciens subtilisin BPN' shown in SEQ ID NO: 2 as determined by alignment of the protease variant amino acid sequence with the Bacillus amyloliquefaciens subtilisin BPN' amino acid sequence.
- said composition comprises a protease variant that comprises an amino acid sequence which differs from the amino acid sequence of SEQ ID NO: 1 in no more than two, three, four, five, six, seven, eight, nine, 10, 1 1 , 12, 13, 14, 15, 16, 17, 18, 19, 20, 21 , 22, 23, 24, or 25 mutations selected from the group of A 16S, T22A, S24R, N62E, N76D, E89P, S 101A/G, S103G/A, V 104L/I, LI 1 IV, S 128N, P129E, A232V, L148I, A158E, G159D/E, R186H, S188D, Y209E, Q236H, Q245R, N248D/R, H249R, N252K R, T253R, and E271F, wherein amino acid positions of the protease variant are numbered according to the numbering of corresponding amino acid positions in the amino acid sequence of Bacillus amylolique
- said composition comprises a protease variant that comprises an amino acid sequence which differs from the amino acid sequence of SEQ ID NO: 1 in no more than two, three, four, five, six, seven, eight, nine, 10, 1 1 , 12, 13, 14, 15, 16, 17, 18, 19, 20, 21 , 22, 23, 24, or 25 mutations selected from the group of A IR, A230E, E271L, Gl 15R, G20R, H249R, K235F, 27V/F/L, L75E, L82R, N 18R, N269R, N43D, N43R, N76D, R45T, S212F, S242R, S24R, S78R, S9A, T22R, V 121E, V244R, V28E, V30E, V4R, and W241 R, wherein amino acid positions of the protease variant are numbered according to the numbering of corresponding amino acid positions in the amino acid sequence of Bacillus amyloliquefacien
- said composition comprises a protease variant that comprises an amino acid sequence which differs from the amino acid sequence of SEQ ID NO: 1 , wherein said protease variant comprises an amino acid sequence which differs from the amino acid sequence of SEQ ID NO: 1 in no more than two, three, four, five, six, seven, eight, nine, 10, 1 1 , 12, 13, 14, 15, 16, 17, 18, 19, 20, 21 , 22, 23, 24, or 25 mutations selected from the group of A I R, A230E, E271 L, Gl 15R, G20R, H249R, K235F, K27V/F L, L75E, L82R, N18R, N269R, N43D, N43R, N76D, R45T, S212F, S242R, S24R, S78R, S9A, T22R, V 121E, V244R, V28E, V30E, V4R, and W241 R, and optionally comprises at least one mutation selected from the group of S
- said protease variant comprises:
- protease variant having a total net charge of 0, - 1 , -2, -3, -4 or -5, preferably 0, - 1 , -2 or -3, relative to B. lentus subtilisin GG36 protease having the amino acid sequence of SEQ ID NO: 1.
- said composition comprises a second non- immunoequivalent protease selected from the group comprising:
- subtilisins EC 3.4.21.62
- trypsin-like or chymotrypsin-like proteases EC 3.4.21.62
- said composition comprises a second non- immunoequivalent protease selected from the group comprising:
- subtilisins EC 3.4.21.62
- B. subtilis B. amyloliquefaciens
- Bacillus pumilus Bacillus gibsonii;
- said composition comprises an additional enzyme selected from the group consisting of hemicellulases, peroxidases, proteases, cellulases, cellobiose dehydrogenases, xyloglucanases, xylanases, lipases, phospholipases, esterases, cutinases, pectinases, mannanases, pectate lyases, keratinases, reductases, oxidases,
- phenoloxidases lipoxygenases, ligninases, pullulanases, tannases, pentosanases, lichenases glucanases, arabinosidases, hyaluronidase, chondroitinase, laccase, amylases and mixtures thereof.
- said additional enzyme is selected from the group consisting of:
- said encapsulate comprises a perfume comprises a perfume micro capsule
- said hueing agent comprises a material selected from the group consisting of basic, acid, hydrophobic, direct and polymeric dyes, and dye-conjugates having a peak absorption wavelength of from 550nm to 650nm and mixtures thereof;
- said detersive surfactant comprises a material selected from the group consisting of anionic detersive surfactants, non-ionic detersive surfactant, cationic detersive surfactants, zwitterionic detersive surfactants and amphoteric detersive surfactants and mixtures thereof;
- said builder comprises a material selected from the group consisting of zeolites, phosphates and mixtures thereof;
- said silicate salt comprises a material selected from the group consisting of
- said brightener preferably comprises a material selected from the group consisting of cold-water soluble brighteners and mixtures thereof;
- said carboxylate polymer comprises a material selected from the group consisting of maleate/acrylate random copolymer or polyacrylate homopolymer and mixtures thereof;
- said soil release polymer comprises a material selected from the group consisting of terephthalate co-polymers and mixtures thereof;
- said cellulosic polymer comprises a material selected from the group consisting of alkyl cellulose, alkyl alkoxyalkyl cellulose, carboxyalkyl cellulose, alkyl carboxyalkyl cellulose and mixtures thereof;
- said bleach catalyst comprises a transition metal catalyst or ligand for forming a transition metal catalyst, or preferably a material selected from the group consisting of iminium cations, iminium polyions; iminium zwitterions; modified amines; modified amine oxides; N-sulphonyl imines; N-phosphonyl imines; N- acyl imines; thiadiazole dioxides; perfluoroimines; cyclic sugar ketones and mixtures thereof;
- said bleach activator comprises a material selected from the group consisting of dodecanoyl oxybenzene sulphonate, decanoyl oxybenzene sulphonate, decanoyl oxybenzoic acid or salts thereof, 3,5,5-trimethyl hexanoyloxybenzene sulphonate, tetraacetyl ethylene diamine (TAED), nonanoyloxybenzene sulphonate (NOBS) and mixtures thereof;
- said source of hydrogen peroxide comprises a material selected from the group consisting of inorganic perhydrate salts, including alkali metal salts such as sodium salts of perborate (usually mono- or tetra-hydrate), percarbonate, persulphate, perphosphate, persilicate salts and mixtures thereof;
- alkali metal salts such as sodium salts of perborate (usually mono- or tetra-hydrate), percarbonate, persulphate, perphosphate, persilicate salts and mixtures thereof;
- said chelant comprises a material selected from the group consisting of DTPA (Diethylene triamine pentaacetic acid), HEDP (Hydroxyethane diphosphonic acid), DTPMP (Diethylene triamine penta(methylene phosphonic acid)), ethylenediaminedisuccinic acid (EDDS), 1 ,2-Dihydroxybenzene-3,5-disulfonic acid disodium salt hydrate, derivatives of said chelants; and
- said composition comprises a fabric hueing agent selected from the group consisting of
- dye-clay conjugates comprising at least one cationic- basic dye and a smectite clay
- said composition comprises a fabric hueing agent selected from the group consisting of
- dye-clay conjugates comprising at least one cationic-basic dye and a smectite clay
- said composition comprises, based on total composition weight:
- compositions according to any of the consumer products disclosed herein wherein said composition is a single or multi-compartment unit dose is disclosed.
- compositions according to any of the consumer products disclosed herein wherein said composition is a multi-compartment unit dose, wherein the protease variant is in a different compartment to any source of hydrogen peroxide and/or chelant.
- an aqueous wash liquor comprising a consumer product comprising an adjunct material and a protease variant comprising:
- said aqueous wash liquor preferably having conductivity of from about 0.1 mS/cm to about 3 mS/cm, from about 0.3 mS/cm to about 2.5 mS/cm, or even from about 0.5 mS/cm to about 2 mS/cm, is disclosed.
- a wash liquor comprising a consumer product comprising an adjunct material and a protease variant comprising:
- N018R-H249R S009A-G020R, G020R-W241 R, S009A-S078R, G020R-G 1 15R, N018R-S024R, S024R-S242R, T022R-G1 15R, N018R-N043R, G020R-N043R, N018R-S242R, S242R-N269R, N018R-V244R, S024R-N269R, G020R-E271 L, S024R-E271 L, V004R-S009A, G020R-N269R, A001 R-S024R, V244R-E271 L, S009A-N018R, W241 R-E271 L, V004R-S024R, S009A-H249R, S009 A-T022R, S 101 G-S
- lentus subtilisin GG36 protease having the amino acid sequence of SEQ ID NO: 1 ; and said laundry detergent wash liquor having conductivity of from greater than about 3 mS/cm to about 30 mS/cm, from about 3.5 mS/cm to about 20 mS/cm, or even from about 4 mS/cm to about 10 mS/cm, is disclosed.
- such consumer product may be a granular or powder laundry detergent.
- any of the consumer products disclosed herein may be in the form of a multi-compartment unit dose.
- the protease variant may be in a different compartment to any additional enzymes and/or chelant.
- compositions may be a liquid laundry detergent, a dish washing product and/or a granular or powder detergent.
- any of the consumer products disclosed herein may be in the form of a multi-compartment unit dose.
- the protease may be in a different compartment to any additional enzymes and/or chelant.
- the consumer product may take any form including a fluid or solid.
- the consumer product may be in the form of a unit dose pouch, especially when in the form of a liquid, and typically the consumer product is at least partially, or even completely, enclosed by a water- soluble pouch.
- consumer product may have any combination of parameters and/or characteristics detailed above.
- Suitable protease variants include enzymes derived from a parent protease, said parent protease' s sequence being at least 90%, at least 95%, at least 96%, at least 97%, at least 98%, at least
- Preferred protease variants having the characteristics defined according to Test Method 2 above.
- Suitable proteases can be derived from subtilisins, particularly those derived from subtilisin Bacillus Lentus of SEQ ID NO: 1 and in one aspect may comprise one or more of the following mutations:
- the enzyme variant comprises at least two of the above mutations.
- suitable proteases include subtlisins, particularly Bacillus Lentus of SEQ ID NO: 1 , that may comprise one or more of the following sets of mutations, insertions or deletions:
- suitable proteases include variants of subtlisins, particularly Bacillus Lentus of SEQ ID NO: 1 , said variants comprising three, four, five, six, seven, eight, nine, 10, 1 1 , 12, 13, 14 or 15 mutations within the group of positions comprising positions 1 , 2, 4, 9, 10, 14, 16, 17, 18, 20, 22, 24, 25, 26, 42, 43, 46, 52, 57, 59, 62, 68, 71 , 72, 74, 75, 76, 78, 82, 86, 89, 91 , 94, 100, 101, 103, 104, 106, 108, 1 1 1 , 1 12, 1 15, 1 17, 1 18, 121 , 128, 129, 144, 148, 158, 159, 160, 166, 185, 186, 188, 197, 203, 209, 210, 212, 214, 215, 217, 224, 230, 231 , 236, 238, 239, 241 , 242, 243
- suitable proteases include variants of subtlisins, particularly Bacillus Lentus of SEQ ID NO: 1 , said variants comprising a total of three mutations selected from the group comprising: AI R, Q2S, V4R, V4S, S9A, R 10S, P14K, A16S, H17R, N18R, G20R, T22A, T22R, S24R, S24W, G25R, G25V, V26F, L42I, N43R, N43A, G46R, P52F, P52E, P52N, T57R, Q59A, N62E, N62Q, V68A, V68C, T71G, I72C, A74C.
- said protease is a variant of subtilisin GG36 having SEQ ID NO: 1 , said variant comprising one or more mutations, and having a total net charge of -5, -4, -3, -2, -1 or 0 relative to subtilisin GG36 wild-type, is disclosed.
- said protease variants are low ionic strength proteases.
- Such low ionic strength proteases are variants of subtilisin GG36 having SEQ ID NO:l, said variants comprising one or more mutations, preferably as defined above, and having a zero or negative total net charge, of -5, -4, -3, -2, -1 or 0, preferably 0, -1, -2 or -3, relative to subtilisin GG36 wild-type. Therefore in accordance with a preferred aspect of the invention there is provided a washing process for fabric comprising washing fabric in an aqueous wash liquor comprising such a zero or net negative total charge protease, and an adjunct material, said wash liquor having low ionic strength.
- wash liquor whose conductivity is from about 0.1 mS/cm to about 3 mS/cm, from about 0.3 mS/cm to about 2.5 mS/cm, or even from about 0.5 mS/cm to about 2 mS/cm.
- protease variants will be used in low concentration detergent compositions.
- the protease preferably comprises mutations selected from:
- the above low ionic strength proteases form part of a detergent composition that is diluted in water, typically within a washing machine, to form a wash liquor, whose conductivity is from about 0.1 mS/cm to about 3 mS/cm, from about 0.3 mS/cm to about 2.5 mS/cm, or even from about 0.5 mS/cm to about 2 mS/cm.
- said proteases are high ionic strength proteases.
- Such high ionic strength proteases are variants of subtilisin GG36 having SEQ ID NO. l , said variants comprising two or more mutations, preferably as defined above and having a total net charge of +5, +4, +3, +2, +1 or 0, preferably a positive total net charge, most preferably +1 , +2 or +3, relative to subtilisin GG36 wild-type. Therefore in accordance with a preferred aspect of the invention there is provided a washing process for fabric comprising washing fabric in an aqueous wash liquor comprising such a zero or net positive charge protease, and an adjunct material , said wash liquor having high ionic strength.
- wash liquor whose conductivity is from above 3 mS/cm to about 30 mS/cm, from about 3.5 mS/cm to about 20 mS/cm, or even from about 4mS/cm to about 10 mS/cm.
- the above high ionic strength proteases forms part of a detergent composition that is diluted in water, typically within a washing machine, to form a wash liquor, whose conductivity is from above about 3 mS/cm to about 30 mS/cm, from about 3.5 mS/cm to about 20 mS/cm, or even from about 4mS/cm to about 10 mS/cm.
- the charge of the protease variants is expressed relative to subtilisin GG36 protease wild- type having the amino acid sequence of SEQ ID NO: 1.
- the amino acids that impart a single negative charge are D and E and those that impart a single positive charge are R, H and K.
- Any amino acid change versus SEQ ID NO: 1 that changes a charge is used to calculate the charge of the protease variant. For example, introducing a negative charge mutation from a wild-type neutral position will add a net charge of - 1 to the protease variant, whereas introducing a negative charge mutation (D or E) from a wild-type positive amino acid residue (R, H or K) will add a net charge of -2. Summing the charge changes from all the amino acid residues that are different for the protease variant versus subtilisin GG36 protease wild-type having the amino acid sequence of SEQ ID NO: 1 gives the charge change of the protease variant.
- the preferred charge range for proteases to be used in low conductivity laundry detergent solutions is -5, -4, -3, -2, - 1 , 0, particularly -2, - 1 ;
- the preferred charge range for proteases to be used in high conductivity laundry detergent solutions is +5, +4, +3, +2, + 1 , 0, particularly +2, +1 .
- Low conductivity solutions are defined as having a conductivity of from about 0.1 mS/cm to about 3 mS/cm, from about 0.3 mS/cm to about 2.5 mS/cm, or even from about 0.5 mS/cm to about 2 mS/cm.
- High conductivity having conductivity solutions are defined as having a conductivity of from about 3 mS/cm to about 30 mS/cm, from about 3.5 mS/cm to about 20 mS/cm, or even from about 4 mS/cm to about 10 mS/cm.
- Suitable methods are known in the art for generating modified polynucleotide sequences of the present invention, including but not limited to site-saturation mutagenesis, scanning mutagenesis, insertional mutagenesis, deletion mutagenesis, random mutagenesis, site- directed mutagenesis, and directed-evolution, as well as various other recombinatorial approaches.
- the commonly used methods include DNA shuffling (See, Stemmer, Proc Natl Acad Sci U S A. 25: 10747-51 [ 1 94]), methods based on non-homologous recombination of genes (e.g. ITCHY) (Ostermeier et al, Bioorg Med Chem.
- the full-length parent polynucleotide is ligated into an appropriate expression plasmid, and the following mutagenesis method is used to facilitate the construction of the modified protease of the present invention, although other methods may be used.
- the method is based on that described by Pisarchik et al. (Pisarchik et al, Prot. Eng. Des. Select., 20:257-265 [2007]).
- an added advantage is provided, in that the restriction enzyme used herein cuts outside its recognition sequence, which allows digestion of practically any nucleotide sequence and precludes formation of a restriction site scar.
- a naturally-occurring gene encoding the full-length protease is obtained and sequenced and scanned for one or more points at which it is desired to make a mutation (deletion, insertion, substitution, or a combination thereof) at one or more amino acids.
- Mutation of the gene in order to change its sequence to conform to the desired sequence is accomplished by primer extension in accord with generally known methods. Fragments to the left and to the right of the desired point(s) of mutation are amplified by PCR and to include the Eam ⁇ 1041 restriction site.
- the left and right fragments are digested with Eam ⁇ 1041 to generate a plurality of fragments having complementary three base overhangs, which are then pooled and ligated to generate a library of modified sequences containing one or more mutations.
- This method avoids the occurrence of frame-shift mutations.
- this method simplifies the mutagenesis process because all of the oligonucleotides can be synthesized so as to have the same restriction site, and no synthetic linkers are necessary to create the restriction sites as is required by some other methods.
- Fluorescent optical brighteners emit at least some visible light.
- fabric hueing agents can alter the tint of a surface as they absorb at least a portion of the visible light spectrum.
- Suitable fabric hueing agents include dyes, dye-clay conjugates, and pigments that satisfy the requirements of Test Method 1 in the Test Method Section of the present specification.
- Suitable dyes include small molecule dyes and polymeric dyes. Suitable small molecule dyes include dyes selected from the group consisting of dyes falling into the Colour Index (C.I.) classifications of Direct Blue, Direct Red, Direct Violet, Acid Blue, Acid Red, Acid Violet, Basic Blue, Basic Violet and Basic Red, or mixtures thereof.
- Hueing dyes are formulated to deposit onto fabrics from the wash liquor so as to improve fabric whiteness perception.
- the hueing agent dye is blue or violet.
- the shading dye(s) may have a peak absorption wavelength of from 550nm to 650nm, or in one aspect from 570nm to 630nm. A combination of dyes which taken together have the visual effect on the human eye as a single dye having a peak absorption wavelength on polyester of from
- 550nm to 650nm 550nm to 650nm, or from 570nm to 630nm. This may be provided for example by mixing a red and green-blue dye to yield a blue or violet shade.
- Dyes are coloured organic molecules which are soluble in aqueous media that contain surfactants. Dyes are described in 'Industrial Dyes', Wiley VCH 2002, K .Hunger (editor). Dyes are listed in the Color Index International published by Society of Dyers and Colourists and the American Association of Textile Chemists and Colorists. Dyes are typically selected from the classes of basic, acid, hydrophobic, direct and polymeric dyes, and dye-conjugates. Those skilled in the art of detergent formulation are able to select suitable hueing dyes from these publications. Polymeric hueing dyes are commercially available, for example from Milliken, Spartanburg, South Carolina, USA.
- Suitable dyes are direct violet 7 , direct violet 9 , direct violet 1 1 , direct violet 26, direct violet 31 , direct violet 35, direct violet 40, direct violet 41 , direct violet 51 , direct violet 66, direct violet 99, acid violet 50, acid blue 9, acid violet 17, acid black 1 , acid red 17, acid blue 29, solvent violet 13, disperse violet 27 disperse violet 26, disperse violet 28, disperse violet 63 and disperse violet 77, basic blue 16, basic blue 65, basic blue 66, basic blue 67, basic blue 71 , basic blue 159, basic violet 19, basic violet 35, basic violet 38, basic violet 48; basic blue 3 , basic blue 75, basic blue 95, basic blue 122, basic blue 124, basic blue 141 , thiazolium dyes, reactive blue 19, reactive blue 163, reactive blue 182, reactive blue 96, Liquitint® Violet CT (Milliken, Spartanburg, USA) and Azo-CM-Cellulose (Megazyme, Bray, Republic of Ireland).
- the aforementioned fabric hueing agents can be used in combination (any mixture of fabric hueing agents can be used).
- Suitable fabric hueing agents can be purchased from Aldrich, Milwaukee, Wisconsin, USA; Ciba Specialty Chemicals, Basel, Switzerland; BASF,
- said consumer product may comprise, based on total consumer product weight, from about 0.001 wt% to about 5 wt%, from about 0.01 wt% to about 2 wt%, or even from about 0.03 wt% to about 0.5 wt%, of said encapsulate comprising a perfume, in one aspect said encapsulated perfume comprises a perfume microcapsule.
- Suitable encapsulates typically comprise a core, a shell having an inner and outer surface, said shell encapsulating said core.
- said core may comprise a material selected from the group consisting of perfumes; brighteners; dyes; insect repellants; silicones; waxes; flavors; vitamins; fabric softening agents; skin care agents in one aspect, paraffins; enzymes; anti-bacterial agents; bleaches; sensates; and mixtures thereof; and said shell may comprise a material selected from the group consisting of polyethylenes;
- aminoplasts in one aspect said aminoplast may comprise a polyureas, polyurethane, and/or polyureaurethane, in one aspect said polyurea may comprise polyoxymethyleneurea and/or melamine
- polysaccharide in one aspect said polysaccharide may comprise alginate and/or chitosan; gelatin; shellac; epoxy resins; vinyl polymers; water insoluble inorganics; silicone; and mixtures thereof.
- said core may comprise perfume.
- said shell may comprise melamine formaldehyde and/or cross linked melamine formaldehyde.
- suitable encapsulates may comprise a core material and a shell, said shell at least partially surrounding said core material, is disclosed. At least 75%, 85% or even 90% of said encapsulates may have a fracture strength of from about 0.2 MPa to about 10 MPa, from about 0.4 MPa to about 5MPa, from about 0.6 MPa to about 3.5 MPa, or even from about 0.7
- At least 75%, 85% or even 90% of said encapsulates may have a particle size of from about 1 microns to about 80 microns, about 5 microns to 60 microns, from about 10 microns to about 50 microns, or even from about 15 microns to about 40 microns.
- At least 75%, 85% or even 90% of said encapsulates may have a particle wall thickness of from about 30 nm to about 250 nm, from about 80 nm to about 180 nm, or even from about 100 nm to about 160 nm.
- said encapsulates' core material may comprise a material selected from the group consisting of a perfume raw material and/or optionally a material selected from the group consisting of vegetable oil, including neat and/or blended vegetable oils including caster oil, coconut oil, cottonseed oil, grape oil, rapeseed, soybean oil, corn oil, palm oil, linseed oil, safflower oil, olive oil, peanut oil, coconut oil, palm kernel oil, castor oil, lemon oil and mixtures thereof; esters of vegetable oils, esters, including dibutyl adipate, dibutyl phthalate, butyl benzyl adipate, benzyl octyl adipate, tricresyl phosphate, trioctyl phosphate and mixtures thereof;
- straight or branched chain hydrocarbons including those straight or branched chain hydrocarbons having a boiling point of greater than about 80 °C; partially hydrogenated terphenyls, dialkyl phthalates, alkyl biphenyls, including monoisopropylbiphenyl, alkylated naphthalene, including dipropylnaphthalene, petroleum spirits, including kerosene, mineral oil and mixtures thereof; aromatic solvents, including benzene, toluene and mixtures thereof; silicone oils; and mixtures there of.
- said encapsulates' wall material may comprise a suitable resin including the reaction product of an aldehyde and an amine, suitable aldehydes include, formaldehyde.
- Suitable amines include melamine, urea, benzoguanamine, glycoluril, and mixtures thereof.
- Suitable melamines include, methylol melamine, methylated methylol melamine, imino melamine and mixtures thereof.
- Suitable ureas include, dimethylol urea, methylated dimethylol urea, urea-resorcinol, and mixtures thereof.
- suitable formaldehyde scavengers may be employed with the encapsulates, for example, in a capsule slurry and/or added to a consumer product before, during or after the encapsulates are added to such consumer product.
- suitable capsules that can be made by following the teaching of USPA 2008/0305982 A l ; and/or USPA 2009/0247449 Al .
- suitable capsules can be purchased from
- the materials for making the aforementioned encapsulates can be obtained from Solutia Inc. (St Louis, Missouri U.S.A.), Cytec Industries (West Paterson, New Jersey U.S.A.), sigma-Aldrich (St. Louis, Missouri U.S.A.), CP Kelco Corp. of San Diego, California, USA; BASF AG of Ludwigshafen, Germany; Rhodia Corp. of Cranbury, New Jersey, USA; Hercules Corp. of Wilmington, Delaware, USA; Agrium Inc.
- a non-limiting set of methods used to make the proteases is given in examples 31 to 43.
- amyloliquefaciens subtilisin BPN' numbering system Each amino acid position of each protease variant, including each protease variant, is numbered according to the numbering of
- An alternative numbering scheme is numbering the specific amino acid sequence of the B. lentus subtilisin GG36 protease, having the amino acid sequence of SEQ ED NO: 1. None of the amino acid positions of the protease variants, including the protease variants, described herein are numbered using this alternative numbering scheme.
- Mutations are named by the one letter code for the parent amino acid, followed by a three digit position number and then the one letter code for the variant amino acid.
- mutating glycine (G) at position 87 to serine (S) is represented as “G087S” or “G87S”.
- Multiple mutations are indicated by inserting a "-" between the mutations.
- Mutations at positions 87 and 90 are represented as either "G087S-A090Y” or "G87S-A90Y” or "G87S + A90Y” or "G087S + A090Y”.
- the one letter code "Z” is used.
- the one letter code "Z" is on the left side of the position number.
- the one letter code "Z" is on the right side of the position number.
- the position number is the position number before the inserted amino acid(s), plus 0.01 for each amino acid.
- an insertion of three amino acids alanine (A), serine (S) and tyrosine (Y) between position 87 and 88 is shown as "Z087.01 A-Z087.02S-Z087.03Y.”
- Z087.01 A-Z087.02S-Z087.03Y an insertion of three amino acids alanine (A), serine (S) and tyrosine (Y) between position 87 and 88.
- the single letter X refers to any of the twenty amino acids.
- wild-type in reference to an amino acid sequence or nucleic acid sequence indicates that the amino acid sequence or nucleic acid sequence is native or naturally occurring sequence.
- naturally-occurring refers to anything (e.g., proteins, amino acids, or nucleic acid sequences) that are found in nature (i.e., have not been manipulated by means of recombinant methods).
- non-naturally occurring refers to anything that is not found in nature (e.g., recombinant nucleic acids produced in the laboratory).
- corresponding to or “corresponds to” or “corresponds” refers to an amino acid residue at the enumerated position in a protein or peptide, or an amino acid residue that is analogous, homologous, or equivalent to an enumerated residue in a protein or peptide.
- corresponding region generally refers to an analogous position along related proteins or a reference protein.
- the terms "derived from” and “obtained from” refer to not only a protease produced or producible by a strain of the organism in question, but also a protease encoded by a DNA sequence isolated from such strain and produced in a host organism containing such DNA sequence. Additionally, the term refers to a protease which is encoded by a DNA sequence of synthetic and/or cDNA origin and which has the identifying characteristics of the protease in question.
- proteases derived from Bacillus refers to those enzymes having proteolytic activity which are naturally-produced by Bacillus, as well as to serine proteases like those produced by Bacillus sources but which through the use of genetic engineering techniques are produced by non-Bacillus organisms transformed with a nucleic acid encoding the serine proteases.
- identity in the context of two nucleic acids or polypeptide sequences refers to the residues in the two sequences that are the same when aligned for maximum correspondence, as measured using one of the following sequence comparison or analysis algorithms.
- homologous genes refers to a pair of genes from different, but usually related species, which correspond to each other and which are identical or very similar to each other.
- the term encompasses genes that are separated by speciation (i.e., the development of new species) (e.g., orthologous genes), as well as genes that have been separated by genetic duplication (e.g., paralogous genes).
- mature form of a protein, polypeptide, or peptide refers to the functional form of the protein, polypeptide, or peptide without the signal peptide sequence and propeptide sequence.
- homology refers to sequence similarity or identity, with identity being preferred. Homology may be determined using standard techniques known in the art (See e.g., Smith and Waterman, Adv. Appl. Math. 2:482 [1981]; Needleman and Wunsch, J. Mol. Biol. 48:443 [1970 ⁇ ; Pearson and Lipman, Proc. Natl. Acad. Sci. USA 85:2444 [1988]; software programs such as GAP, BESTFIT, FASTA, and TFASTA in the Wisconsin Genetics Software Package (Genetics Computer Group, Madison, WI); and Devereux et al., Nucl. Acid Res.
- PILEUP creates a multiple sequence alignment from a group of related sequences using progressive, pair-wise alignments. It can also plot a tree showing the clustering relationships used to create the alignment. PILEUP uses a simplification of the progressive alignment method of Feng and Doolittle (See, Feng and Doolittle, J. Mol. Evol. 35:351-360 [ 1987]). The method is similar to that described by Higgins and Sharp (See, Higgins and Sharp, CABIOS 5: 151-153 [1989]).
- Useful PILEUP parameters including a default gap weight of 3.00, a default gap length weight of 0.10, and weighted end gaps.
- BLAST BLAST algorithm
- WU-BLAST-2 WU-BLAST-2 uses several search parameters, most of which are set to the default values.
- the HSP S and HSP S2 parameters are dynamic values and are established by the program itself depending upon the composition of the particular sequence and composition of the particular database against which the sequence of interest is being searched. However, the values may be adjusted to increase sensitivity.
- the percent sequence identity between a reference sequence and a test sequence of interest may be readily determined by one skilled in the art.
- the percent identity shared by polynucleotide or polypeptide sequences is determined by direct comparison of the sequence information between the molecules by aligning the sequences and determining the identity by methods known in the art.
- An example of an algorithm that is suitable for determining sequence similarity is the BLAST algorithm, ⁇ See, Altschul, et al, J. Mol. Biol., 215:403-410 [ 1990]).
- Software for performing BLAST analyses is publicly available through the National Center for Biotechnology Information.
- This algorithm involves first identifying high scoring sequence pairs (HSPs) by identifying short words of length W in the query sequence that either match or satisfy some positive-valued threshold score T when aligned with a word of the same length in a database sequence. These initial neighborhood word hits act as starting points to find longer HSPs containing them. The word hits are expanded in both directions along each of the two sequences being compared for as far as the cumulative alignment score can be increased.
- HSPs high scoring sequence pairs
- Extension of the word hits is stopped when: the cumulative alignment score falls off by the quantity X from a maximum achieved value; the cumulative score goes to zero or below; or the end of either sequence is reached.
- the BLAST algorithm parameters W, T, and X determine the sensitivity and speed of the alignment.
- the BLAST program uses as defaults a wordlength (W) of 1 1 , the BLOSUM62 scoring matrix ⁇ See, Henikoff and Henikoff, Proc. Natl. Acad. Sci. USA 89: 10915 [ 1992]) alignments (B) of 50, expectation (E) of 10, M'5, N'-4, and a comparison of both strands.
- the BLAST algorithm then performs a statistical analysis of the similarity between two sequences ⁇ See e.g., Karlin and Altschul, supra).
- One measure of similarity provided by the BLAST algorithm is the smallest sum probability (P(N)), which provides an indication of the probability by which a match between two nucleotide or amino acid sequences would occur by chance.
- P(N) the smallest sum probability
- a nucleic acid is considered similar to a serine protease nucleic acid of this invention if the smallest sum probability in a comparison of the test nucleic acid to a serine protease nucleic acid is less than about 0.1 , more preferably less than about 0.01 , and most preferably less than about 0.001.
- test nucleic acid encodes a serine protease polypeptide
- it is considered similar to a specified serine protease nucleic acid if the comparison results in a smallest sum probability of less than about 0.5, and more preferably less than about 0.2.
- Percent "identical” or “identity” in the context of two or more nucleic acid or polypeptide sequences refers to two or more sequences that are the same or have a specified percentage of nucleic acid residues or amino acid residues, respectively, that are the same, when compared and aligned for maximum similarity, as determined using a sequence comparison algorithm or by visual inspection.
- Percent sequence identity or “% identity” or “% sequence identity or “% amino acid sequence identity” of a subject amino acid sequence to a reference (i.e., query) amino acid sequence means that the subject amino acid sequence is identical (i.e., on an amino acid-by- amino acid basis) by a specified percentage to the query amino acid sequence over a comparison length when the sequences are optimally aligned.
- 80% amino acid sequence identity or 80% identity with respect to two amino acid sequences means that 80% of the amino acid residues in two optimally aligned amino acid sequences are identical.
- Percent sequence identity or “% identity” or “% sequence identity or “% nucleotide sequence identity” of a subject nucleic acid sequence to a reference (i.e. query) nucleic acid sequence means that the subject nucleic acid sequence is identical (i.e., on a nucleotide-by- nucleotide basis for a polynucleotide sequence) by a specified percentage to the query sequence over a comparison length when the sequences are optimally aligned.
- 80% nucleotide sequence identity or 80% identity with respect to two nucleic acid sequences means that 80% of the nucleotide residues in two optimally aligned nucleic acid sequences are identical.
- the percent sequence identity or % sequence identity" or "% identity" of a subject sequence to a query sequence can be calculated by optimally aligning the two sequences and comparing the two optimally aligned sequences over the comparison length. The number of positions in the optimal alignment at which identical residues occur in both sequences are determined, thereby providing the number of matched positions, and the number of matched positions is then divided by the total number of positions of the comparison length (which, unless otherwise specified, is the length of the query sequence). The resulting number is multiplied by 100 to yield the percent sequence identity of the subject sequence to the query sequence.
- Optimal alignment refers to the alignment of two (or more) sequences giving the highest percent identity score.
- optimal alignment of two protein sequences can be achieved by manually aligning the sequences such that the maximum number of identical amino acid residues in each sequence are aligned together or by using software programs or procedures described herein or known in the art.
- Optimal alignment of two nucleic acid sequences can be achieved by manually aligning the sequences such that the maximum number of identical nucleotide residues in each sequence are aligned together or by using software programs or procedures described herein or known in the art.
- two polypeptide sequences are deemed "optimally aligned" when they are aligned using defined parameters, such as a defined amino acid substitution matrix, gap existence penalty (also termed gap open penalty), and gap extension penalty, so as to achieve the highest similarity score possible for that pair of sequences.
- a defined amino acid substitution matrix such as a defined amino acid substitution matrix, gap existence penalty (also termed gap open penalty), and gap extension penalty, so as to achieve the highest similarity score possible for that pair of sequences.
- gap existence penalty also termed gap open penalty
- gap extension penalty e.g., BLOSUM62 scoring matrix (See, Henikoff and Henikoff, supra) is often used as a default scoring substitution matrix in polypeptide sequence alignment algorithms (e.g., BLASTP).
- the gap existence penalty is imposed for the introduction of a single amino acid gap in one of the aligned sequences, and the gap extension penalty is imposed for each residue position in the gap.
- the alignment score is defined by the amino acid positions of each sequence at which the alignment begins and ends (e.g., the alignment window), and optionally by the insertion of a gap or multiple gaps into one or both sequences, so as to achieve the highest possible similarity score.
- Optimal alignment between two or more sequences can be determined manually by visual inspection or by using a computer, such as, but not limited to for example, the BLASTP program for amino acid sequences and the BLASTN program for nucleic acid sequences (See e.g., Altschul et al.. Nucleic Acids Res. 25(17):3389-3402 ( 1997); See also, the National Center for Biotechnology Information (NCBI) website).
- a computer such as, but not limited to for example, the BLASTP program for amino acid sequences and the BLASTN program for nucleic acid sequences (See e.g., Altschul et al.. Nucleic Acids Res. 25(17):3389-3402 ( 1997); See also, the National Center for Biotechnology Information (NCBI) website).
- NCBI National Center for Biotechnology Information
- the consumer products can comprise one or more enzymes which provide cleaning performance and/or fabric care benefits.
- suitable enzymes include, but are not limited to, hemicellulases, peroxidases, proteases, cellulases, xylanases, lipases, phospholipases, esterases, cutinases, pectinases, mannanases, pectate lyases, keratinases, reductases, oxidases, phenoloxidases, lipoxygenases, ligninases, pullulanases, tannases, pentosanases, malanases, B- glucanases, arabinosidases, hyaluronidase, chondroitinase, laccase, and amylases, or mixtures thereof.
- a typical combination is an enzyme cocktail that may comprise, for example, a protease and lipase in conjunction with amylase.
- aforementioned additional enzymes may be present at levels from about 0.00001 % to about 2%, from about 0.0001 % to about 1 % or even from about 0.001 % to about 0.5% enzyme protein by weight of the consumer product.
- suitable enzymes would include a protease.
- Suitable proteases include metalloproteases and serine proteases, including neutral or alkaline microbial serine proteases, such as subtilisins (EC 3.4.21.62).
- Suitable proteases include those of animal, vegetable or microbial origin. In one aspect, such suitable protease may be of microbial origin.
- the suitable proteases include chemically or genetically modified mutants of the aforementioned suitable proteases.
- the suitable protease may be a serine protease, such as an alkaline microbial protease or/and a trypsin-type protease. Examples of suitable neutral or alkaline proteases include:
- subtilisins (EC 3.4.21.62), including those derived from Bacillus, such as Bacillus lentus, B. alkalophilus, B. subtilis, B. amyloliquefaciens, Bacillus pumilus and Bacillus gibsonii described in US 6,312,936 B l , US 5,679,630, US 4,760,025, US 7,262,042 and WO09/021867.
- trypsin-type or chymotrypsin-type proteases such as trypsin (e.g. , of porcine or bovine origin), including the Fusarium protease described in US5288627 and the chymotrypsin proteases derived from Cellumonas described in US PA 2008/0063774A 1.
- metalloproteases including those derived from Bacillus amyloliquefaciens described in US PA 2008/029361 OA 1.
- Suitable proteases include those derived from Bacillus gibsonii or Bacillus Lentus.
- Suitable commercially available protease enzymes include those sold under the trade names Alcalase®, Savinase®, Primase®, Durazym®, Polarzyme®, annase®, Liquanase®, Liquanase Ultra®, Savinase Ultra®, Ovozyme®, Neutrase®, Everlase® and Esperase® by Novozymes A/S (Denmark), those sold under the tradename Maxatase®, Maxacal®,
- BLAP BLAP
- BLAP R BLAP with S3T + V4I + V 199M + V205I + L217D
- BLAP X BLAP with S3T + V4I + V205I
- BLAP F49 BLAP with S3T + V4I + A 194P + V 1 9M + V205I + L217D
- the consumer product may comprise a protease that is not
- an immunoequivalent protease will have a high degree of identity (>80%) with BPN' and will cross- react with the same antibody.
- Suitable non-immunoequivalent enzymes will include those derived from Bacillus Lentus, Bacillus gibsonii and the metalloprotease derived from Bacillus amyloliquefaciens.
- Suitable alpha-amylases include those of bacterial or fungal origin. Chemically or genetically modified mutants (variants) are included.
- a suitable alkaline alpha-amylase may be derived from a strain of Bacillus, such as Bacillus licheniformis, Bacillus amyloliquefaciens, Bacillus stearothermophilus, Bacillus subtilis, or other Bacillus sp., such as Bacillus sp. NCIB 12289, NCIB 12512, NCIB 12513, DSM 9375 (USP 7, 153,818) DSM 12368, DSMZ no. 12649, SM API 378 (US 6,979,731 ), KSM K36 or SM K38 (US 6,916,645).
- Suitable amylases include:
- 2008/0193999 A 1 the wild-type enzyme from Bacillus SP722, especially variants with deletions in the 183 and 184 positions and variants described in US 6, 187,576, which is incorporated herein by reference.
- variants exhibiting at least 95% identity with the wild-type enzyme from Bacillus sp.707 (SEQ ID NO:7 in US 6,093, 562), especially those comprising one or more of the following mutations M202, M208, S255, R 172, and/or M261 .
- said amylase comprises one or more of M202L, M202V, M202S, M202T, M202I, M202Q, M202W, S255N and/or R 172Q. Particularly suitable are those comprising the M202L or M202T mutations.
- Suitable commercially available alpha-amylases include DURAMYL®, LIQUEZYME®, TERMAMYL®, TERMAMYL ULTRA®, NATALASE®, SUPRAMYL®, STAINZYME®, STAINZYME PLUS®, FUNGAMYL® and BAN® (Novozymes AJS, Bagsvaerd, Denmark), KEMZYM® AT 9000 Biozym Biotech Trading GmbH Wehlistrasse 27b A- 1200 Wien Austria, RAPIDASE® , PURASTAR®, ENZYSIZE®, OPTISIZE HT PLUS® and PURASTAR OXAM® (Genencor International Inc., Palo Alto, California) and KAM® (Kao, 14- 10
- suitable amylases include NATALASE®, STAINZYME® and STAINZYME PLUS® and mixtures thereof.
- such additional enzyme may be selected from the group consisting of: lipases, including "first cycle lipases” such as those described in U.S. Patent 6,939,702 B l and US PA 2009/0217464.
- the lipase is a first-wash lipase, in one aspect, a variant of the wild-type lipase from Thermomyces lanuginosus comprising T231R and N233R mutations.
- the wild-type sequence is the 269 amino acids (amino acids 23 - 291 ) of the Swissprot accession number Swiss-Prot 059952 (derived from Thermomyces lanuginosus (Humicola lanuginosa)).
- Suitable lipases would include those sold under the tradenames Lipex®, Lipolex® and
- the composition comprises a variant of Thermomyces lanuginosa lipase having >90% identity with the wild type amino acid and comprising substitution(s) at T231 and/or N233, in one aspect, T231R and N233R.
- other enzymes include cellulases of bacterial or fungal origin. Chemically modified or protein engineered mutants are included. Suitable' cellulases include cellulases from the genera Bacillus, Pseudomonas, Humicola, Fusarium, Thielavia, Acremonium, e.g., the fungal cellulases produced from Humicola insolens, Myceliophthora thermophila and Fusarium oxysporum disclosed in US 4,435,307, US 5,648,263, US 5,691 , 178, US 5,776,757 and US 5,691 , 178. Suitable cellulases include the alkaline or neutral cellulases having colour care benefits.
- cellulases examples include cellulases described in US 5,520,838, US 5,948,672, US 5,919,691 , US 6,001 ,639, WO 98/08940.
- Other examples are cellulase variants such as those described in US 6, 1 14,296, US 5,457,046, US 5,457,046, US 5,686,593, US 5,763,254, US 6, 1 17,664, US PA 2009/0170747 A 1 and PCT/DK98/00299.
- Commercially available cellulases include CELLUZYME®, and CAREZYME® (Novozymes A S), CLAZINASE®, and
- the cellulase may be a bacterial cleaning cellulase.
- Such bacterial cleaning cellulases are endo beta 1 ,4- glucanases and have a structure which does not comprise a class A Carbohydrate Binding Module (CBM).
- CBM Carbohydrate Binding Module
- a class A CBM is defined according to A. B. Boraston et al. Biochemical Journal 2004, Volume 382 (part 3) pages 769-781.
- the cellulase does not comprise a class A CBM from families 1 , 2a, 3, 5 and 10.
- the bacterial cleaning cellulase may be a glycosyl hydrolase having enzymatic activity towards amorphous cellulose substrates, wherein the glycosyl hydrolase is selected from GH families 5, 7, 12, 16, 44 or 74.
- the cellulase may be a glycosyl hydrolase selected from GH family 5.
- the cellulase may be Celluclean®, supplied by Novozymes. This cellulase is described in more detail in US 7, 141 ,403.
- the glycosyl hydrolase (GH) family definition is described in more detail in Biochem J. 1991 , v280, 309-316.
- Another suitable bacterial cleaning cellulase is a glycosyl hydrolase having enzymatic activity towards both xyloglucan and amorphous cellulose substrates, wherein the glycosyl hydrolase is selected from GH families 5, 12, 44 or 74. In one aspect, the glycosyl hydrolase selected from GH family 44.
- the glycosyl hydrolase enzyme may belong to glycosyl hydrolase family 44.
- Suitable glycosyl hydrolases may be selected from the group consisting of: GH family 44 glycosyl hydrolases from Paenibacillus polyxyma (wild-type) such as XYG1006 described in US 7,361 ,736 or are variants thereof; GH family 12 glycosyl hydrolases from Bacillus licheniformis (wild-type) such as Seq. No.
- Suitable glycosyl hydrolases may be selected from the group consisting of: GH family 44 glycosyl hydrolases from Paenibacillus polyxyma (wild-type) such as XYG 1006 or are variants thereof.
- Suitable bacterial cleaning cellulases are sold under the tradenames Celluclean® and Whitezyme® (Novozymes A/S, Bagsvaerd, Denmark).
- the composition may comprise a fungal cleaning cellulase belonging to Glycosyl Hydrolase family 45 having a molecular weight of from 17kDa to 30 kDa, for example the endoglucanases sold under the tradename Biotouch® NCD, DCC and DCL (AB Enzymes, Darmstadt, Germany).
- Other suitable enzymes include pectate lyases sold under the tradenames Pectawash®, Pectaway® and mannanases sold under the tradenames Mannaway® (all from Novozymes A/S, Bagsvaerd, Denmark), and Purabrite® (Genencor International Inc., Palo Alto, California).
- the composition comprises a Guerbet nonionic surfactant.
- the Guerbet nonionic surfactant is a secondary alcohol-based detersive surfactant having the formula:
- R linear or branched, substituted or unsubstituted, saturated or unsaturated C2- g alkyl
- R 2 linear or branched, substituted or unsubstituted, saturated or unsaturated C2-
- R 1 + R 2 moieties wherein the total number of carbon atoms present in R 1 + R 2 moieties is in the range of from 7 to 13; wherein EO/PO are alkoxy moieties selected from ethoxy, propoxy, or mixtures thereof;
- n is the average degree of alkoxylation and is in the range of from 4 to 10.
- laundry detergents comprise strong inorganic builder, with either phosphate builder typically sodium tripolyphosphate (STPP), or zeolite typically sodium aluminosilicate builder being used as the predominant strong builder.
- phosphate builder typically sodium tripolyphosphate (STPP)
- zeolite typically sodium aluminosilicate builder
- the amount of strong builder selected from phosphate and/or zeolite builder is no greater than 10 wt% based on the total weight of the detergent composition, preferably below 8 wt%, or even more preferably below 5 or 4 or 3 or 2 or 1 wt% .
- compositions of the invention are low builder compostions comprising from 0 wt% to 10wt% zeolite builder, and 0 wt to 10 wt% phosphate builder, the total amount of phosphate and/or zeolite not exceeding 10 wt%, and preferably being below 10 wt as described above.
- the compositions of the invention comprise from 0 wt% to 8 wt%, or from 0 wt% to 5 or 4 wt%, or from 0 wt% to 3 or even less than 2 wt% zeolite builder. It may even be preferred for the composition to be essentially free from zeolite builder.
- the composition comprises no deliberately added zeolite builder. This is especially preferred if it is desirable for the composition to be very highly soluble, to minimise the amount of water-insoluble residues (for example, which may deposit on fabric surfaces), and also when it is highly desirable to have transparent wash liquor.
- Zeolite builders include zeolite A, zeolite X, zeolite P and zeolite MAP.
- compositions of the invention may comprise from 0 wt% to 10 wt% phosphate builder.
- the composition preferably comprises from 0 wt% to 8 wt%, or from 0 wt to 5 or 4 wt%, or from 0 wt% to 3 or even 2 wt% phosphate builder. It may even be preferred for the composition to be essentially free from phosphate builder. By essentially free from phosphate builder it is typically meant that the composition comprises no deliberately added phosphate builder. This is especially preferred if it is desirable for the composition to have a very good environmental profile.
- Phosphate builders include sodium tripolyphosphate.
- the total level of weak builders selected from layered silicate (S S-6), citric acid, citrate salts and nitrilo triacetic acid or salt thereof is below 15 wt%, more preferably below 8 wt%, more preferably below 4 wt% or even below 3 or 2 wt% based on the total weight of the detergent composition.
- the level of each of layered silicate, citric acid, citrate salts and nitrilo triacetic acid or salt thereof will be below 10 wt% or even below 5 t% or wt% based on the total weight of the composition.
- builders bring several benefits to the formulator, their main role is to sequester divalent metal ions (such as calcium and magnesium ions) from the wash solution that would otherwise interact negatively with the surfactant system. Builders are also effective at removing metal ions and inorganic soils from the fabric surface too, leading to improved removal of particulate and beverage stains. It would therefore be expected that reduction of their levels would negatively impact on cleaning performance and therefore, preparation of detergent compositions that are effective with the claimed reduced levels of phosphate and zeolite builders is surprising.
- divalent metal ions such as calcium and magnesium ions
- the term "reserve alkalinity” is a measure of the buffering capacity of the detergent composition (g/NaOH/lOOg detergent composition) determined by titrating a 1 % (w/v) solution of detergent composition with hydrochloric acid to pH 7.5 i.e in order to calculate Reserve Alkalinity as defined herein:
- the RA of the detergent compositions of the invention may preferably be greater than 7.5 and preferably greater than 8.
- the RA may be greater than 9 or even greater than 9.5 or 10 or higher.
- the RA may be up to 20 or higher.
- Adequate reserve alkalinity may be provided, for example, by one or more of alkali metal silicates (excluding crystalline layered silicate), typically amorphous silicate salts, generally 1 .2 to 2.2 ratio sodium salts, alkali metal typically sodium carbonate, bicarbonate and/or sesquicarbonates.
- alkali metal silicates typically amorphous silicate salts, generally 1 .2 to 2.2 ratio sodium salts
- alkali metal typically sodium carbonate, bicarbonate and/or sesquicarbonates.
- STPP and persalts such as perborates and percarbonates also contribute to alkalinity. Buffering is necessary to maintain an alkaline pH during the wash process counteracting the acidity of soils, especially fatty acids liberated by the lipase enzyme.
- the detergent composition preferably comprises from 0 wt% to 50 wt silicate salt, more usually 5 to 30 wt% silicate salt, or 7 to 20 wt% silicate salt, usually sodium silicate.
- the detergent compositions of the invention may comprise a carbonate salt, typically from 1 wt% to 70 wt%, or from 5 wt% to 50 wt% or from 10 wt% to 30 wt% carbonate salt.
- Preferred carbonate salts are sodium carbonate and/or sodium bicarbonate and/or sodium sesquicarbonate.
- the carbonate salt may be incorporated into the detergent composition wholly or partially via a mixed salt such as Burkeite.
- a highly preferred carbonate salt is sodium carbonate.
- the composition may comprise from 5 wt% to 50 wt% sodium carbonate, or from 10 to 40 wt or even 15 to 35 wt% sodium carbonate. It may also be desired for the composition to comprise from 1 wt% to 20 wt% sodium bicarbonate, or even 2 to 10 or 8 wt .
- the weight ratio of sodium carbonate and/or sodium silicate to zeolite builder may be at least 5: 1 , preferably at least 10: 1 , or at least 15: 1 , or at least 20: 1 or even at least 25: 1
- the carbonate salt, or at least part thereof is typically in particulate form, typically having a weight average particle size in the range of from 200 to 500 micrometers. However, it may be preferred for the carbonate salt, or at least part thereof, to be in micronised particulate form, typically having a weight average particle size in the range of from 4 to 40 micrometers; this is especially preferred when the carbonate salt, or at least part thereof, is in the form of a co-particulate admixture with a detersive surfactant, such as an alkoxylated anionic detersive surfactant.
- a detersive surfactant such as an alkoxylated anionic detersive surfactant.
- the levels of carbonate and/or silicate salts typically sodium carbonate and sodium silicate will be from 10 to 70 wt%, or from 10 or even 15 to 50 wt% based on the total weight of the composition.
- adjuncts illustrated hereinafter are suitable for use in the instant consumer products and may be desirably incorporated in certain embodiments of the invention, for example to assist or enhance cleaning performance, for treatment of the substrate to be cleaned, or to modify the aesthetics of the consumer product as is the case with perfumes, colorants, dyes or the like.
- the levels of any such adjuncts incorporated in any consumer product are in addition to any materials previously recited for incorporation. The precise nature of these additional components/adjunct materials, and levels of incorporation thereof, will depend on the physical form of the consumer product and the nature of the cleaning operation for which it is to be used.
- Suitable adjunct materials include, but are not limited to, surfactants, builders, chelating agents, dye transfer inhibiting agents, dispersants, additional enzymes, and enzyme stabilizers, catalytic materials, bleach activators, hydrogen peroxide, sources of hydrogen peroxide, preformed peracids, polymeric dispersing agents, clay soil removal/anti-redeposition agents, brighteners, suds suppressors, dyes, perfumes, structure elasticizing agents, fabric softeners, carriers, hydrotropes, processing aids, solvents and/or pigments.
- suitable examples of such other adjuncts and levels of use are found in U.S. Patent Nos. 5,576,282, 6,306,812 B l and 6,326,348 B l that are incorporated by reference.
- adjunct ingredients are not essential to Applicants' consumer products.
- adjuncts materials do not contain one or more of the following adjuncts materials: surfactants, builders, chelating agents, dye transfer inhibiting agents, dispersants, additional enzymes, and enzyme stabilizers, catalytic materials, bleach activators, hydrogen peroxide, sources of hydrogen peroxide, preformed peracids, polymeric dispersing agents, clay soil removal/anti-redeposition agents, brighteners, suds suppressors, dyes, perfumes, structure elasticizing agents, fabric softeners, carriers, hydrotropes, processing aids, solvents and/or pigments.
- one or more adjuncts may be present as detailed below: Bleaching Agents -
- the consumer products of the present invention may comprise one or more bleaching agents.
- Suitable bleaching agents other than bleaching catalysts include photobleaches, bleach activators, hydrogen peroxide, sources of hydrogen peroxide, pre-formed peracids and mixtures thereof.
- the consumer products of the present invention may comprise from about 0.1 % to about 50% or even from about 0.1 % to about 25% bleaching agent by weight of the subject consumer product.
- suitable bleaching agents include:
- photobleaches for example sulfonated zinc phthalocyanine sulfonated aluminium phthalocyanines, xanthene dyes and mixtures thereof;
- Suitable preformed peracids include, but are not limited to, compounds selected from the group consisting of percarboxylic acids and salts, percarbonic acids and salts, perimidic acids and salts, peroxymonosulfuric acids and salts, for example, Oxone ®, and mixtures thereof.
- sources of hydrogen peroxide for example, inorganic perhydrate salts, including alkali metal salts such as sodium salts of perborate (usually mono- or tetra-hydrate),
- inorganic perhydrate salts are selected from the group consisting of sodium salts of perborate, percarbonate and mixtures thereof.
- inorganic perhydrate salts are typically present in amounts of from 0.05 to 40 wt%, or 1 to 30 wt% of the overall consumer product and are typically incorporated into such consumer products as a crystalline solid that may be coated. Suitable coatings include, inorganic salts such as alkali metal silicate, carbonate or borate salts or mixtures thereof, or organic materials such as water-soluble or dispersible polymers, waxes, oils or fatty soaps; and
- suitable leaving groups are benzoic acid and derivatives thereof - especially benzene sulphonate.
- Suitable bleach activators include dodecanoyl oxybenzene sulphonate, decanoyl oxybenzene sulphonate, decanoyl oxybenzoic acid or salts thereof, 3,5,5-trimethyl hexanoyloxybenzene sulphonate, tetraacetyl ethylene diamine (TAED) and nonanoyloxybenzene sulphonate (NOBS).
- TAED tetraacetyl ethylene diamine
- NOBS nonanoyloxybenzene sulphonate
- Suitable bleach activators are also disclosed in US 6,380, 144. While any suitable bleach activator may be employed, in one aspect of the invention the subject consumer product may comprise NOBS, TAED or mixtures thereof.
- the peracid and/or bleach activator is generally present in the consumer product in an amount of from about 0.1 to about 60 wt%, from about 0.5 to about 40 wt % or even from about 0.6 to about 10 wt% based on the consumer product.
- One or more hydrophobic peracids or precursors thereof may be used in combination with one or more hydrophilic peracid or precursor thereof.
- the amounts of hydrogen peroxide source and peracid or bleach activator may be selected such that the molar ratio of available oxygen (from the peroxide source) to peracid is from 1 : 1 to 35: 1 , or even 2: 1 to 10: 1.
- Surfactants - The consumer products according to the present invention may comprise a surfactant or surfactant system wherein the surfactant can be selected from nonionic surfactants, anionic surfactants, cationic surfactants, ampholytic surfactants, zwitterionic surfactants, semi- polar nonionic surfactants and mixtures thereof.
- surfactant is typically present at a level of from about 0.1 % to about 60%, from about 1 % to about 50% or even from about 5% to about 40% by weight of the subject consumer product.
- Suitable anionic detersive surfactants include sulphate and sulphonate detersive surfactants.
- Suitable sulphonate detersive surfactants include alkyl benzene sulphonate, in one aspect, Cio alkyl benzene sulphonate.
- Suitable alkyl benzene sulphonate (LAS) may be obtained, by sulphonating commercially available linear alkyl benzene (LAB); suitable LAB includes low 2- phenyl LAB, such as those supplied by Sasol under the tradename Isochem® or those supplied by Petresa under the tradename Petrelab®, other suitable LAB include high 2-phenyl LAB, such as those supplied by Sasol under the tradename Hyblene®.
- a suitable anionic detersive surfactant is alkyl benzene sulphonate that is obtained by DETAL catalyzed process, although other synthesis routes, such as HF, may also be suitable.
- Suitable sulphate detersive surfactants include alkyl sulphate, in one aspect, Cs alkyl sulphate, or predominantly alkyl sulphate.
- alkyl alkoxylated sulphate in one aspect, alkyl ethoxylated sulphate, in one aspect, a Cs-is alkyl alkoxylated sulphate, in another aspect.
- a Cg alkyl ethoxylated sulphate typically the alkyl alkoxylated sulphate has an average degree of alkoxylation of from 0.5 to 20, or from 0.5 to 10, typically the alkyl alkoxylated sulphate is a C 8 .
- alkyl ethoxylated sulphate having an average degree of ethoxylation of from 0.5 to 10, from 0.5 to 7, from 0.5 to 5 or even from 0.5 to 3.
- alkyl sulphate, alkyl alkoxylated sulphate and alkyl benzene sulphonates may be linear or branched, substituted or un-substituted.
- the detersive surfactant may be a mid-chain branched detersive surfactant, in one aspect, a mid-chain branched anionic detersive surfactant, in one aspect, a mid-chain branched alkyl sulphate and/or a mid-chain branched alkyl benzene sulphonate, for example a mid-chain branched alkyl sulphate.
- the mid-chain branches are C alkyl groups, typically methyl and/or ethyl groups.
- Suitable non-ionic detersive surfactants are selected from the group consisting of: Cg-Cie alkyl ethoxylates, such as, NEODOL® non-ionic surfactants from Shell; C6-C 12 alkyl phenol alkoxylates wherein the alkoxylate units may be ethyleneoxy units, propyleneoxy units or a mixture thereof; C 12-C 18 alcohol and C6-C12 alkyl phenol condensates with ethylene
- oxide/propylene oxide block polymers such as Pluronic® from BASF; C 14-C22 mid-chain branched alcohols; C 14-C22 mid-chain branched alkyl alkoxylates, typically having an average degree of alkoxylation of from 1 to 30; alkylpolysaccharides, in one aspect, alkylpolyglycosides; polyhydroxy fatty acid amides; ether capped poly(oxyalkylated) alcohol surfactants; and mixtures thereof.
- Pluronic® from BASF
- C 14-C22 mid-chain branched alcohols C 14-C22 mid-chain branched alkyl alkoxylates, typically having an average degree of alkoxylation of from 1 to 30
- alkylpolysaccharides in one aspect, alkylpolyglycosides
- polyhydroxy fatty acid amides polyhydroxy fatty acid amides
- ether capped poly(oxyalkylated) alcohol surfactants and mixtures thereof.
- Suitable non-ionic detersive surfactants include alkyl polyglucoside and/or an alkyl alkoxylated alcohol.
- non-ionic detersive surfactants include alkyl alkoxylated alcohols, in one aspect C alkyl alkoxylated alcohol, for example a Cs-ig alkyl ethoxylated alcohol, the alkyl alkoxylated alcohol may have an average degree of alkoxylation of from 1 to 50, from 1 to 30, from 1 to 20, or from 1 to 10.
- the alkyl alkoxylated alcohol may be a Cs-is alkyl ethoxylated alcohol having an average degree of ethoxylation of from 1 to 10, from 1 to 7, more from 1 to 5 or from 3 to 7.
- the alkyl alkoxylated alcohol can be linear or branched, and substituted or un-substituted.
- Suitable cationic detersive surfactants include alkyl pyridinium compounds, alkyl quaternary ammonium compounds, alkyl quaternary phosphonium compounds, alkyl ternary sulphonium compounds, and mixtures thereof.
- Suitable cationic detersive surfactants are quaternary ammonium compounds having the general formula:
- R is a linear or branched, substituted or unsubstituted C6-i 8 alkyl or alkenyl moiety
- Ri and R2 are independently selected from methyl or ethyl moieties
- R3 is a hydroxyl, hydroxymethyl or a hydroxyethyl moiety
- X is an anion which provides charge neutrality
- suitable anions include: halides, for example chloride; sulphate; and sulphonate.
- Suitable cationic detersive surfactants are mono-C6- i 8 alkyl mono-hydroxyethyl di-methyl quaternary ammonium chlorides.
- Highly suitable cationic detersive surfactants are mono-Cg.io alkyl mono- hydroxyethyl di-methyl quaternary ammonium chloride, mono-Cio-12 alkyl mono-hydroxyethyl di-methyl quaternary ammonium chloride and mono-Cio alkyl mono-hydroxyethyl di-methyl quaternary ammonium chloride.
- the consumer products of the present invention may comprise one or more detergent builders or builder systems.
- the subject consumer product will typically comprise at least about 1 %, from about 2% to about 60% or even from about 5% to about 10% builder by weight of the subject consumer product.
- the composition may even be substantially free of builder; substantially free means "no deliberately added" zeolite and/or phosphate.
- Typical zeolite builders include zeolite A, zeolite P and zeolite MAP.
- a typical phosphate builder is sodium tri-polyphosphate.
- Chelating Agents - The consumer products herein may contain a chelating agent.
- Suitable chelating agents include copper, iron and/or manganese chelating agents and mixtures thereof.
- the subject consumer product may comprise from about 0.005% to about 15% or even from about 3.0% to about 10% chelating agent by weight of the subject consumer product.
- Suitable chelants include DTPA (Diethylene triamine pentaacetic acid), HEDP (Hydroxyethane diphosphonic acid), DTPMP (Diethylene triamine penta(methylene phosphonic acid)), 1 ,2-Dihydroxybenzene-3,5-disulfonic acid disodium salt hydrate, ethylenediamine, diethylene triamine, ethylenediaminedisuccinic acid (EDDS), N- hydroxyethylethylenediaminetri-acetic acid (HEDTA), triethylenetetraaminehexaacetic acid (TTHA), N-hydroxyethyliminodiacetic acid (HEIDA), dihydroxyethylglycine (DHEG), ethylenediaminetetrapropionic acid (EDTP) and derivatives thereof.
- DTPA Diethylene triamine pentaacetic acid
- HEDP Hydroxyethane diphosphonic acid
- DTPMP Diethylene triamine penta(methylene phosphonic acid)
- the consumer products of the present invention may also include one or more dye transfer inhibiting agents.
- Suitable polymeric dye transfer inhibiting agents include, but are not limited to, polyvinylpyrrolidone polymers, polyamine N- oxide polymers, copolymers of N-vinylpyrrolidone and N-vinylimidazole, polyvinyloxazolidones and polyvinylimidazoles or mixtures thereof.
- the dye transfer inhibiting agents may be present at levels from about 0.0001 % to about 10%, from about 0.01 % to about 5% or even from about 0.1 % to about 3% by weight of the consumer product.
- Brighteners - The consumer products of the present invention can also contain additional components that may tint articles being cleaned, such as fluorescent brighteners.
- composition may comprise C.I. fluorescent brightener 260, preferably in alpha- crystalline form having the following structure:
- the brightener is a soluble brightener, such as the C.I. fluorescent brightener 260 in alpha-crystalline form.
- the brightener is predominantly in alpha-crystalline form, which means that typically at least 50wt%, at least 75wt%, at least 90wt%, at least 99wt%, or even substantially all, of the C.I. fluorescent brightener 260 is in alpha-crystalline form.
- the brightener is preferably in micronized particulate form, having a weight average primary particle size of from 3 to 30 micrometers, from 3 micrometers to 20 micrometers, or from 3 to 10 micrometers.
- the composition may comprise C.I. fluorescent brightener 260 in beta-crystalline form, and the weight ratio of: (i) C.I. fluorescent brightener 260 in alpha-crystalline form, to (ii) C.I. fluorescent brightener 260 in beta-crystalline form may be at least 0.1 , or at least 0.6.
- BE680847 relates to a process for making C.I fluorescent brightener 260 in alpha- crystalline form.
- Suitable fluorescent brightener levels include lower levels of from about 0.01 , from about 0.05, from about 0. 1 or even from about 0.2 wt % to upper levels of 0.5 or even 0.75 wt .
- Carboxylate polymer - The consumer products of the present invention may also include one or more carboxylate polymers such as a maleate/acrylate random copolymer or polyacrylate homopolymer.
- the carboxylate polymer is a polyacrylate homopolymer having a molecular weight of from 4,000 Da to 9,000 Da, or from 6,000 Da to 9,000 Da.
- Soil release polymer - The consumer products of the present invention may also include one or more soil release polymers having a structure as defined by one of the following structures (I), (II) or (III):
- a, b and c are from 1 to 200;
- d, e and f are from 1 to 50;
- Ar is a 1 ,4-substituted phenylene
- sAr is 1 ,3-substituted phenylene substituted in position 5 with SC ⁇ Me;
- Me is Li, K, Mg/2, Ca/2, Al/3, ammonium, mono-, di-, tri-, or tetraalkylammonium wherein the alkyl groups are C
- R' , R 2 , R 3 , R ⁇ R 5 and R 6 are independently selected from H or Ci-Cis n- or iso-alkyl; and R 7 is a linear or branched C 1-C18 alkyl, or a linear or branched C2-C 3 o alkenyl, or a cycloalkyl group with 5 to 9 carbon atoms, or a C 8 -C3o aryl group, or a C6-C 30 aryl alkyl group.
- Suitable soil release polymers are polyester soil release polymers such as Repel-o-tex polymers, including Repel-o-tex SF, SF-2 and SRP6 supplied by Rhodia.
- Other suitable soil release polymers include Texcare polymers, including Texcare SRA 100, SRA300, SRN 100, SRN 170, SRN240, SRN300 and SRN325 supplied by Clariant.
- Other suitable soil release polymers are Marloquest polymers, such as Marloquest SL supplied by Sasol.
- Cellulosic polymer - The consumer products of the present invention may also include one or more cellulosic polymers including those selected from alkyl cellulose, alkyl alkoxyalkyl cellulose, carboxyalkyl cellulose, alkyl carboxyalkyl cellulose.
- the cellulosic polymers are selected from the group comprising carboxymethyl cellulose, methyl cellulose, methyl hydroxyethyl cellulose, methyl carboxymethyl cellulose, and mixures thereof.
- the carboxymethyl cellulose has a degree of carboxymethyl substitution from 0.5 to 0.9 and a molecular weight from 100,000 Da to 300,000 Da.
- Bleach Catalysts may also include one or more bleach catalysts, such as transitiona metal catalysts or ligands capable of forming a transition metal catalyst for example as described in EP1 109965, or EP1240378 or 9,or bleach catalysts capable of accepting an oxygen atom from a peroxyacid and/or salt thereof, and transferring the oxygen atom to an oxidizeable substrate.
- Suitable bleach catalysts include, but are not limited to: iminium cations and polyions; iminium zwitterions; modified amines;
- the laundry detergent composition comprises a bleach ingredient, the bleach ingredient have a logP o/w no greater than 0, no greater than -0.5, no greater than - 1.0, no greater than - 1.5, no greater than -2.0, no greater than -2.5, no greater than -3.0, or even no greater than -3.5.
- the method for determining logP Q/w is described in more detail below.
- the bleach ingredient is capable of generating a bleaching species having a Xso of from 0.01 to about 0.30, from 0.05 to about 0.25, or even from about 0.10 to 0.20.
- the method for determining Xso is described in more detail below.
- bleaching ingredients having an isoquinolinium structure are capable of generating a bleaching species that has an oxaziridinium structure.
- the Xso is that of the oxaziridinium bleaching species.
- the inventors believe that controlling the electophilicity and hydrophobicity in this above described manner enables the bleach ingredient to be delivered substantially only to areas of the fabric that are more hydrophobic, and that contain electron rich soils, including visible chromophores, that are susceptible to bleaching by highly electrophilic oxidants.
- the bleach catalyst has a structure corresponding to general formula below:
- R 13 is selected from the group consisting of 2-ethylhexyl, 2-propylheptyl, 2- butyloctyl, 2-pentylnonyl, 2-hexyldecyl, n-dodecyl, n-tetradecyl, n-hexadecyl, n-octadecyl, iso- nonyl, iso-decyl, iso-tridecyl and iso-pentadecyl;
- Log P 0/w is determined according to the method found in Brooke, D. N., Dobbs, A. J., Williams, N, Ecotoxicology and Environmental Safety ( 1986) 1 1 (3): 251 -260.
- the parameter Xso is determined according to the method described in Adam, W., Haas, W., Lohray, B. B. Journal of the American Chemical Society (1991) 1 13(16) 6202-6208.
- Silicate salts - The consumer products of the present invention can also contain silicate salts, such as sodium or potassium silicate.
- the composition may comprise from 0wt% to less than 10wt% silicate salt, to 9wt%, or to 8wt , or to 7wt%, or to 6wt%, or to 5wt%, or to 4wt%, or to 3wt%, or even to 2wt%, and preferably from above 0wt%, or from 0.5wt , or even from lwt% silicate salt.
- a suitable silicate salt is sodium silicate.
- Dispersants - The consumer products of the present invention can also contain dispersants.
- Suitable water-soluble organic materials include the homo- or co-polymeric acids or their salts, in which the polycarboxylic acid comprises at least two carboxyl radicals separated from each other by not more than two carbon atoms.
- Enzyme Stabilizers - Enzymes for use in detergents can be stabilized by various techniques.
- the enzymes employed herein can be stabilized by the presence of water-soluble sources of calcium and/or magnesium ions in the finished consumer products that provide such ions to the enzymes.
- a reversible protease inhibitor such as a boron compound, or compounds such as calcium formate, sodium formate and 1 ,2-propane diol can be added to further improve stability.
- Catalytic Metal Complexes - Applicants' compositions may include catalytic metal complexes.
- One type of metal-containing bleach catalyst is a catalyst system comprising a transition metal cation of defined bleach catalytic activity, such as copper, iron, titanium, ruthenium, tungsten, molybdenum, or manganese cations, an auxiliary metal cation having little or no bleach catalytic activity, such as zinc or aluminum cations, and a sequestrate having defined stability constants for the catalytic and auxiliary metal cations, particularly
- compositions herein can be catalyzed by means of a manganese compound.
- a manganese compound Such compounds and levels of use are well known in the art and include, for example, the manganese- based catalysts disclosed in U.S. 5,576,282.
- Cobalt bleach catalysts useful herein are known, and are described, for example, in U.S.
- compositions herein may also suitably include a transition metal complex of ligands such as bispidones (US 7,501 ,389) and/or macropolycyclic rigid ligands - abbreviated as "MRLs".
- MRLs macropolycyclic rigid ligands - abbreviated as "MRLs”.
- the compositions and processes herein can be adjusted to provide on the order of at least one part per hundred million of the active MRL species in the aqueous washing medium, and will typically provide from about 0.005 ppm to about 25 ppm, from about 0.05 ppm to about 10 ppm, or even from about 0.1 ppm to about 5 ppm, of the MRL in the wash liquor.
- Suitable transition-metals in the instant transition-metal bleach catalyst include, for example, manganese, iron and chromium.
- Suitable MRLs include 5, 12-diethyl- 1 ,5,8, 12- tetraazabicyclo[6.6.2]hexadecane.
- Suitable transition metal MRLs are readily prepared by known procedures, such as taught for example in U.S. 6,225,464.
- Solvents - Suitable solvents include water and other solvents such as lipophilic fluids.
- suitable lipophilic fluids include siloxanes, other silicones, hydrocarbons, glycol ethers, glycerine derivatives such as glycerine ethers, perfluorinated amines, perfluorinated and hydrofluoroether solvents, low-volatility nonfluorinated organic solvents, diol solvents, other environmentally-friendly solvents and mixtures thereof.
- consumer products of the present invention can be formulated into any suitable form and prepared by any process chosen by the formulator, non-limiting examples of which are described in Applicants' examples and in U.S. 4,990,280; U.S. 20030087791 A 1 ; U.S.
- the present invention includes a method for cleaning and /or treating a situs inter alia a fabric surface.
- Such method includes the steps of contacting an embodiment of Applicants' cleaning consumer product, in neat form or diluted in a wash liquor, with at least a portion of a situs then optionally rinsing such fabric surface.
- the situs may be subjected to a washing step prior to the aforementioned rinsing step.
- washing includes but is not limited to, scrubbing, and mechanical agitation.
- the present invention includes a method for laundering a fabric. The method comprises the steps of contacting a fabric to be laundered with a said cleaning laundry solution comprising at least one embodiment of
- the fabric may comprise most any fabric capable of being laundered in normal consumer use conditions.
- the solution typically has a pH of from about 7 to about 1 1.
- the consumer products may be employed at concentrations of from about 500 ppm to about 15,000 ppm in solution.
- the water temperatures typically range from about 5 °C to about 90 °C.
- the water to fabric ratio is typically from about 1 : 1 to about 30: 1.
- IEC-B detergent IEC 60456 Washing Machine Reference Base Detergent Type B, supplied by wfk, Briiggen-Bracht, Germany, to each pot.
- the assays were performed using a Biomek FX Robot (Beckman Coulter) or a multichannel pipettor (e.g., Rainin PipetLite, Mettler-Toledo) and a SpectraMAX MTP Reader (type 340; Molecular Devices).
- TCA Assay for Protein Content Determination in 96-well Microtiter Plates B. subtilis cultures were grown 2-3 days at 37 °C, shaking at 250-300 rpm with humidified aeration. The cells were removed from the enzyme-containing culture supernatant, by centrifugation and/or filtration. The protease concentration was determined using a TCA precipitation assay.
- the turbidity/light scattering increase in the samples correlates to the total amount of precipitable protein in the culture supernatant.
- the calculations were performed by subtracting the "baseline” reading (obtained after addition of HC1) from the "test" reading (obtained after addition of TCA) to provide a relative measure of total protein present.
- a standard curve can be created by calibrating the TCA readings with AAPF protease assays (see below) of clones with known specific activity.
- the TCA results are linear with respect to protein concentration from 50 to 500 parts per million (ppm) of protein (where 1 ppm corresponds to 1 mg/L) and can thus be plotted directly against enzyme performance for the purpose of choosing variants with desired performance.
- suc-AAPF-pNA working solution 1 ml suc-AAPF-pNA stock solution was added to 100 ml Tris/Ca buffer and mixed well for at least 10 seconds. The assay was performed by adding 10 ⁇ of diluted protease solution to each well of a 96-well MTP, immediately followed by the addition of 190 ⁇ of 1 mg/ml suc-AAPF-pNA working solution.
- Eglin c serine protease concentration and specific activity was determined by titration with an inhibitor called eglin c.
- Eglin c from the leech Hirudo medicinalis is a tight- binding protein inhibitor of subtilisins and ASP protease (Heinz et al., Biochemistry, 31 : 8755-66 [ 1992]), and can therefore be used to measure protease enzyme concentration, which in turn permits specific activity to be calculated.
- the gene for eglin c was synthesized and expressed in E. coli by standard methods. Its properties and inhibitory potency were the same as eglin c purchased from Sigma.
- a sample of Bacillus lentus subtilisin of known specific activity was diluted in 100 mM Tris buffer, pH 8.6, containing 1 mM CaC12 and 0.005% TWEEN®-80 (Tris/Ca buffer), to a concentration appropriate for AAPF protease assay described above.
- Tris/Ca buffer Tris/Ca buffer
- Several dilutions of the eglin c stock solution were also made in the Tris/Ca buffer.
- An aliquot of each diluted eglin c solution was mixed with an equal volume of the diluted Bacillus lentus subtilisin solution.
- the concentration of eglin c in each sample was then calculated based on the decrease of the observed protease activity as compared to the uninhibited subtilisin sample that was mixed with Tris/Ca buffer only (without eglin c).
- concentration of eglin c in the stock solution was determined.
- subtilisin variants were diluted in 100 mM Tris buffer, pH 8.6, containing 1 mM CaCl 2 and 0.005% TWEEN®-80 (Tris/Ca buffer). Several dilutions of the eglin c stock solution of known concentration were also made in the Tris/Ca buffer. An aliquot of each diluted eglin c solution was mixed with an equal volume of a subtilisin variant solution. The mixed solutions were incubated at room temperature for 15-30 minutes and the protease activity of each sample was then measured by AAPF assay.
- the concentration of the eglin c necessary for the complete inhibition of each subtilisin enzyme variant was calculated. This concentration is equivalent to the enzyme concentration in the sample.
- An aliquot of the Tris/Ca buffer only, without eglin c, was also mixed with each subtilisin variant sample and the protease activity in the absence of eglin c was measured by AAPF assay. The specific activity of the subtilisin variants was then calculated using the enzyme concentrations as determined above.
- BMI blood, milk and ink stained microswatches
- MTP 96 well microtiter plates
- Detergents were prepared by mixing for at least 30 minutes in 2 mM sodium carbonate, buffered to pH 10.3 with the appropriate level of water hardness (3: 1 Ca:Mg. - CaCb : MgCl2*6H 2 0) in Milli-Q water as described in Table 1 - 1 and Table 6-4.
- the detergents were aliquoted into 50 ml conical tubes (Falcon), centrifuged to remove precipitate, and chilled on ice for 30 minutes prior to use.
- Enzyme concentrations were equalized to a desired fixed concentration ranging from 20-50 ppm relative to a standard of purified GG36 (enzyme of SEQ ID NO: l ).
- the specific activity of GG36 using AAPF as a substrate was used to convert baseline subtracted TCA values into enzyme concentration in ppm.
- enzyme concentration was determined in ppm, a simple formula was used to calculate the volume of each variant required to add to a fixed volume of buffer (300-600 ⁇ _) in order to achieve the desired stock enzyme concentration:
- a Perkin-Elmer Janus robot with a Versispan 8 channel arm was used to dispense variable volumes of enzyme from the source plate (Axygen half deep well plate with pooled harvested variants used in the TCA enzyme concentration assay) into the buffer-filled destination plate using conductive tips. Samples were mixed three times by pipetting up and down. The accuracy of the enzyme dilutions was validated by measuring the AAPF activity of the equalized plate and comparing it to that of the source plate, to veryify that the correct dilutions had been made.
- the MTP was sealed with foil (Bio-Rad) and incubated in iEMS incubator/shaker (Thermo/Labsystems) pre-set to 16°C in a cold room set to 4oC or at 32°C on the benchtop for 30 minutes at 1400 rpm. Following incubation, 120 ⁇ ]_ of supernatant was transferred to a fresh MTP (Corning 9017) and read at 600 nm using the SpectraMax reader. True absorbance readings were obtained by subtracting a blank control (no enzyme) from each value.
- a performance index (PI) was calculated for each variant.
- the performance index is the ratio of the absorbance of the supernatant produced by variant enzyme cleaning to the absorbance produced by GG36 cleaning at a fixed enzyme concentration.
- PI values were calculated by dividing the absorbance of a variant by that of the control on a given plate.
- a standard curve ⁇ e.g. Langmuir or four parameter logistic nonlinear regression model fit
- the PI is determined by dividing the absorbance of the variants by the calculated absorbance for the control at the same enzyme concentration.
- Example 28 2.3 12 2
- Example 29 5.9 12 2
- TEST METHOD 2 - For Test Method 2 the BMI microswatch assay is run using the detergent of Example 29.
- the detergent is dissolved in water that has a hardness of 12gpg and adjusted to a temperature of 16°C.
- Performance of the variant enzymes is then determined as per the BMI microswatch assay described.
- the performance index is determined by comparing the performance of the variant with that of the enzyme of SEQ ID NO: 1 , with in all cases the enzyme dosage range being 0.1-5ppm. Enzymes having a performance index of 1.1 or greater are viewed to be cold water proteases.
- TEST METHOD 3 - For Test Method 3 the BMI microswatch assay is run using the detergent of Example 26.
- the detergent is dissolved in water that has a hardness of 6gpg and adjusted to a temperature of 16°C.
- Performance of the variant enzymes is then determined as per the BMI microswatch assay described.
- the performance index is determined by comparing the performance of the variant with that of the enzyme of SEQ ID NO: 1 , with in all cases the enzyme dosage range being 0.1 -5ppm. Enzymes having a performance index of 1.1 or greater are viewed to be cold water proteases.
- TEST METHOD 4 - For Test Method 4 the BMI microswatch assay is run using the detergent of Example 26.
- the detergent is dissolved in water that has a hardness of 6gpg and adjusted to a temperature of 16°C.
- Performance of the variant enzymes is then determined as per the BMI microswatch assay described.
- the performance index is determined by comparing the performance of the variant with that of a reference enzyme, said reference enzyme being the enzyme of SEQ ID NO: 1 consisting the A158E mutation, with in all cases the enzyme dosage range being 0.1-5ppm. Enzymes having a performance index of 1.0 or greater are viewed to be cold water proteases.
- TEST METHOD 5 Electrical conductivity of an aqueous solution is assayed according to the standard method ASTM Dl 125 and reported in units of milliSiemens/cm, abbreviated to mS/cm in this patent.
- TEST METHOD 6 For Test Method 6, the BMI microswatch assay is run using one of the detergents of Examples 36a - 36n. The detergent is dissolved in water that has a hardness as specified in Table 6-4 and adjusted to a temperature of 16°C. Performance of the variant enzymes is then determined as per the BMI microswatch assay described. The performance index is determined by comparing the performance of the variant with that of the enzyme of SEQ ID NO: 1 , with in all cases the enzyme dosage range being 0. l-5ppm. Enzymes having a performance index of 1.1 or greater are viewed to be cold water proteases.
- Liquid laundry detergent compositions suitable for front-loading automatic washing machines.
- Alkylbenzene sulfonic acid 7 1 1 4.5 1.2 1.5 12.5 5.2 4
- n from 20 to 30,
- x from 3 to 8, or sulphated or sulphonated
- Liquid laundry detergent compositions suitable for top-loading automatic washing machines.
- Amylase (Termamyl Ultra®) 1 .1
- Pectate Lyase (Pectawash®) 0.1 0.2
- n from 20 to 30,
- Random graft co-polymer 1 0.4 0.2 1.0 0.5 0.6 1.0 0.8 1.0
- Random graft copolymer is a polyvinyl acetate grafted polyethylene oxide copolymer having a polyethylene oxide backbone and multiple polyvinyl acetate side chains.
- the molecular weight of the polyethylene oxide backbone is about 6000 and the weight ratio of the polyethylene oxide to polyvinyl acetate is about 40 to 60 and no more than 1 grafting point per 50 ethylene oxide units.
- 2 Polyethylenimine (MW 600) with 20 ethoxylate groups per -NH.
- x from 3 to 8, or sulphated or sulphonated variants
- Random graft co-polymer 1 1.46 0.5
- Random graft copolymer is a polyvinyl acetate grafted polyethylene oxide copolymer having a polyethylene oxide backbone and multiple polyvinyl acetate side chains.
- the molecular weight of the polyethylene oxide backbone is about 6000 and the weight ratio of the polyethylene oxide to polyvinyl acetate is about 40 to 60 and no more than 1 grafting point per 50 ethylene oxide units.
- the protease of this invention is separately added to these formulations.
- Surfactant ingredients can be obtained from BASF, Ludwigshafen, Germany (Lutensol®); Shell Chemicals, London, UK; Stepan, Northfield, Illinois, USA; Huntsman, Huntsman, Salt Lake City, Utah, USA; Clariant, Sulzbach, Germany (Praepagen®).
- Zeolite can be obtained from Industrial Zeolite (UK) Ltd, Grays, Essex, UK.
- Citric acid and sodium citrate can be obtained from Jungbunzlauer, Basel, Switzerland.
- Sodium percarbonate, sodium carbonate, sodium bicarbonate and sodium sesquicarbonate can be obtained from Solvay, Brussels, Belgium.
- Acrylate/maleate copolymers can be obtained from BASF, Ludwigshafen, Germany.
- Carboxymethylcellulose and hydrophobically modified carboxymethyl cellulose can be obtained from CPKelco, Arnhem, The Netherlands.
- C.I. Fluorescent Brightener 260 can be obtained from 3V Sigma, Bergamo, Italy as Optiblanc® Optiblanc® 2M/G, Optiblanc® 2MG/LT Extra, or Optiblanc® Ecobright.
- Tetrasodium S,S-ethylenediamine disuccinate can be obtained from Innospec, Ellesmere Port,
- Terephthalate co-polymer can be obtained from Clariant under the tradename Repelotex SF 2.
- 1-Hydroxyethane - 1 , 1 -diphosphonic acid can be obtained from Thermphos, Vlissingen-Oost, The Netherlands.
- Enzymes Natalase ®, Termamyl ®, Stainzyme Plus®, Celluclean® and Mannaway ® can be obtained from Novozymes, Bagsvaerd, Denmark.
- Zinc phthalocyanine tetrasulfonate can be obtained from Ciba Specialty Chemicals, Basel, Switzerland, as Tinolux® BMC.
- Suds suppressor granule can be obtained from Dow Corning, Barry, UK.
- Random graft copolymer is a polyvinyl acetate grafted polyethylene oxide copolymer having a polyethylene oxide backbone and multiple polyvinyl acetate side chains.
- the molecular weight of the polyethylene oxide backbone is about 6000 and the weight ratio of the polyethylene oxide to polyvinyl acetate is about 40 to 60 and no more than 1 grafting point per 50 ethylene oxide units.
- GG36 SELs The construction of GG36 SELs described in this example was performed by GE EART using their proprietary methods and technology platform for gene optimization, gene synthesis, library generation and analysis (WO 2004/059556A3, European Patent Nos. 0 200 362 and 0 201 184; and US Patent Nos. 4,683, 195, 4,683,202 and 6,472, 184).
- the GG36 SELs were produced at positions pre-selected by the inventors using the pHPLT-GG36 B. subtilis expression plasmid ⁇ See, FIG. 2).
- This B. subtilis expression plasmid contains the GG36 expression cassette shown below, the B. licheniformis LAT promoter (Plat), and additional elements from pUB 1 10 (McKenzie et al., Plasmid, 15:93- 103, 1986) including a replicase gene (reppUB), a
- neomycin/kanamycin resistance gene neo
- bleo bleomycin resistance marker
- Protein sequence of GG36 (signal sequence is shown in lower case letters, propeptide in lower case, underlined text, and GG36 mature protease sequence in uppercase letters) vrskklwivastallisvafsssiasaaeeakekyligfneqeavsefveqveandevailseeeeveiellhefetipylsvelspedvdal eldpaisvieedaevttmAOSVPWGISRVOAPAAHNRGLTGSGVKVAVLDTGISTHPDLNIRGGA SFVPGEPSTQDGNGHGTHVAGTIAALNNSIGVLGVAPSAELYAVKVLGASGSGSVSSIAQ GLEWAGNNGMHVANLSLGSPSPSATLEQAVNSATSRGVLVVAASGNSGAGSISYPARY ANAMAVGATDQ NNRASFSQYGAGLDIVAPGVNVQSTYPGSTYASLNGTSMATPHVA GAAALVKQKNPSWSNVQIRNHLKNT
- the method of mutagenesis was based on the codon-specific mutation approach in which all possible amino acid substitutions are simultaneously created at a specific codon of interest using forward and reverse mutagenesis primers that contain a degenerate codon, NNS ((A,C,T or G), (A,C,T or G), (C or G)) at the site of interest.
- each of the GG36 SELs three PCR reactions were performed: two mutagenesis reactions (primary PCR 1 and PCR2) to introduce the mutated codon of interest in the mature GG36 DNA sequence using the NNS forward and reverse mutagenesis primers (25-45 nucleotides long), and a third reaction to fuse the two mutagenesis PCR products together to construct the pHPLT-GG36 expression vector having the desired mutated codons in the mature GG36 sequence.
- the Phusion High-Fidelity DNA Polymerase (Finnzymes catalog no. F-530L) was used for all PCRs, and the reactions were executed according to manufacturer's protocols that were supplied with the polymerase. In particular, for primary PCR 1 , 1 uL (10 uM) of each of the pHPLT- Bglll-Fw primer and a NNS reverse mutagenesis primer were used, and for primary PCR 2, 1 (10 uM) of the pHPLT-Bglll-Rv primer and a NNS forward mutagenesis primer were used. Each reaction also included 1 ⁇ of the pHPLT-GG36 plasmid template DNA (0.1 - 1 ng/ ⁇ ).
- the amplified linear 859 bp fragment encoding the GG36 variant gene was purified (using QIAGEN ® Qiaquick PCR purification kit) and digested with the Sacl and HindlHI restriction enzymes to create cohesive ends on both sides of the fusion fragment. About 50ng of plasmid pHPLT-GG36 was also purified after digestion with Sacl and HindlHI, resulting in a 3.9kb vector backbone fragment. The digested vector fragment was ligated with 50ng of the digested 859bp fragment encoding the variant enzyme using the T4 DNA ligase (Invitrogen) following the manufacturer's protocol for cloning of cohesive ends. Subsequently, the ligation mixture was used to transform B.
- T4 DNA ligase Invitrogen
- subtilis cells (AaprE, AnprE, oppA, AspoIIE, degUHy32, AamyE::[xylR,pxylA-comK]) as described (WO 2002/014490).
- the B. subtilis strains carrying the GG36 variant plasmids were inoculated into microtiter plates containing 150 ⁇ 1 Luria broth medium supplemented with lOpg/ml neomycin. Plates were grown overnight at 37°C with 300 rpm shaking and 80% humidity using Enzyscreen lids for microtiter plates (Enzyscreen). Ten microliters from the overnight culture plate were used to inoculate a new microtiter plate containing 190 ⁇ 1 of MBD medium (a MOPS based defined medium) with lOug/ml neomycin. MBD medium was prepared essentially as known in the art (See, Neidhardt el al., J.
- the micronutrients were made up as a 100X stock solution containing in one liter, 400 mg FeS0 4 7H 2 0, 100 mg MnS0 4 .H 2 0, 100 mg ZnS0 4 7H 2 0, 50 mg CuCl 2 2H 2 0, 100 mg CoCl 2 6H 2 0, 100 mg NaMo0 4 2H 2 0, 100 mg Na 2 B 4 0 7 10H 2 O, 10 ml of 1M CaCl 2 , and 10 ml of 0.5 M sodium citrate.
- the MBD medium containing microtiter plates were grown for 68 hours at 37°C, 300 rpm, and 80% humidity using Enzyscreen lids (Enzyscreen) for determining protein expression.
- the NHJ4 set of GG36 variants described in Table 4-4 below were constructed using the pHPLT-GG36 B. subtilis expression plasmid ( Figure 2) using PCR fusion or the QuikChange ® Multi Site-directed mutagenesis kit ("QCMS kit"; Stratagene) as described below.
- QCMS kit QuikChange ® Multi Site-directed mutagenesis kit
- Table 4-4 Construction of NHJ4 variants by QuikChange ® Multi Site-Directed Mutagenesis (QCMS) Variants created by the QuikChange ® Multi Site-Directed Mutagenesis are shown in Table 4-4.
- the parent plasmid pHPLT-GG36 template DNA
- Site-directed mutants were made by a QuikChange ® Multi Site-Directed
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Plant Pathology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Enzymes And Modification Thereof (AREA)
- Detergent Compositions (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
Description
Claims
Priority Applications (26)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
MX2012012913A MX339810B (en) | 2010-05-06 | 2011-05-05 | Consumer products with protease variants. |
RU2012144735/10A RU2598717C2 (en) | 2010-05-06 | 2011-05-05 | Consumer goods with protease versions |
EP19182103.2A EP3575389A3 (en) | 2010-05-06 | 2011-05-05 | Consumer products with protease variants |
EP16177383.3A EP3095861B1 (en) | 2010-05-06 | 2011-05-05 | Consumer products with protease variants |
ES11720664.9T ES2625751T3 (en) | 2010-05-06 | 2011-05-05 | Consumer products with protease variants |
PL16177383T PL3095861T3 (en) | 2010-05-06 | 2011-05-05 | Consumer products with protease variants |
CN2011800227382A CN103068977A (en) | 2010-05-06 | 2011-05-05 | Consumer products with protease variants |
DK11720664.9T DK2566960T3 (en) | 2010-05-06 | 2011-05-05 | CONSUMER PRODUCTS WITH PROTEASE VARIETIES |
JP2013509256A JP5813753B2 (en) | 2010-05-06 | 2011-05-05 | Consumer products with protease variants |
BR112012028466-5A BR112012028466B1 (en) | 2010-05-06 | 2011-05-05 | PRODUCT COMPOSITION WITH PROTEASE VARIANTS AND METHOD FOR TREATING AND / OR CLEANING A SURFACE |
EP11720664.9A EP2566960B1 (en) | 2010-05-06 | 2011-05-05 | Consumer products with protease variants |
ES12722015T ES2809509T3 (en) | 2011-05-05 | 2012-05-04 | Compositions and Methods Comprising Serine Protease Variants |
CN201610329893.3A CN106065381B (en) | 2011-05-05 | 2012-05-04 | Composition and method comprising serine protease variants |
PCT/US2012/036503 WO2012151480A2 (en) | 2011-05-05 | 2012-05-04 | Compositions and methods comprising serine protease variants |
HUE12722015A HUE050079T2 (en) | 2010-05-06 | 2012-05-04 | Compositions and methods comprising serine protease variants |
BR112013028440A BR112013028440A2 (en) | 2011-05-05 | 2012-05-04 | compositions and methods comprising serine protease variants |
JP2014508193A JP5933688B2 (en) | 2011-05-05 | 2012-05-04 | Compositions and methods comprising serine protease variants |
CN201280021968.1A CN103502446B (en) | 2011-05-05 | 2012-05-04 | Comprise compositions and the method for serine protease variants |
RU2013147763A RU2663114C2 (en) | 2011-05-05 | 2012-05-04 | Methods and compositions comprising serine protease variants |
EP12722015.0A EP2705145B1 (en) | 2011-05-05 | 2012-05-04 | Compositions and methods comprising serine protease variants |
MX2013012950A MX357386B (en) | 2011-05-05 | 2012-05-04 | Compositions and methods comprising serine protease variants. |
ZA2012/08019A ZA201208019B (en) | 2010-05-06 | 2012-10-24 | Consumer products with protease variants |
ZA2013/07499A ZA201307499B (en) | 2011-05-05 | 2013-10-08 | Compositions and methods comprising serine protease variants |
JP2015142243A JP6367161B2 (en) | 2011-05-05 | 2015-07-16 | Compositions and methods comprising serine protease variants |
US15/177,681 US20160362641A1 (en) | 2011-05-05 | 2016-06-09 | Compositions and methods comprising serine protease variants |
US16/892,338 US20200299618A1 (en) | 2011-05-05 | 2020-06-04 | Compositions and methods comprising serine protease variants |
Applications Claiming Priority (8)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US33200610P | 2010-05-06 | 2010-05-06 | |
US33215110P | 2010-05-06 | 2010-05-06 | |
US61/332,151 | 2010-05-06 | ||
US61/332,006 | 2010-05-06 | ||
US39236410P | 2010-10-12 | 2010-10-12 | |
US39218810P | 2010-10-12 | 2010-10-12 | |
US61/392,188 | 2010-10-12 | ||
US61/392,364 | 2010-10-12 |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2012/036503 Continuation-In-Part WO2012151480A2 (en) | 2011-05-05 | 2012-05-04 | Compositions and methods comprising serine protease variants |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2011140316A1 true WO2011140316A1 (en) | 2011-11-10 |
WO2011140316A4 WO2011140316A4 (en) | 2012-02-02 |
Family
ID=44140761
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2011/035389 WO2011140364A1 (en) | 2010-05-06 | 2011-05-05 | Compositions and methods comprising subtilisin variants |
PCT/US2011/035319 WO2011140316A1 (en) | 2010-05-06 | 2011-05-05 | Consumer products with protease variants |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2011/035389 WO2011140364A1 (en) | 2010-05-06 | 2011-05-05 | Compositions and methods comprising subtilisin variants |
Country Status (14)
Country | Link |
---|---|
US (4) | US20130260438A1 (en) |
EP (6) | EP2566961B1 (en) |
JP (6) | JP5813753B2 (en) |
CN (5) | CN108410585A (en) |
BR (2) | BR112012028466B1 (en) |
CA (1) | CA2798451C (en) |
DK (3) | DK3095861T3 (en) |
ES (3) | ES2694398T3 (en) |
HU (3) | HUE045202T2 (en) |
MX (2) | MX336737B (en) |
PL (2) | PL2566960T3 (en) |
RU (2) | RU2598717C2 (en) |
WO (2) | WO2011140364A1 (en) |
ZA (1) | ZA201208019B (en) |
Cited By (102)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2540825A2 (en) | 2011-06-30 | 2013-01-02 | The Procter & Gamble Company | Cleaning compositions comprising amylase variants reference to a sequence listing |
EP2551336A1 (en) | 2011-07-25 | 2013-01-30 | The Procter & Gamble Company | Detergent compositions |
CN103502446A (en) * | 2011-05-05 | 2014-01-08 | 宝洁公司 | Compositions and methods comprising serine protease variants |
WO2014200656A1 (en) | 2013-06-13 | 2014-12-18 | Danisco Us Inc. | Alpha-amylase from streptomyces umbrinus |
WO2014200657A1 (en) | 2013-06-13 | 2014-12-18 | Danisco Us Inc. | Alpha-amylase from streptomyces xiamenensis |
WO2014200658A1 (en) | 2013-06-13 | 2014-12-18 | Danisco Us Inc. | Alpha-amylase from promicromonospora vindobonensis |
WO2014204596A1 (en) | 2013-06-17 | 2014-12-24 | Danisco Us Inc. | Alpha-amylase from bacillaceae family member |
WO2015050723A1 (en) | 2013-10-03 | 2015-04-09 | Danisco Us Inc. | Alpha-amylases from exiguobacterium, and methods of use, thereof |
WO2015050724A1 (en) | 2013-10-03 | 2015-04-09 | Danisco Us Inc. | Alpha-amylases from a subset of exiguobacterium, and methods of use, thereof |
WO2015077126A1 (en) | 2013-11-20 | 2015-05-28 | Danisco Us Inc. | Variant alpha-amylases having reduced susceptibility to protease cleavage, and methods of use, thereof |
WO2015112340A1 (en) | 2014-01-22 | 2015-07-30 | The Procter & Gamble Company | Method of treating textile fabrics |
WO2015112338A1 (en) | 2014-01-22 | 2015-07-30 | The Procter & Gamble Company | Method of treating textile fabrics |
WO2015112339A1 (en) | 2014-01-22 | 2015-07-30 | The Procter & Gamble Company | Fabric treatment composition |
WO2015112341A1 (en) | 2014-01-22 | 2015-07-30 | The Procter & Gamble Company | Fabric treatment composition |
WO2016081437A1 (en) | 2014-11-17 | 2016-05-26 | The Procter & Gamble Company | Benefit agent delivery compositions |
WO2016096714A1 (en) * | 2014-12-15 | 2016-06-23 | Henkel Ag & Co. Kgaa | Detergent composition comprising subtilase variants |
EP3075823A1 (en) | 2015-03-30 | 2016-10-05 | The Procter and Gamble Company | A spray-dried laundry detergent base particle |
EP3075830A2 (en) | 2015-04-02 | 2016-10-05 | The Procter and Gamble Company | Solid free-flowing particulate laundry detergent composition |
EP3075826A1 (en) | 2015-03-30 | 2016-10-05 | The Procter and Gamble Company | Solid free-flowing particulate laundry detergent composition |
EP3075825A1 (en) | 2015-03-30 | 2016-10-05 | The Procter and Gamble Company | Solid free-flowing particulate laundry detergent composition |
EP3075827A1 (en) | 2015-03-30 | 2016-10-05 | The Procter and Gamble Company | Solid free-flowing particulate laundry detergent composition |
EP3075829A1 (en) | 2015-03-30 | 2016-10-05 | The Procter and Gamble Company | Solid free-flowing particulate laundry detergent composition |
EP3075834A1 (en) | 2015-04-02 | 2016-10-05 | The Procter and Gamble Company | Solid free-flowing particulate laundry detergent composition |
EP3075831A1 (en) | 2015-03-30 | 2016-10-05 | The Procter and Gamble Company | Solid free-flowing particulate laundry detergent composition |
EP3075828A1 (en) | 2015-03-30 | 2016-10-05 | The Procter and Gamble Company | Solid free-flowing particulate laundry detergent composition |
EP3075824A1 (en) | 2015-03-30 | 2016-10-05 | The Procter and Gamble Company | Solid free-flowing particulate laundry detergent composition |
WO2016161219A1 (en) | 2015-04-02 | 2016-10-06 | The Procter & Gamble Company | Solid free-flowing particulate laundry detergent composition |
WO2016160869A1 (en) | 2015-03-30 | 2016-10-06 | The Procter & Gamble Company | Solid free-flowing particulate laundry detergent composition |
EP3088503A1 (en) | 2015-04-29 | 2016-11-02 | The Procter and Gamble Company | Method of treating a fabric |
EP3088505A1 (en) | 2015-04-29 | 2016-11-02 | The Procter and Gamble Company | Method of treating a fabric |
EP3088504A1 (en) | 2015-04-29 | 2016-11-02 | The Procter and Gamble Company | Method of treating a fabric |
EP3088506A1 (en) | 2015-04-29 | 2016-11-02 | The Procter and Gamble Company | Detergent composition |
EP3088502A1 (en) | 2015-04-29 | 2016-11-02 | The Procter and Gamble Company | Method of treating a fabric |
EP3153425A1 (en) | 2015-10-06 | 2017-04-12 | The Procter and Gamble Company | Flexible box bag comprising detergent powder and a scoop |
EP3173467A1 (en) | 2015-11-26 | 2017-05-31 | The Procter & Gamble Company | Cleaning compositions comprising enzymes |
WO2017173190A2 (en) | 2016-04-01 | 2017-10-05 | Danisco Us Inc. | Alpha-amylases, compositions & methods |
WO2017173324A2 (en) | 2016-04-01 | 2017-10-05 | Danisco Us Inc. | Alpha-amylases, compositions & methods |
EP3243896A1 (en) | 2016-05-09 | 2017-11-15 | The Procter and Gamble Company | Detergent composition comprising a fatty acid decarboxylase |
EP3243898A2 (en) | 2016-05-09 | 2017-11-15 | The Procter & Gamble Company | Detergent composition comprising an oleic acid-transforming enzyme |
EP3243897A1 (en) | 2016-05-09 | 2017-11-15 | The Procter & Gamble Company | Detergent composition comprising a fatty acid-transforming enzyme |
EP2365055B1 (en) | 2010-03-01 | 2017-12-20 | The Procter and Gamble Company | Composition comprising substituted cellulosic polymer and amylase |
EP3269729A1 (en) | 2016-07-14 | 2018-01-17 | The Procter and Gamble Company | Detergent composition |
WO2018067482A1 (en) | 2016-10-03 | 2018-04-12 | The Procter & Gamble Company | Laundry detergent composition |
WO2018067493A1 (en) | 2016-10-03 | 2018-04-12 | The Procter & Gamble Company | Spray-dried base detergent particle giving rise to a low ph in the wash |
WO2018067485A1 (en) | 2016-10-03 | 2018-04-12 | The Procter & Gamble Company | Low ph laundry detergent composition |
WO2018067486A1 (en) | 2016-10-03 | 2018-04-12 | The Procter & Gamble Company | Low ph laundry detergent composition |
WO2018067481A1 (en) | 2016-10-03 | 2018-04-12 | The Procter & Gamble Company | Laundry detergent composition |
WO2018067487A1 (en) | 2016-10-03 | 2018-04-12 | The Procter & Gamble Company | Low ph laundry detergent composition |
WO2018067484A1 (en) | 2016-10-03 | 2018-04-12 | The Procter & Gamble Company | Laundry detergent composition |
WO2018067488A1 (en) | 2016-10-03 | 2018-04-12 | The Procter & Gamble Company | Low ph laundry detergent composition |
WO2018067483A1 (en) | 2016-10-03 | 2018-04-12 | The Procter & Gamble Company | Laundry detergent composition |
EP3330348A1 (en) | 2016-12-02 | 2018-06-06 | The Procter & Gamble Company | Cleaning compositions including enzymes |
WO2018102479A1 (en) | 2016-12-02 | 2018-06-07 | The Procter & Gamble Company | Cleaning compositions including enzymes |
EP3339420A1 (en) | 2016-12-22 | 2018-06-27 | The Procter & Gamble Company | Laundry detergent composition |
EP3339414A1 (en) | 2016-12-22 | 2018-06-27 | The Procter & Gamble Company | Laundry detergent composition |
EP3339407A1 (en) | 2016-12-22 | 2018-06-27 | The Procter & Gamble Company | Laundry detergent composition |
EP3339417A1 (en) | 2016-12-22 | 2018-06-27 | The Procter & Gamble Company | Laundry detergent composition |
EP3339416A1 (en) | 2016-12-22 | 2018-06-27 | The Procter & Gamble Company | Laundry detergent composition |
EP3339413A1 (en) | 2016-12-22 | 2018-06-27 | The Procter & Gamble Company | Laundry detergent composition |
EP3339418A1 (en) | 2016-12-22 | 2018-06-27 | The Procter & Gamble Company | Laundry detergent composition |
EP3339419A1 (en) | 2016-12-22 | 2018-06-27 | The Procter & Gamble Company | Laundry detergent composition |
EP3339415A1 (en) | 2016-12-22 | 2018-06-27 | The Procter & Gamble Company | Laundry detergent composition |
WO2018118825A1 (en) | 2016-12-22 | 2018-06-28 | The Procter & Gamble Company | Laundry detergent composition |
EP3357994A1 (en) | 2017-02-01 | 2018-08-08 | The Procter & Gamble Company | Cleaning compositions comprising amylase variants |
EP3546557A1 (en) | 2018-03-28 | 2019-10-02 | The Procter & Gamble Company | Catalase inhibition during a laundering process |
EP3546558A1 (en) | 2018-03-28 | 2019-10-02 | The Procter & Gamble Company | Laundry detergent composition |
EP3546559A1 (en) | 2018-03-28 | 2019-10-02 | The Procter & Gamble Company | Laundry detergent composition |
EP3546554A1 (en) | 2018-03-28 | 2019-10-02 | The Procter & Gamble Company | Spray-drying process |
WO2019191171A1 (en) | 2018-03-28 | 2019-10-03 | The Procter & Gamble Company | Laundry detergent composition |
WO2019191172A1 (en) | 2018-03-28 | 2019-10-03 | The Procter & Gamble Company | Process for preparing a spray-dried laundry detergent particle |
WO2019191173A1 (en) | 2018-03-28 | 2019-10-03 | The Procter & Gamble Company | Process for preparing a spray-dried laundry detergent particle |
EP3594319A1 (en) | 2018-07-12 | 2020-01-15 | The Procter & Gamble Company | A solid free-flowing particulate laundry detergent composition |
US10731111B2 (en) | 2015-11-25 | 2020-08-04 | Conopco, Inc. | Liquid laundry detergent composition |
WO2020222996A1 (en) | 2019-04-29 | 2020-11-05 | The Procter & Gamble Company | A process for making a laundry detergent composition |
EP3754010A1 (en) | 2019-06-17 | 2020-12-23 | The Procter & Gamble Company | A solid free-flowing particulate laundry detergent composition comprises a detersive surfactant and a linear polyamine salt |
WO2020264552A1 (en) | 2019-06-24 | 2020-12-30 | The Procter & Gamble Company | Cleaning compositions comprising amylase variants |
WO2021081547A3 (en) * | 2019-10-24 | 2021-06-03 | The Procter & Gamble Company | Automatic dishwashing detergent composition comprising a protease |
CN113302295A (en) * | 2018-12-03 | 2021-08-24 | 诺维信公司 | Powder detergent composition |
EP3936595A1 (en) | 2020-07-06 | 2022-01-12 | The Procter & Gamble Company | A process for making a particulate laundry detergent composition |
WO2022077022A1 (en) | 2020-10-09 | 2022-04-14 | The Procter & Gamble Company | Packaged laundry detergent product |
WO2022178432A1 (en) | 2021-02-22 | 2022-08-25 | Danisco Us Inc. | Methods and compositions for producing proteins of interest in pigment deficient bacillus cells |
EP4108754A1 (en) | 2021-06-25 | 2022-12-28 | The Procter & Gamble Company | A process for making a packaged laundry detergent powder |
EP4108756A1 (en) | 2021-06-25 | 2022-12-28 | The Procter & Gamble Company | A laundry detergent powder |
EP4123005A1 (en) | 2021-07-19 | 2023-01-25 | The Procter & Gamble Company | Cleaning composition comprising bacterial spores |
EP4212608A1 (en) | 2022-01-14 | 2023-07-19 | The Procter & Gamble Company | A method of making a spray-dried laundry detergent particle |
WO2023150903A1 (en) | 2022-02-08 | 2023-08-17 | The Procter & Gamble Company | A method of laundering fabric |
WO2023150905A1 (en) | 2022-02-08 | 2023-08-17 | The Procter & Gamble Company | A method of laundering fabric |
EP4234672A1 (en) | 2022-02-24 | 2023-08-30 | The Procter & Gamble Company | Water-soluble unit dose article comprising a fibrous non-woven sheet and a hueing dye particle |
EP4234666A1 (en) | 2022-02-24 | 2023-08-30 | The Procter & Gamble Company | Water-soluble unit dose article comprising a fibrous non-woven sheet and a surfactant system |
EP4279570A1 (en) | 2022-05-19 | 2023-11-22 | The Procter & Gamble Company | A process for making a particulate laundry detergent composition |
WO2023225459A2 (en) | 2022-05-14 | 2023-11-23 | Novozymes A/S | Compositions and methods for preventing, treating, supressing and/or eliminating phytopathogenic infestations and infections |
EP4299703A1 (en) | 2022-06-27 | 2024-01-03 | The Procter & Gamble Company | A solid free-flowing particulate laundry detergent composition |
EP4299704A1 (en) | 2022-06-27 | 2024-01-03 | The Procter & Gamble Company | A method of laundering and drying fabric |
EP4299701A1 (en) | 2022-06-27 | 2024-01-03 | The Procter & Gamble Company | A solid free-flowing particulate laundry detergent composition |
EP4299702A1 (en) | 2022-06-27 | 2024-01-03 | The Procter & Gamble Company | A solid free-flowing particulate laundry detergent composition |
EP4342970A1 (en) | 2022-09-21 | 2024-03-27 | Milliken & Company | Coloured fabric hueing dye agent particles |
EP4342969A1 (en) | 2022-09-21 | 2024-03-27 | The Procter & Gamble Company | A solid detergent cleaning composition |
EP4364929A1 (en) | 2022-11-01 | 2024-05-08 | The Procter & Gamble Company | Sealing jaws and water-soluble unit dose article comprising a fibrous non-woven sheet |
EP4364930A1 (en) | 2022-11-01 | 2024-05-08 | The Procter & Gamble Company | Sealing jaws and water-soluble unit dose article comprising a fibrous non-woven sheet |
EP4382592A1 (en) | 2022-12-06 | 2024-06-12 | The Procter & Gamble Company | Water-soluble unit dose article comprising a fibrous non-woven sheet and a surfactant system |
EP4389867A1 (en) | 2022-12-23 | 2024-06-26 | The Procter & Gamble Company | A process of making a laundry detergent article |
EP4389866A1 (en) | 2022-12-23 | 2024-06-26 | The Procter & Gamble Company | A process of making a water-soluble detergent unit dose article |
Families Citing this family (96)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP5813753B2 (en) | 2010-05-06 | 2015-11-17 | ザ プロクター アンド ギャンブルカンパニー | Consumer products with protease variants |
TR201901382T4 (en) | 2011-05-05 | 2019-02-21 | Danisco Inc | Compositions and methods comprising serine protease variants. |
US20130123162A1 (en) * | 2011-11-10 | 2013-05-16 | The Procter & Gamble Company | Consumer products |
DK3354728T3 (en) | 2012-12-21 | 2020-07-27 | Danisco Us Inc | ALPHA-amylase variants |
WO2014099525A1 (en) | 2012-12-21 | 2014-06-26 | Danisco Us Inc. | Paenibacillus curdlanolyticus amylase, and methods of use, thereof |
DK2970930T4 (en) | 2013-03-11 | 2022-03-14 | Danisco Us Inc | COMBINATORY ALPHA AMYLASE VARIANTS |
WO2014194034A2 (en) | 2013-05-29 | 2014-12-04 | Danisco Us Inc. | Novel metalloproteases |
WO2014194032A1 (en) | 2013-05-29 | 2014-12-04 | Danisco Us Inc. | Novel metalloproteases |
WO2014194054A1 (en) | 2013-05-29 | 2014-12-04 | Danisco Us Inc. | Novel metalloproteases |
JP6367930B2 (en) | 2013-05-29 | 2018-08-01 | ダニスコ・ユーエス・インク | Novel metalloprotease |
AR098006A1 (en) | 2013-10-15 | 2016-04-27 | Danisco Us Inc | CLAY Granule |
US20160289653A1 (en) | 2013-11-14 | 2016-10-06 | Danisco Us Inc. | Stable Enzymes by Glycation Reduction |
EP3910057A1 (en) | 2013-12-13 | 2021-11-17 | Danisco US Inc. | Serine proteases of the bacillus gibsonii-clade |
WO2015089441A1 (en) | 2013-12-13 | 2015-06-18 | Danisco Us Inc. | Serine proteases of bacillus species |
US10005850B2 (en) | 2013-12-16 | 2018-06-26 | E I Du Pont De Nemours And Company | Use of poly alpha-1,3-glucan ethers as viscosity modifiers |
EP3789407B1 (en) | 2013-12-18 | 2024-07-24 | Nutrition & Biosciences USA 4, Inc. | Cationic poly alpha-1,3-glucan ethers |
US20150232785A1 (en) | 2014-02-14 | 2015-08-20 | E I Du Pont De Nemours And Company | Polysaccharides for viscosity modification |
US9695253B2 (en) | 2014-03-11 | 2017-07-04 | E I Du Pont De Nemours And Company | Oxidized poly alpha-1,3-glucan |
JP6585698B2 (en) | 2014-03-21 | 2019-10-02 | ダニスコ・ユーエス・インク | Serine protease of Bacillus species |
US9714403B2 (en) | 2014-06-19 | 2017-07-25 | E I Du Pont De Nemours And Company | Compositions containing one or more poly alpha-1,3-glucan ether compounds |
EP3158043B1 (en) | 2014-06-19 | 2021-03-10 | Nutrition & Biosciences USA 4, Inc. | Compositions containing one or more poly alpha-1,3-glucan ether compounds |
CN116240202A (en) | 2014-07-04 | 2023-06-09 | 诺维信公司 | Subtilase variants and polynucleotides encoding same |
EP3739029A1 (en) | 2014-07-04 | 2020-11-18 | Novozymes A/S | Subtilase variants and polynucleotides encoding same |
WO2016061438A1 (en) | 2014-10-17 | 2016-04-21 | Danisco Us Inc. | Serine proteases of bacillus species |
WO2016065238A1 (en) | 2014-10-24 | 2016-04-28 | Danisco Us Inc. | Method for producing alcohol by use of a tripeptidyl peptidase |
EP3212783B1 (en) | 2014-10-27 | 2024-06-26 | Danisco US Inc. | Serine proteases |
US20180010074A1 (en) | 2014-10-27 | 2018-01-11 | Danisco Us Inc. | Serine proteases of bacillus species |
WO2016069552A1 (en) | 2014-10-27 | 2016-05-06 | Danisco Us Inc. | Serine proteases |
US20170335306A1 (en) | 2014-10-27 | 2017-11-23 | Danisco Us Inc. | Serine proteases |
EP3212782B1 (en) | 2014-10-27 | 2019-04-17 | Danisco US Inc. | Serine proteases |
CN108064306B (en) | 2014-12-23 | 2022-11-01 | 营养与生物科学美国4公司 | Enzymatically produced cellulose |
EP3294884B1 (en) | 2015-05-13 | 2021-01-27 | Danisco US Inc. | Aprl-clade protease variants and uses thereof |
WO2016201069A1 (en) | 2015-06-09 | 2016-12-15 | Danisco Us Inc | Low-density enzyme-containing particles |
DK3307427T3 (en) | 2015-06-09 | 2023-11-06 | Danisco Us Inc | OSMOTIC BURST CAPSULES |
WO2016201040A1 (en) | 2015-06-09 | 2016-12-15 | Danisco Us Inc. | Water-triggered enzyme suspension |
WO2016205755A1 (en) | 2015-06-17 | 2016-12-22 | Danisco Us Inc. | Bacillus gibsonii-clade serine proteases |
EP3153426B1 (en) | 2015-10-06 | 2018-07-18 | The Procter & Gamble Company | Flexible box bag comprising soluble unit dose detergent pouch |
CN108603183B (en) | 2015-11-05 | 2023-11-03 | 丹尼斯科美国公司 | Paenibacillus species and bacillus species mannanases |
US20190153417A1 (en) | 2015-11-05 | 2019-05-23 | Danisco Us Inc | Paenibacillus sp. mannanases |
US10183087B2 (en) * | 2015-11-10 | 2019-01-22 | American Sterilizer Company | Cleaning and disinfecting composition |
JP6997706B2 (en) | 2015-11-13 | 2022-01-18 | ニュートリション・アンド・バイオサイエンシーズ・ユーエスエー・フォー,インコーポレイテッド | Glucan fiber composition for use in laundry care and textile care |
US10844324B2 (en) | 2015-11-13 | 2020-11-24 | Dupont Industrial Biosciences Usa, Llc | Glucan fiber compositions for use in laundry care and fabric care |
WO2017083229A1 (en) | 2015-11-13 | 2017-05-18 | E. I. Du Pont De Nemours And Company | Glucan fiber compositions for use in laundry care and fabric care |
JP2019500058A (en) | 2015-12-09 | 2019-01-10 | ダニスコ・ユーエス・インク | α-Amylase combination mutant |
US20180362946A1 (en) | 2015-12-18 | 2018-12-20 | Danisco Us Inc. | Polypeptides with endoglucanase activity and uses thereof |
US20170321157A1 (en) * | 2016-05-03 | 2017-11-09 | The Procter & Gamble Company | Automatic dishwashing detergent composition |
WO2017192692A1 (en) | 2016-05-03 | 2017-11-09 | Danisco Us Inc | Protease variants and uses thereof |
CN109072213A (en) | 2016-05-05 | 2018-12-21 | 丹尼斯科美国公司 | Ease variants and application thereof |
US11661567B2 (en) | 2016-05-31 | 2023-05-30 | Danisco Us Inc. | Protease variants and uses thereof |
JP7152319B2 (en) | 2016-06-17 | 2022-10-12 | ダニスコ・ユーエス・インク | Protease variants and uses thereof |
WO2018085524A2 (en) | 2016-11-07 | 2018-05-11 | Danisco Us Inc | Laundry detergent composition |
US10550443B2 (en) | 2016-12-02 | 2020-02-04 | The Procter & Gamble Company | Cleaning compositions including enzymes |
US20200392477A1 (en) | 2016-12-21 | 2020-12-17 | Danisco Us Inc. | Protease variants and uses thereof |
CN110312794B (en) | 2016-12-21 | 2024-04-12 | 丹尼斯科美国公司 | Bacillus gibsonii clade serine protease |
JP2018104705A (en) * | 2016-12-27 | 2018-07-05 | 花王株式会社 | Powder detergent composition for fiber product |
US11453871B2 (en) * | 2017-03-15 | 2022-09-27 | Danisco Us Inc. | Trypsin-like serine proteases and uses thereof |
EP3601515A1 (en) | 2017-03-31 | 2020-02-05 | Danisco US Inc. | Delayed release enzyme formulations for bleach-containing detergents |
US20210095268A1 (en) | 2017-03-31 | 2021-04-01 | Danisco Us Inc | Alpha-amylase combinatorial variants |
MX2019014556A (en) | 2017-06-30 | 2020-02-07 | Danisco Us Inc | Low-agglomeration, enzyme-containing particles. |
EP3668973A2 (en) | 2017-08-18 | 2020-06-24 | Danisco US Inc. | Alpha-amylase variants |
EP3717643A1 (en) | 2017-11-29 | 2020-10-07 | Danisco US Inc. | Subtilisin variants having improved stability |
CA3086202A1 (en) | 2017-12-21 | 2019-06-27 | Danisco Us Inc. | Enzyme-containing, hot-melt granules comprising a thermotolerant desiccant |
MX2020008302A (en) | 2018-02-08 | 2020-10-14 | Danisco Us Inc | Thermally-resistant wax matrix particles for enzyme encapsulation. |
CN108334745B (en) * | 2018-03-19 | 2022-02-08 | 青岛理工大学 | Nonlinear hybrid system modeling method in polymerase chain reaction process |
EP3799601A1 (en) | 2018-06-19 | 2021-04-07 | Danisco US Inc. | Subtilisin variants |
US20210214703A1 (en) | 2018-06-19 | 2021-07-15 | Danisco Us Inc | Subtilisin variants |
EP3810658A1 (en) | 2018-06-20 | 2021-04-28 | The Procter & Gamble Company | A product comprising polysaccharide derivatives |
CA3108284A1 (en) | 2018-07-31 | 2020-02-06 | Danisco Us Inc | Variant alpha-amylases having amino acid substitutions that lower the pka of the general acid |
WO2020047215A1 (en) | 2018-08-30 | 2020-03-05 | Danisco Us Inc | Enzyme-containing granules |
JP2022503923A (en) | 2018-09-27 | 2022-01-12 | ダニスコ・ユーエス・インク | Composition for cleaning medical equipment |
US20210355469A1 (en) | 2018-10-12 | 2021-11-18 | Danisco Us Inc | Alpha-amylases with mutations that improve stability in the presence of chelants |
US20230028935A1 (en) | 2018-11-28 | 2023-01-26 | Danisco Us Inc | Subtilisin variants having improved stability |
AU2020272127B2 (en) | 2019-04-12 | 2022-12-08 | Ecolab Usa Inc. | Antimicrobial multi-purpose cleaner and methods of making and using the same |
US20220220419A1 (en) | 2019-05-24 | 2022-07-14 | Danisco Us Inc | Subtilisin variants and methods of use |
WO2020247582A1 (en) | 2019-06-06 | 2020-12-10 | Danisco Us Inc | Methods and compositions for cleaning |
EP4048683A2 (en) | 2019-10-24 | 2022-08-31 | Danisco US Inc | Variant maltopentaose/maltohexaose-forming alpha-amylases |
WO2022047149A1 (en) | 2020-08-27 | 2022-03-03 | Danisco Us Inc | Enzymes and enzyme compositions for cleaning |
CN112745993B (en) * | 2020-12-28 | 2022-06-24 | 厦门琥珀日化科技股份有限公司 | Microcapsule essence and preparation method and application thereof |
US20240117275A1 (en) | 2021-01-29 | 2024-04-11 | Danisco Us Inc. | Compositions for cleaning and methods related thereto |
EP4363565A1 (en) | 2021-06-30 | 2024-05-08 | Danisco US Inc. | Variant lipases and uses thereof |
WO2023034486A2 (en) | 2021-09-03 | 2023-03-09 | Danisco Us Inc. | Laundry compositions for cleaning |
CN117957318A (en) | 2021-09-13 | 2024-04-30 | 丹尼斯科美国公司 | Particles containing bioactive substances |
WO2023114939A2 (en) | 2021-12-16 | 2023-06-22 | Danisco Us Inc. | Subtilisin variants and methods of use |
WO2023114936A2 (en) | 2021-12-16 | 2023-06-22 | Danisco Us Inc. | Subtilisin variants and methods of use |
CN118715318A (en) | 2021-12-16 | 2024-09-27 | 丹尼斯科美国公司 | Subtilisin variants and uses thereof |
CN118647716A (en) | 2021-12-16 | 2024-09-13 | 丹尼斯科美国公司 | Maltopentaose/maltohexaose variant alpha-amylase |
WO2023168234A1 (en) | 2022-03-01 | 2023-09-07 | Danisco Us Inc. | Enzymes and enzyme compositions for cleaning |
WO2023250301A1 (en) | 2022-06-21 | 2023-12-28 | Danisco Us Inc. | Methods and compositions for cleaning comprising a polypeptide having thermolysin activity |
CN116286565B (en) * | 2022-07-12 | 2024-06-11 | 湖北佶凯星生物科技有限公司 | Bacillus subtilis strain for high yield of alkaline protease and application thereof |
WO2024050343A1 (en) | 2022-09-02 | 2024-03-07 | Danisco Us Inc. | Subtilisin variants and methods related thereto |
WO2024050339A1 (en) | 2022-09-02 | 2024-03-07 | Danisco Us Inc. | Mannanase variants and methods of use |
WO2024050346A1 (en) | 2022-09-02 | 2024-03-07 | Danisco Us Inc. | Detergent compositions and methods related thereto |
WO2024102698A1 (en) | 2022-11-09 | 2024-05-16 | Danisco Us Inc. | Subtilisin variants and methods of use |
WO2024163584A1 (en) | 2023-02-01 | 2024-08-08 | Danisco Us Inc. | Subtilisin variants and methods of use |
WO2024186819A1 (en) | 2023-03-06 | 2024-09-12 | Danisco Us Inc. | Subtilisin variants and methods of use |
WO2024191711A1 (en) | 2023-03-16 | 2024-09-19 | Nutrition & Biosciences USA 4, Inc. | Brevibacillus fermentate extracts for cleaning and malodor control and use thereof |
Citations (87)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4430243A (en) | 1981-08-08 | 1984-02-07 | The Procter & Gamble Company | Bleach catalyst compositions and use thereof in laundry bleaching and detergent compositions |
US4435307A (en) | 1980-04-30 | 1984-03-06 | Novo Industri A/S | Detergent cellulase |
EP0200362A2 (en) | 1985-03-28 | 1986-11-05 | F. Hoffmann-La Roche Ag | Process for amplifying, detecting, and/or cloning nucleic acid sequences |
EP0201184A2 (en) | 1985-03-28 | 1986-11-12 | F. Hoffmann-La Roche Ag | Process for amplifying nucleic acid sequences |
US4683195A (en) | 1986-01-30 | 1987-07-28 | Cetus Corporation | Process for amplifying, detecting, and/or-cloning nucleic acid sequences |
US4760025A (en) | 1984-05-29 | 1988-07-26 | Genencor, Inc. | Modified enzymes and methods for making same |
US4762636A (en) | 1986-02-28 | 1988-08-09 | Ciba-Geigy Corporation | Process for the preparation of granules containing an active substance and to the use thereof as speckles for treating substrates |
US4990280A (en) | 1988-03-14 | 1991-02-05 | Danochemo A/S | Photoactivator dye composition for detergent use |
WO1994002597A1 (en) | 1992-07-23 | 1994-02-03 | Novo Nordisk A/S | MUTANT α-AMYLASE, DETERGENT, DISH WASHING AGENT, AND LIQUEFACTION AGENT |
US5288627A (en) | 1988-01-07 | 1994-02-22 | Novo Nordisk A/S | Endoprotease from Fusarium oxysporumDSM 2672 for use in detergents |
US5352604A (en) | 1989-08-25 | 1994-10-04 | Henkel Research Corporation | Alkaline proteolytic enzyme and method of production |
US5457046A (en) | 1990-05-09 | 1995-10-10 | Novo Nordisk A/S | Enzyme capable of degrading cellullose or hemicellulose |
WO1995030010A1 (en) * | 1994-05-02 | 1995-11-09 | The Procter & Gamble Company | Subtilisin bpn' variants having decreased adsorption and increased hydrolysis |
US5486303A (en) | 1993-08-27 | 1996-01-23 | The Procter & Gamble Company | Process for making high density detergent agglomerates using an anhydrous powder additive |
US5489392A (en) | 1994-09-20 | 1996-02-06 | The Procter & Gamble Company | Process for making a high density detergent composition in a single mixer/densifier with selected recycle streams for improved agglomerate properties |
US5516448A (en) | 1994-09-20 | 1996-05-14 | The Procter & Gamble Company | Process for making a high density detergent composition which includes selected recycle streams for improved agglomerate |
US5520838A (en) | 1991-01-16 | 1996-05-28 | The Procter & Gamble Company | Compact detergent compositions with high activity cellulase |
US5565422A (en) | 1995-06-23 | 1996-10-15 | The Procter & Gamble Company | Process for preparing a free-flowing particulate detergent composition having improved solubility |
US5569645A (en) | 1995-04-24 | 1996-10-29 | The Procter & Gamble Company | Low dosage detergent composition containing optimum proportions of agglomerates and spray dried granules for improved flow properties |
US5574005A (en) | 1995-03-07 | 1996-11-12 | The Procter & Gamble Company | Process for producing detergent agglomerates from high active surfactant pastes having non-linear viscoelastic properties |
US5576282A (en) | 1995-09-11 | 1996-11-19 | The Procter & Gamble Company | Color-safe bleach boosters, compositions and laundry methods employing same |
US5595967A (en) | 1995-02-03 | 1997-01-21 | The Procter & Gamble Company | Detergent compositions comprising multiperacid-forming bleach activators |
US5597936A (en) | 1995-06-16 | 1997-01-28 | The Procter & Gamble Company | Method for manufacturing cobalt catalysts |
US5648263A (en) | 1988-03-24 | 1997-07-15 | Novo Nordisk A/S | Methods for reducing the harshness of a cotton-containing fabric |
US5679630A (en) | 1993-10-14 | 1997-10-21 | The Procter & Gamble Company | Protease-containing cleaning compositions |
US5691178A (en) | 1988-03-22 | 1997-11-25 | Novo Nordisk A/S | Fungal cellulase composition containing alkaline CMC-endoglucanase and essentially no cellobiohydrolase |
US5691297A (en) | 1994-09-20 | 1997-11-25 | The Procter & Gamble Company | Process for making a high density detergent composition by controlling agglomeration within a dispersion index |
WO1998008940A1 (en) | 1996-08-26 | 1998-03-05 | Novo Nordisk A/S | A novel endoglucanase |
US5763385A (en) | 1996-05-14 | 1998-06-09 | Genencor International, Inc. | Modified α-amylases having altered calcium binding properties |
US5856164A (en) | 1994-03-29 | 1999-01-05 | Novo Nordisk A/S | Alkaline bacillus amylase |
US5879584A (en) | 1994-09-10 | 1999-03-09 | The Procter & Gamble Company | Process for manufacturing aqueous compositions comprising peracids |
WO1999020727A1 (en) * | 1997-10-22 | 1999-04-29 | The Procter & Gamble Company | Cleaning compositions containing multiply-substituted protease variants |
US5919691A (en) | 1994-10-06 | 1999-07-06 | Novo Nordisk A/S | Enzyme and enzyme preparation with endoglucanase activity |
US5948672A (en) | 1990-05-09 | 1999-09-07 | Novo Nordisk A/S | Cellulase preparation comprising an endoglucanase enzyme |
US6001639A (en) | 1995-03-17 | 1999-12-14 | Novo Nordisk A/S | Endoglucanases |
US6093562A (en) | 1996-02-05 | 2000-07-25 | Novo Nordisk A/S | Amylase variants |
US6114296A (en) | 1992-10-06 | 2000-09-05 | Novo Nordisk A/S | Cellulase variants |
US6117664A (en) | 1994-03-03 | 2000-09-12 | Novo Nordisk A/S | Alkaline cellulases |
EP1070115A2 (en) | 1998-04-07 | 2001-01-24 | Unilever Plc | Coloured granular composition for use in particulate detergent compositions |
US6187576B1 (en) | 1997-10-13 | 2001-02-13 | Novo Nordisk A/S | α-amylase mutants |
US6225464B1 (en) | 1997-03-07 | 2001-05-01 | The Procter & Gamble Company | Methods of making cross-bridged macropolycycles |
EP1109965A1 (en) | 1998-09-01 | 2001-06-27 | Unilever Plc | Method of treating a textile |
US6268197B1 (en) | 1997-07-07 | 2001-07-31 | Novozymes A/S | Xyloglucan-specific alkaline xyloglucanase from bacillus |
US6291412B1 (en) | 1998-05-18 | 2001-09-18 | Ciba Specialty Chemicals Corporation | Water-soluble granules of phthalocyanine compounds |
US6297037B1 (en) | 1993-02-11 | 2001-10-02 | Christopher C. Barnett | Oxidatively stable alpha-amylase |
US6306812B1 (en) | 1997-03-07 | 2001-10-23 | Procter & Gamble Company, The | Bleach compositions containing metal bleach catalyst, and bleach activators and/or organic percarboxylic acids |
US6312936B1 (en) | 1997-10-23 | 2001-11-06 | Genencor International, Inc. | Multiply-substituted protease variants |
US6326348B1 (en) | 1996-04-16 | 2001-12-04 | The Procter & Gamble Co. | Detergent compositions containing selected mid-chain branched surfactants |
WO2002014490A2 (en) | 2000-08-11 | 2002-02-21 | Genencor International, Inc. | Bacillus transformation, transformants and mutant libraries |
US6380144B1 (en) | 1996-07-31 | 2002-04-30 | The Procter & Gamble Company | Detergent composition |
EP1240378A1 (en) | 1999-12-24 | 2002-09-18 | Unilever Plc | Method of treating a textile |
WO2002077242A2 (en) | 2001-03-27 | 2002-10-03 | Novozymes A/S | Family 74 xyloglucanases |
US6472184B1 (en) | 1997-08-22 | 2002-10-29 | Peter Hegemann | Method for producing nucleic acid polymers |
US20030087790A1 (en) | 2001-08-20 | 2003-05-08 | Unilever Home & Personal Care Usa, Division Of Conopco, Inc. | Photobleach speckle and laundry detergent compositions containing it |
US20030087791A1 (en) | 2001-08-20 | 2003-05-08 | Unilever Home & Personal Care Usa, Division Of Conopco, Inc. | Photobleach speckle and laundry detergent compositions containing it |
US6566112B2 (en) | 1997-11-19 | 2003-05-20 | Genencor International, Inc. | Cellulase producing actinomycetes, cellulase produced therefrom and method of producing same |
US6630340B2 (en) | 2000-03-01 | 2003-10-07 | Novozymes A/S | Family 5 xyloglucanases |
US6632646B1 (en) * | 1989-06-26 | 2003-10-14 | Novozymes A/S | Modified subtilisins and detergent compositions containing same |
US6673589B2 (en) | 1997-10-30 | 2004-01-06 | Novozymes A/S | α-amylase mutants |
US20040048764A1 (en) | 2002-09-11 | 2004-03-11 | Kim Dong Gyu | Complex salt for anti-spotting detergents |
WO2004059556A2 (en) | 2002-12-23 | 2004-07-15 | Geneart Gmbh | Method and device for optimizing a nucleotide sequence for the purpose of expression of a protein |
US6916645B2 (en) | 1998-12-21 | 2005-07-12 | Kao Corporation | Amylases |
US6939702B1 (en) | 1999-03-31 | 2005-09-06 | Novozymes A/S | Lipase variant |
US20050227891A1 (en) | 2002-09-04 | 2005-10-13 | Pierre Dreyer | Formulations comprising water-soluble granulates |
US6979731B1 (en) | 1995-06-14 | 2005-12-27 | Kao Corporation | Gene encoding alkaline liquefying α-amylase |
US20060089284A1 (en) | 2002-06-06 | 2006-04-27 | Miracle Gregory S | Organic catalyst with enhanced enzyme compatibility |
US7141403B2 (en) | 2001-06-06 | 2006-11-28 | Novozymes A/S | Endo-beta-1,4-glucanases |
US7153818B2 (en) | 2000-07-28 | 2006-12-26 | Henkel Kgaa | Amylolytic enzyme extracted from bacillus sp. A 7-7 (DSM 12368) and washing and cleaning agents containing this novel amylolytic enzyme |
WO2007006305A1 (en) * | 2005-07-08 | 2007-01-18 | Novozymes A/S | Subtilase variants |
US7172891B2 (en) | 2002-04-19 | 2007-02-06 | Novozymes, Inc. | Polypeptides having xyloglucanase activity and nucleic acids encoding same |
US7208459B2 (en) | 2004-06-29 | 2007-04-24 | The Procter & Gamble Company | Laundry detergent compositions with efficient hueing dye |
US20070173430A1 (en) | 2006-01-23 | 2007-07-26 | The Procter & Gamble Company | Composition comprising a lipase and a bleach catalyst |
US7262042B2 (en) | 2001-12-20 | 2007-08-28 | Henkel Kommanditgesellschaft Auf Aktien (Henkel Kgaa) | Alkaline protease from Bacillus gibsonii (DSM 14393) and washing and cleaning products comprising said alkaline protease |
US20080063774A1 (en) | 2003-11-19 | 2008-03-13 | Wolfgang Aehle | Multiple mutation variants of serine protease |
US7361736B2 (en) | 2000-02-24 | 2008-04-22 | Novozymes A/S | Family 44 xyloglucanases |
US7378264B2 (en) | 1995-02-03 | 2008-05-27 | Novozymes A/S | α-amylase mutants |
US20080193999A1 (en) | 2004-07-05 | 2008-08-14 | Novozymes A/S | Alpha-Amylase Variants With Altered Properties |
US20080293610A1 (en) | 2005-10-12 | 2008-11-27 | Andrew Shaw | Use and production of storage-stable neutral metalloprotease |
US20080305982A1 (en) | 2007-06-11 | 2008-12-11 | Johan Smets | Benefit agent containing delivery particle |
WO2009021867A2 (en) | 2007-08-10 | 2009-02-19 | Henkel Ag & Co. Kgaa | Agents containing proteases |
US7501389B2 (en) | 2003-10-31 | 2009-03-10 | Conopco Inc. | Bispidon-derivated ligands and complexes thereof for catalytically bleaching a substrate |
US20090093391A1 (en) * | 2007-10-04 | 2009-04-09 | Lanxess Deutschland Gmbh | Liquid washing compositions and liquid cleaning compositions |
US20090170747A1 (en) | 1996-09-17 | 2009-07-02 | Novozymes A/S | Cellulase variants |
US20090217464A1 (en) | 2008-02-29 | 2009-09-03 | Philip Frank Souter | Detergent composition comprising lipase |
US20090247449A1 (en) | 2008-03-26 | 2009-10-01 | John Allen Burdis | Delivery particle |
WO2010056634A1 (en) * | 2008-11-11 | 2010-05-20 | Danisco Us Inc. | Compositions and methods comprising a subtilisin variant |
WO2010056640A2 (en) * | 2008-11-11 | 2010-05-20 | Danisco Us Inc. | Compositions and methods comprising serine protease variants |
Family Cites Families (101)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BE680847A (en) | 1963-05-27 | 1966-11-14 | ||
GB1296839A (en) | 1969-05-29 | 1972-11-22 | ||
GB1372034A (en) | 1970-12-31 | 1974-10-30 | Unilever Ltd | Detergent compositions |
US4302544A (en) | 1979-10-15 | 1981-11-24 | University Of Rochester | Asporogenous mutant of B. subtilis for use as host component of HV1 system |
US4450235A (en) | 1982-04-21 | 1984-05-22 | Cpc International Inc. | Asporogenic mutant of bacillus subtilis useful as a host in a host-vector system |
US4561998A (en) | 1982-05-24 | 1985-12-31 | The Procter & Gamble Company | Near-neutral pH detergents containing anionic surfactant, cosurfactant and fatty acid |
US4550862A (en) | 1982-11-17 | 1985-11-05 | The Procter & Gamble Company | Liquid product pouring and measuring package with self draining feature |
US4597898A (en) | 1982-12-23 | 1986-07-01 | The Proctor & Gamble Company | Detergent compositions containing ethoxylated amines having clay soil removal/anti-redeposition properties |
US4515707A (en) | 1983-06-27 | 1985-05-07 | The Chemithon Corporation | Intermediate product for use in producing a detergent bar and method for producing same |
WO1985000382A1 (en) | 1983-07-06 | 1985-01-31 | Gist-Brocades N.V. | Molecular cloning and expression in industrial microorganism species |
US4515705A (en) | 1983-11-14 | 1985-05-07 | The Procter & Gamble Company | Compositions containing odor purified proteolytic enzymes and perfumes |
US4537706A (en) | 1984-05-14 | 1985-08-27 | The Procter & Gamble Company | Liquid detergents containing boric acid to stabilize enzymes |
US5700676A (en) | 1984-05-29 | 1997-12-23 | Genencor International Inc. | Modified subtilisins having amino acid alterations |
US5972682A (en) | 1984-05-29 | 1999-10-26 | Genencor International, Inc. | Enzymatically active modified subtilisins |
US5264366A (en) | 1984-05-29 | 1993-11-23 | Genencor, Inc. | Protease deficient bacillus |
US4965188A (en) | 1986-08-22 | 1990-10-23 | Cetus Corporation | Process for amplifying, detecting, and/or cloning nucleic acid sequences using a thermostable enzyme |
DK154572C (en) | 1985-08-07 | 1989-04-24 | Novo Industri As | ENZYMATIC DETERGENT ADDITIVE, DETERGENT AND METHOD FOR WASHING TEXTILES |
US4933287A (en) | 1985-08-09 | 1990-06-12 | Gist-Brocades N.V. | Novel lipolytic enzymes and their use in detergent compositions |
DK122686D0 (en) | 1986-03-17 | 1986-03-17 | Novo Industri As | PREPARATION OF PROTEINS |
JP2503986B2 (en) | 1986-08-08 | 1996-06-05 | 関西ペイント株式会社 | Non-toxic antifouling paint composition |
ES2058119T3 (en) | 1986-08-29 | 1994-11-01 | Novo Nordisk As | ENZYMATIC DETERGENT ADDITIVE. |
GB8629837D0 (en) | 1986-12-13 | 1987-01-21 | Interox Chemicals Ltd | Bleach activation |
US4765916A (en) | 1987-03-24 | 1988-08-23 | The Clorox Company | Polymer film composition for rinse release of wash additives |
US4972017A (en) | 1987-03-24 | 1990-11-20 | The Clorox Company | Rinse soluble polymer film composition for wash additives |
WO1988009367A1 (en) | 1987-05-29 | 1988-12-01 | Genencor, Inc. | Cutinase cleaning composition |
ATE125865T1 (en) | 1987-08-28 | 1995-08-15 | Novo Nordisk As | RECOMBINANT HUMICOLA LIPASE AND METHOD FOR PRODUCING RECOMBINANT HUMICOLA LIPASES. |
JPS6474992A (en) | 1987-09-16 | 1989-03-20 | Fuji Oil Co Ltd | Dna sequence, plasmid and production of lipase |
DE68924654T2 (en) | 1988-01-07 | 1996-04-04 | Novonordisk As | Specific protease. |
CN1056187C (en) * | 1988-02-11 | 2000-09-06 | 金克克国际有限公司 | Proteolytic enzymes and their use in detergents |
JP3079276B2 (en) | 1988-02-28 | 2000-08-21 | 天野製薬株式会社 | Recombinant DNA, Pseudomonas sp. Containing the same, and method for producing lipase using the same |
US4977252A (en) | 1988-03-11 | 1990-12-11 | National Starch And Chemical Investment Holding Corporation | Modified starch emulsifier characterized by shelf stability |
US4968451A (en) | 1988-08-26 | 1990-11-06 | The Procter & Gamble Company | Soil release agents having allyl-derived sulfonated end caps |
WO1990009446A1 (en) | 1989-02-17 | 1990-08-23 | Plant Genetic Systems N.V. | Cutinase |
DK316989D0 (en) * | 1989-06-26 | 1989-06-26 | Novo Nordisk As | ENZYMES |
EP0405901B1 (en) * | 1989-06-26 | 2004-09-01 | Unilever Plc | Enzymatic detergent compositions |
DE4023458A1 (en) * | 1989-08-31 | 1991-03-07 | Kali Chemie Ag | NEW HIGH ALKALINE PROTEASES |
US5352603A (en) | 1989-08-31 | 1994-10-04 | Kali-Chemie Ag | Highly alkaline proteases |
KR100236540B1 (en) | 1990-04-14 | 2000-01-15 | 레클로우크스 라우에르 | Alkaline bacillus lipases, coding dna sequences thereof and bacilli which produce these lipases |
US5354559A (en) | 1990-05-29 | 1994-10-11 | Grain Processing Corporation | Encapsulation with starch hydrolyzate acid esters |
SG52693A1 (en) | 1991-01-16 | 1998-09-28 | Procter & Gamble | Detergent compositions with high activity cellulase and softening clays |
GB9108136D0 (en) | 1991-04-17 | 1991-06-05 | Unilever Plc | Concentrated detergent powder compositions |
US5340735A (en) | 1991-05-29 | 1994-08-23 | Cognis, Inc. | Bacillus lentus alkaline protease variants with increased stability |
PL178045B1 (en) * | 1992-07-17 | 2000-02-29 | Genencor Int | Highly alkaline serine proteases |
CA2150562A1 (en) | 1992-12-01 | 1994-06-09 | Palle Schneider | Enhancement of enzyme reactions |
WO1994016048A1 (en) | 1993-01-18 | 1994-07-21 | The Procter & Gamble Company | Machine dishwashing detergent compositions |
WO1994026859A1 (en) | 1993-05-08 | 1994-11-24 | Henkel Kommanditgesellschaft Auf Aktien | Silver-corrosion protection agent (i) |
ES2134944T3 (en) | 1993-05-08 | 1999-10-16 | Henkel Kgaa | SILVER ANTICORROSIVE AGENT II. |
DK77393D0 (en) | 1993-06-29 | 1993-06-29 | Novo Nordisk As | ENZYMER ACTIVATION |
US5698504A (en) | 1993-07-01 | 1997-12-16 | The Procter & Gamble Company | Machine dishwashing composition containing oxygen bleach and paraffin oil and benzotriazole compound silver tarnishing inhibitors |
MA23346A1 (en) * | 1993-10-14 | 1995-04-01 | Genencor Int | VARIANTS OF THE SUB-USE |
US5861271A (en) | 1993-12-17 | 1999-01-19 | Fowler; Timothy | Cellulase enzymes and systems for their expressions |
ES2302330T3 (en) | 1994-02-24 | 2008-07-01 | Henkel Kommanditgesellschaft Auf Aktien | IMPROVED AND DETERGENT ENZYMES THAT CONTAIN THEM. |
ES2364776T3 (en) | 1994-02-24 | 2011-09-14 | HENKEL AG & CO. KGAA | IMPROVED AND DETERGENT ENZYMES THAT CONTAIN THEM. |
US5691295A (en) | 1995-01-17 | 1997-11-25 | Cognis Gesellschaft Fuer Biotechnologie Mbh | Detergent compositions |
DE4411223A1 (en) * | 1994-03-31 | 1995-10-05 | Solvay Enzymes Gmbh & Co Kg | Use of alkaline proteases in commercial textile washing processes |
US5686014A (en) | 1994-04-07 | 1997-11-11 | The Procter & Gamble Company | Bleach compositions comprising manganese-containing bleach catalysts |
JP3139277B2 (en) | 1994-05-10 | 2001-02-26 | 松下電器産業株式会社 | Water purifier and water purification system |
PE6995A1 (en) | 1994-05-25 | 1995-03-20 | Procter & Gamble | COMPOSITION INCLUDING A PROPOXYLATED POLYKYLENE OAMINE POLYKYLENE OAMINE POLYMER AS DIRT SEPARATION AGENT |
EP0766727B1 (en) | 1994-06-17 | 2002-08-14 | Genencor International, Inc. | Cleaning method based on compositions containing a hemicellulase plant cell wall degrading enzyme and the use thereof in cleaning methods |
GB2294268A (en) | 1994-07-07 | 1996-04-24 | Procter & Gamble | Bleaching composition for dishwasher use |
PT796317E (en) | 1994-12-09 | 2000-08-31 | Procter & Gamble | COMPOSITION FOR AUTOMATIC WASHING OF LOICA CONTAINING PARTICLES OF PEROXIDES OF DIACYL |
ES2158320T3 (en) | 1995-06-16 | 2001-09-01 | Procter & Gamble | COMPOSITIONS FOR AUTOMATIC DISHWASHERS THAT INCLUDE COBALT CATALYSTS. |
DE19530816A1 (en) | 1995-08-23 | 1997-02-27 | Cognis Bio Umwelt | Use of mutant subtilisin protease in cosmetic products |
JP4121556B2 (en) | 1995-09-18 | 2008-07-23 | ザ プロクター アンド ギャンブル カンパニー | Delivery system |
US5929022A (en) | 1996-08-01 | 1999-07-27 | The Procter & Gamble Company | Detergent compositions containing amine and specially selected perfumes |
GB2327947A (en) | 1997-08-02 | 1999-02-10 | Procter & Gamble | Detergent tablet |
US6376445B1 (en) | 1997-08-14 | 2002-04-23 | Procter & Gamble Company | Detergent compositions comprising a mannanase and a protease |
RU2269572C2 (en) * | 1997-10-23 | 2006-02-10 | Джененкор Интернэшнл, Инк. | Multisubstituted protease (variants) |
ES2368718T3 (en) * | 1997-10-23 | 2011-11-21 | Danisco Us Inc. | SUBTILISINE VARIATIONS WITH MULTIPLE SUBSTITUTIONS. |
US5935826A (en) | 1997-10-31 | 1999-08-10 | National Starch And Chemical Investment Holding Corporation | Glucoamylase converted starch derivatives and their use as emulsifying and encapsulating agents |
KR100762164B1 (en) | 1997-11-21 | 2007-10-01 | 노보자임스 에이/에스 | Protease variants and compositions |
EP1042501B2 (en) | 1997-12-24 | 2011-03-30 | Genencor International, Inc. | Method for assaying the wash performance of an enzyme. |
CN100497614C (en) | 1998-06-10 | 2009-06-10 | 诺沃奇梅兹有限公司 | Mannanases |
AU1223000A (en) | 1998-10-23 | 2000-05-15 | Procter & Gamble Company, The | Methods for screening protease variants for use in detergent compositions |
US6376450B1 (en) | 1998-10-23 | 2002-04-23 | Chanchal Kumar Ghosh | Cleaning compositions containing multiply-substituted protease variants |
US6294514B1 (en) | 1998-11-24 | 2001-09-25 | The Procter & Gamble Company | Process for preparing mono-long chain amine oxide surfactants with low nitrite, nitrosamine and low residual peroxide |
JP2002531457A (en) | 1998-11-30 | 2002-09-24 | ザ、プロクター、エンド、ギャンブル、カンパニー | Method for producing cross-linked tetraaza macrocycles |
US6440991B1 (en) | 2000-10-02 | 2002-08-27 | Wyeth | Ethers of 7-desmethlrapamycin |
US6582914B1 (en) | 2000-10-26 | 2003-06-24 | Genencor International, Inc. | Method for generating a library of oligonucleotides comprising a controlled distribution of mutations |
DK1373296T3 (en) * | 2001-03-23 | 2012-01-09 | Procter & Gamble | Proteins producing an altered immunogenic response, and methods for their preparation and use |
GB0114847D0 (en) | 2001-06-18 | 2001-08-08 | Unilever Plc | Water soluble package and liquid contents thereof |
DK200101090A (en) * | 2001-07-12 | 2001-08-16 | Novozymes As | Subtilase variants |
EP1523553B1 (en) * | 2002-01-16 | 2009-12-02 | Genencor International, Inc. | Multiply-substituted protease variants |
TWI319007B (en) * | 2002-11-06 | 2010-01-01 | Novozymes As | Subtilase variants |
DE60319347T2 (en) | 2003-05-23 | 2009-02-19 | The Procter & Gamble Company, Cincinnati | Detergent composition for use in a fabric washing or dishwashing machine |
DE602004029393D1 (en) | 2003-11-06 | 2010-11-11 | Danisco Us Inc | TGF-BETA1 BINDING AND SUPPORTED PEPTIDES |
DK2664670T3 (en) | 2003-12-03 | 2015-07-27 | Danisco Us Inc | perhydrolase |
DE102004027091A1 (en) * | 2004-06-02 | 2005-12-29 | Henkel Kgaa | Performance enhanced alkaline protease variants and detergents and cleaners containing these performance enhanced alkaline protease variants |
US20100120651A1 (en) * | 2005-07-11 | 2010-05-13 | Genencor International, Inc. | Enzyme fabric care tablets for consumers and methods |
JP2010501024A (en) | 2006-06-05 | 2010-01-14 | ザ プロクター アンド ギャンブル カンパニー | Enzyme stabilizer |
EP2059591B1 (en) | 2006-07-18 | 2012-09-05 | Danisco US Inc. | Dishwashing composition that contains a protease variant |
DK2074205T4 (en) * | 2006-10-06 | 2017-02-06 | Novozymes As | CELLULOTIC ENZYME COMPOSITIONS AND APPLICATIONS THEREOF |
CN101784662B (en) * | 2007-06-06 | 2014-11-05 | 丹尼斯科美国公司 | Methods for improving protein properties |
EP2100947A1 (en) | 2008-03-14 | 2009-09-16 | The Procter and Gamble Company | Automatic dishwashing detergent composition |
US20110256610A1 (en) * | 2008-06-06 | 2011-10-20 | Viktor Yuryevich Alekseyev | Compositions And Methods Comprising Variant Microbial Proteases |
EP2166092A1 (en) * | 2008-09-18 | 2010-03-24 | The Procter and Gamble Company | Detergent composition |
EP3031894A1 (en) * | 2008-11-11 | 2016-06-15 | Danisco US Inc. | Proteases comprising one or more combinable mutations |
CN102762222B (en) * | 2009-12-09 | 2015-11-25 | 丹尼斯科美国公司 | Comprise compositions and the method for ease variants |
WO2011072117A1 (en) * | 2009-12-09 | 2011-06-16 | The Procter & Gamble Company | Fabric and home care products |
CN102858970B (en) * | 2010-04-15 | 2017-07-21 | 丹尼斯科美国公司 | Composition and method comprising misfolded proteins enzyme |
JP5813753B2 (en) | 2010-05-06 | 2015-11-17 | ザ プロクター アンド ギャンブルカンパニー | Consumer products with protease variants |
-
2011
- 2011-05-05 JP JP2013509256A patent/JP5813753B2/en active Active
- 2011-05-05 CN CN201810171223.2A patent/CN108410585A/en active Pending
- 2011-05-05 CN CN2011800227382A patent/CN103068977A/en active Pending
- 2011-05-05 PL PL11720664T patent/PL2566960T3/en unknown
- 2011-05-05 WO PCT/US2011/035389 patent/WO2011140364A1/en active Application Filing
- 2011-05-05 WO PCT/US2011/035319 patent/WO2011140316A1/en active Application Filing
- 2011-05-05 ES ES11730124.2T patent/ES2694398T3/en active Active
- 2011-05-05 MX MX2012012789A patent/MX336737B/en unknown
- 2011-05-05 DK DK16177383.3T patent/DK3095861T3/en active
- 2011-05-05 CN CN2011800226924A patent/CN102933708A/en active Pending
- 2011-05-05 DK DK11720664.9T patent/DK2566960T3/en active
- 2011-05-05 DK DK11730124.2T patent/DK2566961T3/en active
- 2011-05-05 ES ES16177383T patent/ES2745011T3/en active Active
- 2011-05-05 EP EP11730124.2A patent/EP2566961B1/en active Active
- 2011-05-05 US US13/696,512 patent/US20130260438A1/en not_active Abandoned
- 2011-05-05 BR BR112012028466-5A patent/BR112012028466B1/en active IP Right Grant
- 2011-05-05 HU HUE16177383A patent/HUE045202T2/en unknown
- 2011-05-05 JP JP2013509272A patent/JP6448904B2/en active Active
- 2011-05-05 EP EP16177383.3A patent/EP3095861B1/en active Active
- 2011-05-05 CA CA2798451A patent/CA2798451C/en active Active
- 2011-05-05 MX MX2012012913A patent/MX339810B/en active IP Right Grant
- 2011-05-05 CN CN201610262453.0A patent/CN105925556B/en active Active
- 2011-05-05 HU HUE11720664A patent/HUE034524T2/en unknown
- 2011-05-05 EP EP20213383.1A patent/EP3868881A3/en active Pending
- 2011-05-05 RU RU2012144735/10A patent/RU2598717C2/en not_active Application Discontinuation
- 2011-05-05 BR BR112012028467-3A patent/BR112012028467B1/en active IP Right Grant
- 2011-05-05 EP EP19182103.2A patent/EP3575389A3/en active Pending
- 2011-05-05 CN CN201610262387.7A patent/CN105925555B/en active Active
- 2011-05-05 PL PL16177383T patent/PL3095861T3/en unknown
- 2011-05-05 EP EP11720664.9A patent/EP2566960B1/en active Active
- 2011-05-05 RU RU2012152482A patent/RU2711984C2/en active
- 2011-05-05 EP EP18182799.9A patent/EP3418382B1/en active Active
- 2011-05-05 ES ES11720664.9T patent/ES2625751T3/en active Active
-
2012
- 2012-05-04 HU HUE12722015A patent/HUE050079T2/en unknown
- 2012-10-24 ZA ZA2012/08019A patent/ZA201208019B/en unknown
-
2015
- 2015-05-27 JP JP2015107987A patent/JP2015187278A/en active Pending
- 2015-12-02 JP JP2015235701A patent/JP6567964B2/en active Active
-
2017
- 2017-08-25 JP JP2017162468A patent/JP2018029592A/en active Pending
- 2017-12-05 US US15/831,913 patent/US20180216092A1/en not_active Abandoned
-
2018
- 2018-01-17 JP JP2018005572A patent/JP7002345B2/en active Active
- 2018-07-10 US US16/030,994 patent/US11447762B2/en active Active
-
2023
- 2023-10-09 US US18/482,990 patent/US20240191220A1/en active Pending
Patent Citations (94)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4435307A (en) | 1980-04-30 | 1984-03-06 | Novo Industri A/S | Detergent cellulase |
US4430243A (en) | 1981-08-08 | 1984-02-07 | The Procter & Gamble Company | Bleach catalyst compositions and use thereof in laundry bleaching and detergent compositions |
US4760025A (en) | 1984-05-29 | 1988-07-26 | Genencor, Inc. | Modified enzymes and methods for making same |
EP0200362A2 (en) | 1985-03-28 | 1986-11-05 | F. Hoffmann-La Roche Ag | Process for amplifying, detecting, and/or cloning nucleic acid sequences |
EP0201184A2 (en) | 1985-03-28 | 1986-11-12 | F. Hoffmann-La Roche Ag | Process for amplifying nucleic acid sequences |
US4683202A (en) | 1985-03-28 | 1987-07-28 | Cetus Corporation | Process for amplifying nucleic acid sequences |
US4683202B1 (en) | 1985-03-28 | 1990-11-27 | Cetus Corp | |
US4683195A (en) | 1986-01-30 | 1987-07-28 | Cetus Corporation | Process for amplifying, detecting, and/or-cloning nucleic acid sequences |
US4683195B1 (en) | 1986-01-30 | 1990-11-27 | Cetus Corp | |
US4762636A (en) | 1986-02-28 | 1988-08-09 | Ciba-Geigy Corporation | Process for the preparation of granules containing an active substance and to the use thereof as speckles for treating substrates |
US5288627A (en) | 1988-01-07 | 1994-02-22 | Novo Nordisk A/S | Endoprotease from Fusarium oxysporumDSM 2672 for use in detergents |
US4990280A (en) | 1988-03-14 | 1991-02-05 | Danochemo A/S | Photoactivator dye composition for detergent use |
US5691178A (en) | 1988-03-22 | 1997-11-25 | Novo Nordisk A/S | Fungal cellulase composition containing alkaline CMC-endoglucanase and essentially no cellobiohydrolase |
US5776757A (en) | 1988-03-24 | 1998-07-07 | Novo Nordisk A/S | Fungal cellulase composition containing alkaline CMC-endoglucanase and essentially no cellobiohydrolase and method of making thereof |
US5648263A (en) | 1988-03-24 | 1997-07-15 | Novo Nordisk A/S | Methods for reducing the harshness of a cotton-containing fabric |
US6632646B1 (en) * | 1989-06-26 | 2003-10-14 | Novozymes A/S | Modified subtilisins and detergent compositions containing same |
US5352604A (en) | 1989-08-25 | 1994-10-04 | Henkel Research Corporation | Alkaline proteolytic enzyme and method of production |
US5457046A (en) | 1990-05-09 | 1995-10-10 | Novo Nordisk A/S | Enzyme capable of degrading cellullose or hemicellulose |
US5763254A (en) | 1990-05-09 | 1998-06-09 | Novo Nordisk A/S | Enzyme capable of degrading cellulose or hemicellulose |
US5948672A (en) | 1990-05-09 | 1999-09-07 | Novo Nordisk A/S | Cellulase preparation comprising an endoglucanase enzyme |
US5686593A (en) | 1990-05-09 | 1997-11-11 | Novo Nordisk A/S | Enzyme capable of degrading cellulose or hemicellulose |
US5520838A (en) | 1991-01-16 | 1996-05-28 | The Procter & Gamble Company | Compact detergent compositions with high activity cellulase |
WO1994002597A1 (en) | 1992-07-23 | 1994-02-03 | Novo Nordisk A/S | MUTANT α-AMYLASE, DETERGENT, DISH WASHING AGENT, AND LIQUEFACTION AGENT |
US6114296A (en) | 1992-10-06 | 2000-09-05 | Novo Nordisk A/S | Cellulase variants |
US6297037B1 (en) | 1993-02-11 | 2001-10-02 | Christopher C. Barnett | Oxidatively stable alpha-amylase |
US5486303A (en) | 1993-08-27 | 1996-01-23 | The Procter & Gamble Company | Process for making high density detergent agglomerates using an anhydrous powder additive |
US5679630A (en) | 1993-10-14 | 1997-10-21 | The Procter & Gamble Company | Protease-containing cleaning compositions |
US6117664A (en) | 1994-03-03 | 2000-09-12 | Novo Nordisk A/S | Alkaline cellulases |
US5856164A (en) | 1994-03-29 | 1999-01-05 | Novo Nordisk A/S | Alkaline bacillus amylase |
WO1995030010A1 (en) * | 1994-05-02 | 1995-11-09 | The Procter & Gamble Company | Subtilisin bpn' variants having decreased adsorption and increased hydrolysis |
US5879584A (en) | 1994-09-10 | 1999-03-09 | The Procter & Gamble Company | Process for manufacturing aqueous compositions comprising peracids |
US5691297A (en) | 1994-09-20 | 1997-11-25 | The Procter & Gamble Company | Process for making a high density detergent composition by controlling agglomeration within a dispersion index |
US5489392A (en) | 1994-09-20 | 1996-02-06 | The Procter & Gamble Company | Process for making a high density detergent composition in a single mixer/densifier with selected recycle streams for improved agglomerate properties |
US5516448A (en) | 1994-09-20 | 1996-05-14 | The Procter & Gamble Company | Process for making a high density detergent composition which includes selected recycle streams for improved agglomerate |
US5919691A (en) | 1994-10-06 | 1999-07-06 | Novo Nordisk A/S | Enzyme and enzyme preparation with endoglucanase activity |
US5595967A (en) | 1995-02-03 | 1997-01-21 | The Procter & Gamble Company | Detergent compositions comprising multiperacid-forming bleach activators |
US7378264B2 (en) | 1995-02-03 | 2008-05-27 | Novozymes A/S | α-amylase mutants |
US5574005A (en) | 1995-03-07 | 1996-11-12 | The Procter & Gamble Company | Process for producing detergent agglomerates from high active surfactant pastes having non-linear viscoelastic properties |
US6001639A (en) | 1995-03-17 | 1999-12-14 | Novo Nordisk A/S | Endoglucanases |
US5569645A (en) | 1995-04-24 | 1996-10-29 | The Procter & Gamble Company | Low dosage detergent composition containing optimum proportions of agglomerates and spray dried granules for improved flow properties |
US6979731B1 (en) | 1995-06-14 | 2005-12-27 | Kao Corporation | Gene encoding alkaline liquefying α-amylase |
US5597936A (en) | 1995-06-16 | 1997-01-28 | The Procter & Gamble Company | Method for manufacturing cobalt catalysts |
US5565422A (en) | 1995-06-23 | 1996-10-15 | The Procter & Gamble Company | Process for preparing a free-flowing particulate detergent composition having improved solubility |
US5576282A (en) | 1995-09-11 | 1996-11-19 | The Procter & Gamble Company | Color-safe bleach boosters, compositions and laundry methods employing same |
US6093562A (en) | 1996-02-05 | 2000-07-25 | Novo Nordisk A/S | Amylase variants |
US6326348B1 (en) | 1996-04-16 | 2001-12-04 | The Procter & Gamble Co. | Detergent compositions containing selected mid-chain branched surfactants |
US5763385A (en) | 1996-05-14 | 1998-06-09 | Genencor International, Inc. | Modified α-amylases having altered calcium binding properties |
US6380144B1 (en) | 1996-07-31 | 2002-04-30 | The Procter & Gamble Company | Detergent composition |
WO1998008940A1 (en) | 1996-08-26 | 1998-03-05 | Novo Nordisk A/S | A novel endoglucanase |
US20090170747A1 (en) | 1996-09-17 | 2009-07-02 | Novozymes A/S | Cellulase variants |
US6306812B1 (en) | 1997-03-07 | 2001-10-23 | Procter & Gamble Company, The | Bleach compositions containing metal bleach catalyst, and bleach activators and/or organic percarboxylic acids |
US6225464B1 (en) | 1997-03-07 | 2001-05-01 | The Procter & Gamble Company | Methods of making cross-bridged macropolycycles |
US6268197B1 (en) | 1997-07-07 | 2001-07-31 | Novozymes A/S | Xyloglucan-specific alkaline xyloglucanase from bacillus |
US6472184B1 (en) | 1997-08-22 | 2002-10-29 | Peter Hegemann | Method for producing nucleic acid polymers |
US6187576B1 (en) | 1997-10-13 | 2001-02-13 | Novo Nordisk A/S | α-amylase mutants |
WO1999020727A1 (en) * | 1997-10-22 | 1999-04-29 | The Procter & Gamble Company | Cleaning compositions containing multiply-substituted protease variants |
US6312936B1 (en) | 1997-10-23 | 2001-11-06 | Genencor International, Inc. | Multiply-substituted protease variants |
US6673589B2 (en) | 1997-10-30 | 2004-01-06 | Novozymes A/S | α-amylase mutants |
US6566112B2 (en) | 1997-11-19 | 2003-05-20 | Genencor International, Inc. | Cellulase producing actinomycetes, cellulase produced therefrom and method of producing same |
EP1070115A2 (en) | 1998-04-07 | 2001-01-24 | Unilever Plc | Coloured granular composition for use in particulate detergent compositions |
US6291412B1 (en) | 1998-05-18 | 2001-09-18 | Ciba Specialty Chemicals Corporation | Water-soluble granules of phthalocyanine compounds |
EP1109965A1 (en) | 1998-09-01 | 2001-06-27 | Unilever Plc | Method of treating a textile |
US6916645B2 (en) | 1998-12-21 | 2005-07-12 | Kao Corporation | Amylases |
US6939702B1 (en) | 1999-03-31 | 2005-09-06 | Novozymes A/S | Lipase variant |
EP1240378A1 (en) | 1999-12-24 | 2002-09-18 | Unilever Plc | Method of treating a textile |
US7361736B2 (en) | 2000-02-24 | 2008-04-22 | Novozymes A/S | Family 44 xyloglucanases |
US6630340B2 (en) | 2000-03-01 | 2003-10-07 | Novozymes A/S | Family 5 xyloglucanases |
US7153818B2 (en) | 2000-07-28 | 2006-12-26 | Henkel Kgaa | Amylolytic enzyme extracted from bacillus sp. A 7-7 (DSM 12368) and washing and cleaning agents containing this novel amylolytic enzyme |
WO2002014490A2 (en) | 2000-08-11 | 2002-02-21 | Genencor International, Inc. | Bacillus transformation, transformants and mutant libraries |
WO2002077242A2 (en) | 2001-03-27 | 2002-10-03 | Novozymes A/S | Family 74 xyloglucanases |
US7141403B2 (en) | 2001-06-06 | 2006-11-28 | Novozymes A/S | Endo-beta-1,4-glucanases |
US20030087790A1 (en) | 2001-08-20 | 2003-05-08 | Unilever Home & Personal Care Usa, Division Of Conopco, Inc. | Photobleach speckle and laundry detergent compositions containing it |
US20030087791A1 (en) | 2001-08-20 | 2003-05-08 | Unilever Home & Personal Care Usa, Division Of Conopco, Inc. | Photobleach speckle and laundry detergent compositions containing it |
US7262042B2 (en) | 2001-12-20 | 2007-08-28 | Henkel Kommanditgesellschaft Auf Aktien (Henkel Kgaa) | Alkaline protease from Bacillus gibsonii (DSM 14393) and washing and cleaning products comprising said alkaline protease |
US7172891B2 (en) | 2002-04-19 | 2007-02-06 | Novozymes, Inc. | Polypeptides having xyloglucanase activity and nucleic acids encoding same |
US20060089284A1 (en) | 2002-06-06 | 2006-04-27 | Miracle Gregory S | Organic catalyst with enhanced enzyme compatibility |
US20050227891A1 (en) | 2002-09-04 | 2005-10-13 | Pierre Dreyer | Formulations comprising water-soluble granulates |
US20050003983A1 (en) | 2002-09-11 | 2005-01-06 | Kim Dong Gyu | Complex salt for anti-spotting detergents |
US20040048764A1 (en) | 2002-09-11 | 2004-03-11 | Kim Dong Gyu | Complex salt for anti-spotting detergents |
WO2004059556A2 (en) | 2002-12-23 | 2004-07-15 | Geneart Gmbh | Method and device for optimizing a nucleotide sequence for the purpose of expression of a protein |
US7501389B2 (en) | 2003-10-31 | 2009-03-10 | Conopco Inc. | Bispidon-derivated ligands and complexes thereof for catalytically bleaching a substrate |
US20080063774A1 (en) | 2003-11-19 | 2008-03-13 | Wolfgang Aehle | Multiple mutation variants of serine protease |
US7208459B2 (en) | 2004-06-29 | 2007-04-24 | The Procter & Gamble Company | Laundry detergent compositions with efficient hueing dye |
US20080193999A1 (en) | 2004-07-05 | 2008-08-14 | Novozymes A/S | Alpha-Amylase Variants With Altered Properties |
WO2007006305A1 (en) * | 2005-07-08 | 2007-01-18 | Novozymes A/S | Subtilase variants |
US20080293610A1 (en) | 2005-10-12 | 2008-11-27 | Andrew Shaw | Use and production of storage-stable neutral metalloprotease |
US20070173430A1 (en) | 2006-01-23 | 2007-07-26 | The Procter & Gamble Company | Composition comprising a lipase and a bleach catalyst |
US20080305982A1 (en) | 2007-06-11 | 2008-12-11 | Johan Smets | Benefit agent containing delivery particle |
WO2009021867A2 (en) | 2007-08-10 | 2009-02-19 | Henkel Ag & Co. Kgaa | Agents containing proteases |
US20090093391A1 (en) * | 2007-10-04 | 2009-04-09 | Lanxess Deutschland Gmbh | Liquid washing compositions and liquid cleaning compositions |
US20090217464A1 (en) | 2008-02-29 | 2009-09-03 | Philip Frank Souter | Detergent composition comprising lipase |
US20090247449A1 (en) | 2008-03-26 | 2009-10-01 | John Allen Burdis | Delivery particle |
WO2010056634A1 (en) * | 2008-11-11 | 2010-05-20 | Danisco Us Inc. | Compositions and methods comprising a subtilisin variant |
WO2010056640A2 (en) * | 2008-11-11 | 2010-05-20 | Danisco Us Inc. | Compositions and methods comprising serine protease variants |
Non-Patent Citations (39)
Title |
---|
"Color Index International", SOCIETY OF DYERS AND COLOURISTS AND THE AMERICAN ASSOCIATION OF TEXTILE CHEMISTS AND COLORISTS |
"Industrial Dyes", 2002, WILEY VCH |
A. B. BORASTON ET AL., BIOCHEMICAL JOURNAL, vol. 382, 2004, pages 769 - 781 |
ADAM, W., HAAS, W., LOHRAY, B. B., JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, vol. 113, no. 16, 1991, pages 6202 - 6208 |
ALTSCHUL ET AL., J. MOL. BIOL, vol. 215, 1990, pages 403 - 410 |
ALTSCHUL ET AL., J. MOL. BIOL., vol. 215, 1990, pages 403 - 410 |
ALTSCHUL ET AL., METH. ENZYMOL., vol. 266, 1996, pages 460 - 480 |
ALTSCHUL ET AL., NUCLEIC ACIDS RES., vol. 25, no. 17, 1997, pages 3389 - 3402 |
BABE ET AL., BIOTECH. APPL. BIOCHEM., vol. 27, 1998, pages 117 - 124 |
BIOCHEM J., vol. V280, 1991, pages 309 - 316 |
BITTKER ET AL., NAT BIOTECHNOL., vol. 20, 2001, pages 1024 - 9 |
BITTKER ET AL., PROC NATL ACAD SCI. USA., vol. 101, 2004, pages 7011 - 6 |
BROOKE, D. N., DOBBS, A. J., WILLIAMS, N, ECOTOXICOLOGY AND ENVIRONMENTAL SAFETY, vol. 11, no. 3, 1986, pages 251 - 260 |
COCO ET AL., NAT BIOTECHNOL., vol. 20, 2002, pages 1246 - 50 |
DEVEREUX ET AL., NUCL. ACID RES., vol. 12, 1984, pages 387 - 395 |
FENG, DOOLITTLE, J. MOL. EVOL., vol. 35, 1987, pages 351 - 360 |
GAYTAN ET AL., NUCLEIC ACIDS RES., vol. 29, 2001, pages E9 |
GAYTAN ET AL., NUCLEIC ACIDS RES., vol. 30, 2002, pages E84 |
GLASER ET AL., J IMMUNOL., vol. 149, 1992, pages 3903 - 13 |
HEINZ ET AL., BIOCHEMISTRY, vol. 31, 1992, pages 8755 - 66 |
HENIKOFF, HENIKOFF, PROC. NATL. ACAD. SCI. USA, vol. 89, 1992, pages 10915 |
HIGGINS, SHARP, CABIOS, vol. 5, 1989, pages 151 - 153 |
KARLIN, ALTSCHUL, PROC. NATL. ACAD. SCI. USA, vol. 90, 1993, pages 5873 - 5787 |
LUTZ ET AL., PROC NATL ACAD SCI USA., vol. 98, 2001, pages 11248 - 53 |
MCKENZIE ET AL., PLASMID, vol. 15, 1986, pages 93 - 103 |
NEEDLEMAN, WUNSCH, J. MOL. BIOL., vol. 48, 1970, pages 443 |
NEIDHARDT ET AL., J. BACTERIOL., vol. 119, 1974, pages 736 - 747 |
NESS ET AL., NAT BIOTECHNOL., vol. 20, 2002, pages 1251 - 5 |
OSTERMEIER ET AL., BIOORG MED CHEM., vol. 7, 1999, pages 2139 - 44 |
OSUNA ET AL., NUCLEIC ACIDS RES., vol. 32, 2004, pages E136 |
PEARSON, LIPMAN, PROC. NATL. ACAD. SCI. USA, vol. 85, 1988, pages 2444 |
PISARCHIK ET AL., PROT. ENG. DES. SELECT., vol. 20, 2007, pages 257 - 265 |
SIEBER, NAT BIOTECHNOL., vol. 19, 2001, pages 456 - 60 |
SMITH, WATERMAN, ADV. APPL. MATH., vol. 2, 1981, pages 482 |
SONDEK, SHORTLE, PROC NATL ACAD SCI USA, vol. 89, 1992, pages 3581 - 5 |
STEMMER, PROC NATL ACAD SCI U S A., vol. 25, 1994, pages 10747 - 51 |
TINDBAEK N ET AL: "Engineering a substrate-specific cold-adapted subtilisin", PROTEIN ENGINEERING, DESIGN AND SELECTION, OXFORD JOURNAL, LONDON, GB, vol. 17, no. 2, 1 February 2004 (2004-02-01), pages 149 - 156, XP008091833, ISSN: 1741-0126, DOI: DOI:10.1093/PROTEIN/GZH019 * |
YÁFIEZ ET AL., NUCLEIC ACIDS RES., vol. 32, 2004, pages E158 |
ZHA ET AL., CHEMBIOCHEM, vol. 3, 2003, pages 34 - 9 |
Cited By (165)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2365055B1 (en) | 2010-03-01 | 2017-12-20 | The Procter and Gamble Company | Composition comprising substituted cellulosic polymer and amylase |
CN103502446A (en) * | 2011-05-05 | 2014-01-08 | 宝洁公司 | Compositions and methods comprising serine protease variants |
WO2013003659A1 (en) | 2011-06-30 | 2013-01-03 | The Procter & Gamble Company | Cleaning compositions comprising amylase variants reference to a sequence listing |
EP2540825A2 (en) | 2011-06-30 | 2013-01-02 | The Procter & Gamble Company | Cleaning compositions comprising amylase variants reference to a sequence listing |
EP3121270A2 (en) | 2011-06-30 | 2017-01-25 | The Procter & Gamble Company | Cleaning compositions comprising amylase variants reference to a sequence listing |
EP2551336A1 (en) | 2011-07-25 | 2013-01-30 | The Procter & Gamble Company | Detergent compositions |
WO2013016368A1 (en) | 2011-07-25 | 2013-01-31 | The Procter & Gamble Company | Detergent compositions |
WO2014200657A1 (en) | 2013-06-13 | 2014-12-18 | Danisco Us Inc. | Alpha-amylase from streptomyces xiamenensis |
WO2014200658A1 (en) | 2013-06-13 | 2014-12-18 | Danisco Us Inc. | Alpha-amylase from promicromonospora vindobonensis |
WO2014200656A1 (en) | 2013-06-13 | 2014-12-18 | Danisco Us Inc. | Alpha-amylase from streptomyces umbrinus |
WO2014204596A1 (en) | 2013-06-17 | 2014-12-24 | Danisco Us Inc. | Alpha-amylase from bacillaceae family member |
WO2015050723A1 (en) | 2013-10-03 | 2015-04-09 | Danisco Us Inc. | Alpha-amylases from exiguobacterium, and methods of use, thereof |
WO2015050724A1 (en) | 2013-10-03 | 2015-04-09 | Danisco Us Inc. | Alpha-amylases from a subset of exiguobacterium, and methods of use, thereof |
WO2015077126A1 (en) | 2013-11-20 | 2015-05-28 | Danisco Us Inc. | Variant alpha-amylases having reduced susceptibility to protease cleavage, and methods of use, thereof |
WO2015112340A1 (en) | 2014-01-22 | 2015-07-30 | The Procter & Gamble Company | Method of treating textile fabrics |
WO2015112338A1 (en) | 2014-01-22 | 2015-07-30 | The Procter & Gamble Company | Method of treating textile fabrics |
WO2015112339A1 (en) | 2014-01-22 | 2015-07-30 | The Procter & Gamble Company | Fabric treatment composition |
WO2015112341A1 (en) | 2014-01-22 | 2015-07-30 | The Procter & Gamble Company | Fabric treatment composition |
WO2016081437A1 (en) | 2014-11-17 | 2016-05-26 | The Procter & Gamble Company | Benefit agent delivery compositions |
EP3399031A1 (en) * | 2014-12-15 | 2018-11-07 | Henkel AG & Co. KGaA | Detergent composition comprising subtilase variants |
US11597894B2 (en) | 2014-12-15 | 2023-03-07 | Henkel Ag & Co. Kgaa | Detergent composition comprising subtilase variants |
US10760036B2 (en) | 2014-12-15 | 2020-09-01 | Henkel Ag & Co. Kgaa | Detergent composition comprising subtilase variants |
EP3608403A3 (en) * | 2014-12-15 | 2020-03-25 | Henkel AG & Co. KGaA | Detergent composition comprising subtilase variants |
WO2016096714A1 (en) * | 2014-12-15 | 2016-06-23 | Henkel Ag & Co. Kgaa | Detergent composition comprising subtilase variants |
EP3075827A1 (en) | 2015-03-30 | 2016-10-05 | The Procter and Gamble Company | Solid free-flowing particulate laundry detergent composition |
EP3075823A1 (en) | 2015-03-30 | 2016-10-05 | The Procter and Gamble Company | A spray-dried laundry detergent base particle |
EP3075828A1 (en) | 2015-03-30 | 2016-10-05 | The Procter and Gamble Company | Solid free-flowing particulate laundry detergent composition |
EP3075824A1 (en) | 2015-03-30 | 2016-10-05 | The Procter and Gamble Company | Solid free-flowing particulate laundry detergent composition |
WO2016160870A1 (en) | 2015-03-30 | 2016-10-06 | The Procter & Gamble Company | Solid free-flowing particulate laundry detergent composition |
WO2016160865A1 (en) | 2015-03-30 | 2016-10-06 | The Procter & Gamble Company | Solid free-flowing particulate laundry detergent composition |
WO2016160866A1 (en) | 2015-03-30 | 2016-10-06 | The Procter & Gamble Company | Solid free-flowing particulate laundry detergent composition |
EP3075829A1 (en) | 2015-03-30 | 2016-10-05 | The Procter and Gamble Company | Solid free-flowing particulate laundry detergent composition |
EP3075826A1 (en) | 2015-03-30 | 2016-10-05 | The Procter and Gamble Company | Solid free-flowing particulate laundry detergent composition |
WO2016160867A1 (en) | 2015-03-30 | 2016-10-06 | The Procter & Gamble Company | Solid free-flowing particulate laundry detergent composition |
WO2016160351A1 (en) | 2015-03-30 | 2016-10-06 | The Procter & Gamble Company | Solid free-flowing particulate laundry detergent composition |
EP3075831A1 (en) | 2015-03-30 | 2016-10-05 | The Procter and Gamble Company | Solid free-flowing particulate laundry detergent composition |
WO2016160869A1 (en) | 2015-03-30 | 2016-10-06 | The Procter & Gamble Company | Solid free-flowing particulate laundry detergent composition |
WO2016160863A1 (en) | 2015-03-30 | 2016-10-06 | The Procter & Gamble Company | A spray-dried laundry detergent base particle |
WO2016160868A1 (en) | 2015-03-30 | 2016-10-06 | The Procter & Gamble Company | Solid free-flowing particulate laundry detergent composition |
EP3075825A1 (en) | 2015-03-30 | 2016-10-05 | The Procter and Gamble Company | Solid free-flowing particulate laundry detergent composition |
WO2016161219A1 (en) | 2015-04-02 | 2016-10-06 | The Procter & Gamble Company | Solid free-flowing particulate laundry detergent composition |
EP3075834A1 (en) | 2015-04-02 | 2016-10-05 | The Procter and Gamble Company | Solid free-flowing particulate laundry detergent composition |
EP3081625A1 (en) | 2015-04-02 | 2016-10-19 | The Procter and Gamble Company | Solid free-flowing particulate laundry detergent composition |
WO2016161217A1 (en) | 2015-04-02 | 2016-10-06 | The Procter & Gamble Company | Solid free-flowing particulate laundry detergent composition |
EP3075830A2 (en) | 2015-04-02 | 2016-10-05 | The Procter and Gamble Company | Solid free-flowing particulate laundry detergent composition |
WO2016161218A1 (en) | 2015-04-02 | 2016-10-06 | The Procter & Gamble Company | Solid free-flowing particulate laundry detergent composition |
EP3088502A1 (en) | 2015-04-29 | 2016-11-02 | The Procter and Gamble Company | Method of treating a fabric |
WO2016176240A1 (en) | 2015-04-29 | 2016-11-03 | The Procter & Gamble Company | Method of treating a fabric |
WO2016176241A1 (en) | 2015-04-29 | 2016-11-03 | The Procter & Gamble Company | Detergent composition |
WO2016176296A1 (en) | 2015-04-29 | 2016-11-03 | The Procter & Gamble Company | Method of laundering a fabric |
WO2016176282A1 (en) | 2015-04-29 | 2016-11-03 | The Procter & Gamble Company | Method of treating a fabric |
EP3088506A1 (en) | 2015-04-29 | 2016-11-02 | The Procter and Gamble Company | Detergent composition |
EP3088504A1 (en) | 2015-04-29 | 2016-11-02 | The Procter and Gamble Company | Method of treating a fabric |
EP3674387A1 (en) | 2015-04-29 | 2020-07-01 | The Procter & Gamble Company | Method of treating a fabric |
WO2016176280A1 (en) | 2015-04-29 | 2016-11-03 | The Procter & Gamble Company | Method of treating a fabric |
EP3088505A1 (en) | 2015-04-29 | 2016-11-02 | The Procter and Gamble Company | Method of treating a fabric |
EP3088503A1 (en) | 2015-04-29 | 2016-11-02 | The Procter and Gamble Company | Method of treating a fabric |
EP3153425A1 (en) | 2015-10-06 | 2017-04-12 | The Procter and Gamble Company | Flexible box bag comprising detergent powder and a scoop |
WO2017062560A1 (en) | 2015-10-06 | 2017-04-13 | The Procter & Gamble Company | Flexible box bag comprising detergent powder and a scoop |
US10731111B2 (en) | 2015-11-25 | 2020-08-04 | Conopco, Inc. | Liquid laundry detergent composition |
WO2017091674A1 (en) | 2015-11-26 | 2017-06-01 | The Procter & Gamble Company | Liquid detergent compositions comprising protease and encapsulated lipase |
EP3173467A1 (en) | 2015-11-26 | 2017-05-31 | The Procter & Gamble Company | Cleaning compositions comprising enzymes |
WO2017173324A2 (en) | 2016-04-01 | 2017-10-05 | Danisco Us Inc. | Alpha-amylases, compositions & methods |
WO2017173190A2 (en) | 2016-04-01 | 2017-10-05 | Danisco Us Inc. | Alpha-amylases, compositions & methods |
EP3243896A1 (en) | 2016-05-09 | 2017-11-15 | The Procter and Gamble Company | Detergent composition comprising a fatty acid decarboxylase |
EP3511403A1 (en) | 2016-05-09 | 2019-07-17 | The Procter & Gamble Company | Detergent composition |
EP3540036A1 (en) | 2016-05-09 | 2019-09-18 | The Procter & Gamble Company | Detergent composition comprising a fatty acid lipoxygenase |
EP3540037A1 (en) | 2016-05-09 | 2019-09-18 | The Procter & Gamble Company | Detergent composition comprising a oleate 10s lipoxygenase |
EP3556835A1 (en) | 2016-05-09 | 2019-10-23 | The Procter & Gamble Company | Detergent composition comprising a fatty acid decarboxylase |
EP3556834A1 (en) | 2016-05-09 | 2019-10-23 | The Procter & Gamble Company | Detergent composition comprising a fatty acid decarboxylase |
EP3243898A2 (en) | 2016-05-09 | 2017-11-15 | The Procter & Gamble Company | Detergent composition comprising an oleic acid-transforming enzyme |
EP3243897A1 (en) | 2016-05-09 | 2017-11-15 | The Procter & Gamble Company | Detergent composition comprising a fatty acid-transforming enzyme |
WO2018013395A1 (en) | 2016-07-14 | 2018-01-18 | The Procter & Gamble Company | Detergent composition |
EP3269729A1 (en) | 2016-07-14 | 2018-01-17 | The Procter and Gamble Company | Detergent composition |
WO2018067484A1 (en) | 2016-10-03 | 2018-04-12 | The Procter & Gamble Company | Laundry detergent composition |
WO2018067489A1 (en) | 2016-10-03 | 2018-04-12 | The Procter & Gamble Company | Low ph laundry detergent composition |
WO2018067486A1 (en) | 2016-10-03 | 2018-04-12 | The Procter & Gamble Company | Low ph laundry detergent composition |
WO2018067493A1 (en) | 2016-10-03 | 2018-04-12 | The Procter & Gamble Company | Spray-dried base detergent particle giving rise to a low ph in the wash |
WO2018067481A1 (en) | 2016-10-03 | 2018-04-12 | The Procter & Gamble Company | Laundry detergent composition |
WO2018067482A1 (en) | 2016-10-03 | 2018-04-12 | The Procter & Gamble Company | Laundry detergent composition |
WO2018067487A1 (en) | 2016-10-03 | 2018-04-12 | The Procter & Gamble Company | Low ph laundry detergent composition |
WO2018067483A1 (en) | 2016-10-03 | 2018-04-12 | The Procter & Gamble Company | Laundry detergent composition |
WO2018067488A1 (en) | 2016-10-03 | 2018-04-12 | The Procter & Gamble Company | Low ph laundry detergent composition |
WO2018067485A1 (en) | 2016-10-03 | 2018-04-12 | The Procter & Gamble Company | Low ph laundry detergent composition |
WO2018067494A1 (en) | 2016-10-03 | 2018-04-12 | The Procter & Gamble Company | Low ph laundry detergent composition |
WO2018102479A1 (en) | 2016-12-02 | 2018-06-07 | The Procter & Gamble Company | Cleaning compositions including enzymes |
EP3330348A1 (en) | 2016-12-02 | 2018-06-06 | The Procter & Gamble Company | Cleaning compositions including enzymes |
EP4001389A1 (en) | 2016-12-02 | 2022-05-25 | The Procter & Gamble Company | Cleaning compositions including enzymes |
WO2018102478A1 (en) | 2016-12-02 | 2018-06-07 | The Procter & Gamble Company | Cleaning compositions including enzymes |
EP3339413A1 (en) | 2016-12-22 | 2018-06-27 | The Procter & Gamble Company | Laundry detergent composition |
EP3339414A1 (en) | 2016-12-22 | 2018-06-27 | The Procter & Gamble Company | Laundry detergent composition |
EP3339421A1 (en) | 2016-12-22 | 2018-06-27 | The Procter & Gamble Company | Laundry detergent composition |
WO2018118824A1 (en) | 2016-12-22 | 2018-06-28 | The Procter & Gamble Company | Laundry detergent composition |
WO2018118825A1 (en) | 2016-12-22 | 2018-06-28 | The Procter & Gamble Company | Laundry detergent composition |
EP3339415A1 (en) | 2016-12-22 | 2018-06-27 | The Procter & Gamble Company | Laundry detergent composition |
EP3339407A1 (en) | 2016-12-22 | 2018-06-27 | The Procter & Gamble Company | Laundry detergent composition |
EP3339419A1 (en) | 2016-12-22 | 2018-06-27 | The Procter & Gamble Company | Laundry detergent composition |
EP3339417A1 (en) | 2016-12-22 | 2018-06-27 | The Procter & Gamble Company | Laundry detergent composition |
EP3339416A1 (en) | 2016-12-22 | 2018-06-27 | The Procter & Gamble Company | Laundry detergent composition |
EP3339418A1 (en) | 2016-12-22 | 2018-06-27 | The Procter & Gamble Company | Laundry detergent composition |
EP3339420A1 (en) | 2016-12-22 | 2018-06-27 | The Procter & Gamble Company | Laundry detergent composition |
WO2018144399A1 (en) | 2017-02-01 | 2018-08-09 | The Procter & Gamble Company | Cleaning compositions comprising amylase variants |
EP3357994A1 (en) | 2017-02-01 | 2018-08-08 | The Procter & Gamble Company | Cleaning compositions comprising amylase variants |
EP3546558A1 (en) | 2018-03-28 | 2019-10-02 | The Procter & Gamble Company | Laundry detergent composition |
WO2019191174A1 (en) | 2018-03-28 | 2019-10-03 | The Procter & Gamble Company | Laundry detergent composition |
WO2019191173A1 (en) | 2018-03-28 | 2019-10-03 | The Procter & Gamble Company | Process for preparing a spray-dried laundry detergent particle |
WO2019191172A1 (en) | 2018-03-28 | 2019-10-03 | The Procter & Gamble Company | Process for preparing a spray-dried laundry detergent particle |
WO2019191171A1 (en) | 2018-03-28 | 2019-10-03 | The Procter & Gamble Company | Laundry detergent composition |
WO2019190794A1 (en) | 2018-03-28 | 2019-10-03 | The Procter & Gamble Company | Spray-drying process |
WO2019191170A1 (en) | 2018-03-28 | 2019-10-03 | The Procter & Gamble Company | Laundry detergent composition |
EP3546554A1 (en) | 2018-03-28 | 2019-10-02 | The Procter & Gamble Company | Spray-drying process |
EP3546559A1 (en) | 2018-03-28 | 2019-10-02 | The Procter & Gamble Company | Laundry detergent composition |
EP3546557A1 (en) | 2018-03-28 | 2019-10-02 | The Procter & Gamble Company | Catalase inhibition during a laundering process |
US11505768B2 (en) | 2018-03-28 | 2022-11-22 | The Procter & Gamble Company | Process for preparing a spray-dried laundry detergent particle |
WO2020013959A1 (en) | 2018-07-12 | 2020-01-16 | The Procter & Gamble Company | A solid free-flowing particulate laundry detergent composition |
EP3594319A1 (en) | 2018-07-12 | 2020-01-15 | The Procter & Gamble Company | A solid free-flowing particulate laundry detergent composition |
CN113302295A (en) * | 2018-12-03 | 2021-08-24 | 诺维信公司 | Powder detergent composition |
WO2020222996A1 (en) | 2019-04-29 | 2020-11-05 | The Procter & Gamble Company | A process for making a laundry detergent composition |
EP3754010A1 (en) | 2019-06-17 | 2020-12-23 | The Procter & Gamble Company | A solid free-flowing particulate laundry detergent composition comprises a detersive surfactant and a linear polyamine salt |
WO2020264552A1 (en) | 2019-06-24 | 2020-12-30 | The Procter & Gamble Company | Cleaning compositions comprising amylase variants |
WO2021081547A3 (en) * | 2019-10-24 | 2021-06-03 | The Procter & Gamble Company | Automatic dishwashing detergent composition comprising a protease |
CN114585719A (en) * | 2019-10-24 | 2022-06-03 | 宝洁公司 | Automatic dishwashing detergent composition comprising protease |
EP3936595A1 (en) | 2020-07-06 | 2022-01-12 | The Procter & Gamble Company | A process for making a particulate laundry detergent composition |
WO2022010753A1 (en) | 2020-07-06 | 2022-01-13 | The Procter & Gamble Company | A process for making a particulate laundry detergent composition |
WO2022077022A1 (en) | 2020-10-09 | 2022-04-14 | The Procter & Gamble Company | Packaged laundry detergent product |
WO2022178432A1 (en) | 2021-02-22 | 2022-08-25 | Danisco Us Inc. | Methods and compositions for producing proteins of interest in pigment deficient bacillus cells |
EP4108756A1 (en) | 2021-06-25 | 2022-12-28 | The Procter & Gamble Company | A laundry detergent powder |
WO2022271931A1 (en) | 2021-06-25 | 2022-12-29 | The Procter & Gamble Company | A laundry detergent powder |
WO2022271930A1 (en) | 2021-06-25 | 2022-12-29 | The Procter & Gamble Company | A process for making a packaged laundry detergent powder |
EP4108754A1 (en) | 2021-06-25 | 2022-12-28 | The Procter & Gamble Company | A process for making a packaged laundry detergent powder |
EP4123005A1 (en) | 2021-07-19 | 2023-01-25 | The Procter & Gamble Company | Cleaning composition comprising bacterial spores |
WO2023004213A1 (en) | 2021-07-19 | 2023-01-26 | The Procter & Gamble Company | Cleaning composition comprising bacterial spores |
EP4212608A1 (en) | 2022-01-14 | 2023-07-19 | The Procter & Gamble Company | A method of making a spray-dried laundry detergent particle |
WO2023137306A1 (en) | 2022-01-14 | 2023-07-20 | The Procter & Gamble Company | A method of making a spray-dried laundry detergent particle |
WO2023150905A1 (en) | 2022-02-08 | 2023-08-17 | The Procter & Gamble Company | A method of laundering fabric |
WO2023150903A1 (en) | 2022-02-08 | 2023-08-17 | The Procter & Gamble Company | A method of laundering fabric |
EP4234672A1 (en) | 2022-02-24 | 2023-08-30 | The Procter & Gamble Company | Water-soluble unit dose article comprising a fibrous non-woven sheet and a hueing dye particle |
EP4234666A1 (en) | 2022-02-24 | 2023-08-30 | The Procter & Gamble Company | Water-soluble unit dose article comprising a fibrous non-woven sheet and a surfactant system |
WO2023164353A1 (en) | 2022-02-24 | 2023-08-31 | The Procter & Gamble Company | Water-soluble unit dose article comprising a fibrous non-woven sheet and a hueing dye particle |
WO2023164354A1 (en) | 2022-02-24 | 2023-08-31 | The Procter & Gamble Company | Water-soluble unit dose article comprising a fibrous non-woven sheet and a surfactant system |
WO2023225459A2 (en) | 2022-05-14 | 2023-11-23 | Novozymes A/S | Compositions and methods for preventing, treating, supressing and/or eliminating phytopathogenic infestations and infections |
EP4279570A1 (en) | 2022-05-19 | 2023-11-22 | The Procter & Gamble Company | A process for making a particulate laundry detergent composition |
WO2023224761A1 (en) | 2022-05-19 | 2023-11-23 | The Procter & Gamble Company | A process for making a particulate laundry detergent composition |
EP4299701A1 (en) | 2022-06-27 | 2024-01-03 | The Procter & Gamble Company | A solid free-flowing particulate laundry detergent composition |
EP4299704A1 (en) | 2022-06-27 | 2024-01-03 | The Procter & Gamble Company | A method of laundering and drying fabric |
EP4299703A1 (en) | 2022-06-27 | 2024-01-03 | The Procter & Gamble Company | A solid free-flowing particulate laundry detergent composition |
EP4299702A1 (en) | 2022-06-27 | 2024-01-03 | The Procter & Gamble Company | A solid free-flowing particulate laundry detergent composition |
WO2024006656A1 (en) | 2022-06-27 | 2024-01-04 | The Procter & Gamble Company | A solid free-flowing particulate laundry detergent composition |
WO2024006658A1 (en) | 2022-06-27 | 2024-01-04 | The Procter & Gamble Company | A method of laundering and drying fabric |
WO2024006655A1 (en) | 2022-06-27 | 2024-01-04 | The Procter & Gamble Company | A solid free-flowing particulate laundry detergent composition |
WO2024006654A1 (en) | 2022-06-27 | 2024-01-04 | The Procter & Gamble Company | A solid free-flowing particulate laundry detergent composition |
WO2024064184A1 (en) | 2022-09-21 | 2024-03-28 | Milliken & Company | Coloured fabric hueing dye agent particles |
EP4342969A1 (en) | 2022-09-21 | 2024-03-27 | The Procter & Gamble Company | A solid detergent cleaning composition |
WO2024064711A1 (en) | 2022-09-21 | 2024-03-28 | The Procter & Gamble Company | A solid detergent cleaning composition |
EP4342970A1 (en) | 2022-09-21 | 2024-03-27 | Milliken & Company | Coloured fabric hueing dye agent particles |
WO2024097149A1 (en) | 2022-11-01 | 2024-05-10 | The Procter & Gamble Company | Sealing jaws and water-soluble unit dose article comprising a fibrous non-woven sheet |
EP4364930A1 (en) | 2022-11-01 | 2024-05-08 | The Procter & Gamble Company | Sealing jaws and water-soluble unit dose article comprising a fibrous non-woven sheet |
WO2024097150A1 (en) | 2022-11-01 | 2024-05-10 | The Procter & Gamble Company | Sealing jaws and water-soluble unit dose article comprising a fibrous non-woven sheet |
EP4364929A1 (en) | 2022-11-01 | 2024-05-08 | The Procter & Gamble Company | Sealing jaws and water-soluble unit dose article comprising a fibrous non-woven sheet |
EP4382592A1 (en) | 2022-12-06 | 2024-06-12 | The Procter & Gamble Company | Water-soluble unit dose article comprising a fibrous non-woven sheet and a surfactant system |
WO2024123757A1 (en) | 2022-12-06 | 2024-06-13 | The Procter & Gamble Company | Water-soluble unit dose article comprising a fibrous non-woven sheet and a surfactant system |
EP4389867A1 (en) | 2022-12-23 | 2024-06-26 | The Procter & Gamble Company | A process of making a laundry detergent article |
EP4389866A1 (en) | 2022-12-23 | 2024-06-26 | The Procter & Gamble Company | A process of making a water-soluble detergent unit dose article |
WO2024137568A1 (en) | 2022-12-23 | 2024-06-27 | The Procter & Gamble Company | A process of making a water-soluble detergent unit dose article |
WO2024137571A1 (en) | 2022-12-23 | 2024-06-27 | The Procter & Gamble Company | A process of making a laundry detergent article |
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP3095861B1 (en) | Consumer products with protease variants | |
US20130123162A1 (en) | Consumer products | |
US20210071113A1 (en) | Fabric and home care products | |
EP3486319B1 (en) | Compositions and methods comprising serine protease variants | |
EP2914720B1 (en) | Compositions and methods comprising thermolysin protease variants | |
US20200299618A1 (en) | Compositions and methods comprising serine protease variants | |
EP2705145B1 (en) | Compositions and methods comprising serine protease variants | |
AU2016323412A1 (en) | Detergent compositions comprising polypeptides having xanthan degrading activity |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WWE | Wipo information: entry into national phase |
Ref document number: 201180022738.2 Country of ref document: CN |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 11720664 Country of ref document: EP Kind code of ref document: A1 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 9423/DELNP/2012 Country of ref document: IN |
|
ENP | Entry into the national phase |
Ref document number: 2013509256 Country of ref document: JP Kind code of ref document: A |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWE | Wipo information: entry into national phase |
Ref document number: MX/A/2012/012913 Country of ref document: MX |
|
REEP | Request for entry into the european phase |
Ref document number: 2011720664 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2011720664 Country of ref document: EP |
|
ENP | Entry into the national phase |
Ref document number: 2012144735 Country of ref document: RU Kind code of ref document: A |
|
REG | Reference to national code |
Ref country code: BR Ref legal event code: B01A Ref document number: 112012028466 Country of ref document: BR |
|
ENP | Entry into the national phase |
Ref document number: 112012028466 Country of ref document: BR Kind code of ref document: A2 Effective date: 20121106 |